Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,28187,-0.113713109033963,0.00291000157785336,-0.119416712126556,-0.10800950594137,0
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,28091,-0.209155138628505,0.00602667678935948,-0.22096742513565,-0.19734285212136,1.93218174172757e-258
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,27562,-0.287855714999286,0.00829766257794748,-0.304119133652063,-0.271592296346509,3.85537273681513e-258
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,28500,0.260912701114168,0.00820070698345531,0.244839315426596,0.27698608680174,2.5967100852988e-218
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,23071,-0.193191364480272,0.00652986917062264,-0.205989908054692,-0.180392820905852,7.66316479517461e-189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,23862,-0.0790860394761427,0.00272968654738588,-0.0844362251090191,-0.0737358538432664,2.02279891988167e-181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,23198,-0.0964166908551012,0.00343732998148487,-0.103153857618812,-0.0896795240913909,2.78800344486843e-170
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,23872,0.0990045704777477,0.00359543586931982,0.0919575161738809,0.106051624781615,2.40172444904693e-164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,23846,-0.149319072773278,0.00559808272790473,-0.160291314919971,-0.138346830626585,1.78113909391317e-154
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,23872,0.0440456092955392,0.00167252137329563,0.0407674674038797,0.0473237511871986,1.08985366558962e-150
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,28239,-0.138502598660945,0.00548531388311757,-0.149253813871856,-0.127751383450035,4.00385572701778e-139
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,28452,-0.0594152817180616,0.00249841299781476,-0.0643121711937785,-0.0545183922423447,8.46558421211105e-124
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,28320,0.0448592434204284,0.0018917001101791,0.0411515112044774,0.0485669756363794,4.13895818370347e-123
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,28224,-0.0982101101113146,0.00419260493162556,-0.106427615777301,-0.0899926044453285,3.37552236526731e-120
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,28148,-0.156832077791396,0.00689222461348096,-0.170340838033819,-0.143323317548973,1.36191227912638e-113
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,28307,0.0497539555826696,0.00222687238334838,0.0453892857113067,0.0541186254540324,1.2690735950517e-109
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,23738,-0.108494666487639,0.00487616434601619,-0.118051948605831,-0.0989373843694477,1.45554694114363e-108
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,27791,0.0807474622032974,0.00364168218162988,0.0736097651273028,0.0878851592792919,5.4074347432529e-108
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,28091,-0.0609175390338009,0.00278467186744363,-0.0663754958939904,-0.0554595821736114,3.3294628998284e-105
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,28521,-0.07689665411891,0.00351968717735126,-0.0837952409865185,-0.0699980672513016,5.96164950867501e-105
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,28321,-0.0505705174080329,0.00232164346465341,-0.0551209385987536,-0.0460200962173122,2.46487296027867e-104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),23428,0.261502217980355,0.0121006856391883,0.237784874127546,0.285219561833164,1.43794688604269e-102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,28452,-0.0934719672164195,0.00440805455050199,-0.102111754135403,-0.0848321802974356,5.04482844571799e-99
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,28091,-0.0509457862018287,0.00244398391327602,-0.0557359946718497,-0.0461555777318077,8.93229878269653e-96
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,28292,-0.0461726662954673,0.00221603339962334,-0.050516091758729,-0.0418292408322055,1.0768332194602e-95
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,28336,0.0530404775106464,0.00258312744169036,0.0479775477249333,0.0581034072963595,5.15707799687591e-93
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,28521,-0.0393350308249344,0.00192667329146222,-0.0431113104762004,-0.0355587511736684,5.48624049409631e-92
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,23872,0.0691862555716808,0.00349123425486195,0.0623434364321513,0.0760290747112102,1.05632540146572e-86
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,27682,-0.112367700655087,0.00567644659080499,-0.123493535973064,-0.101241865337109,1.29763315367062e-86
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,28494,0.083535655990975,0.00422928901944177,0.0752462495128691,0.0918250624690809,2.93476909540793e-86
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,27529,-0.0791672999328875,0.00404696818452156,-0.0870993575745497,-0.0712352422912252,1.22388951894766e-84
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,27682,-0.0688784221426784,0.00352960603960059,-0.0757964499802955,-0.0619603943050612,3.05089033129508e-84
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,28307,-0.0442195602204676,0.0022698292329465,-0.0486684255170428,-0.0397706949238925,5.60697329866767e-84
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,28404,-0.153550795976427,0.00806356701312517,-0.169355387322152,-0.137746204630702,2.40348410683274e-80
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,28182,0.227948173511969,0.0120377085296817,0.204354264793793,0.251542082230145,1.79157847513234e-79
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,23872,0.0619897757667084,0.00327651325410535,0.0555678097886619,0.0684117417447548,3.00329354463097e-79
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,26272,-0.0522042591047594,0.00276958088159342,-0.0576326376326825,-0.0467758805768363,9.89137828964971e-79
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,27418,-0.0696546650825924,0.00374723336395452,-0.0769992424759433,-0.0623100876892415,1.18448973570487e-76
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,23737,-0.107296435230458,0.00578320200894323,-0.118631511167987,-0.0959613592929297,2.66959608733741e-76
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,27544,-0.0636210614619736,0.00349568187932496,-0.0704725979454505,-0.0567695249784967,1.39754808577812e-73
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,28187,-0.0657123195837567,0.00362101123662262,-0.0728095016075371,-0.0586151375599764,3.51209789398404e-73
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,23846,-0.112282257730476,0.00620665606261455,-0.124447303613201,-0.100117211847752,1.15814482395624e-72
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,23188,-0.150543588390395,0.00834411215410564,-0.166898048212442,-0.134189128568347,2.85492319266243e-72
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,28174,-0.102754351579105,0.00573491590732596,-0.113994786757464,-0.0915139164007462,2.15404020788749e-71
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,28253,0.0240567156821029,0.00134302970118255,0.0214243774677851,0.0266890538964207,2.35033638199962e-71
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,27910,-0.0882092525838865,0.00492736071595242,-0.0978668795871532,-0.0785516255806197,2.85595025345263e-71
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,23337,-0.063367284253592,0.00353958208221012,-0.0703048651347238,-0.0564297033724601,3.38132846131741e-71
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,28224,0.0565373149600722,0.00318786774107961,0.0502890941875562,0.0627855357325883,5.38975447509213e-70
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,23198,-0.0713259658377424,0.00407307404994168,-0.0793091909756281,-0.0633427406998567,3.21525090100197e-68
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,23862,-0.0390061992567169,0.0022340873325358,-0.0433850104284871,-0.0346273880849468,7.69721599886931e-68
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,23893,0.0784973013018283,0.0045734751922965,0.0695332899249272,0.0874613126787294,1.23216797689176e-65
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,23862,0.0679424583216729,0.00401243888638199,0.0600780781043642,0.0758068385389816,6.08209941127733e-64
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,23725,-0.0629554368076931,0.00375715010955585,-0.0703194510224225,-0.0555914225929636,1.17134412098537e-62
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,27702,-0.0622798656048047,0.00373679458972075,-0.0696039830006574,-0.0549557482089521,4.59912614976338e-62
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,27562,-0.0859902354610073,0.00522010040836298,-0.0962216322613988,-0.0757588386606159,1.12116125858659e-60
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,27338,-0.112622717117457,0.00685200224007537,-0.126052641508004,-0.0991927927269088,2.04564974592255e-60
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,28091,-0.0893849692739438,0.0054656660908789,-0.100097674812066,-0.0786722637358211,7.71914618805042e-60
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,28091,-0.0393039405482608,0.00241409662516614,-0.0440355699335865,-0.0345723111629352,2.51857248717198e-59
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,28176,-0.0434640928485694,0.00267216192744021,-0.0487015302263522,-0.0382266554707865,3.23037773745752e-59
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,28344,-0.0660197529311532,0.00407038800306928,-0.073997713417169,-0.0580417924451374,6.76568581126434e-59
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23198,-0.062852676714876,0.0038859835219832,-0.0704692044179631,-0.0552361490117889,1.6042089518356e-58
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,23846,-0.0287391998710871,0.00178659637908506,-0.0322409287740938,-0.0252374709680804,6.45787587460031e-58
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,28307,-0.0270315444233787,0.00168843895501124,-0.0303408847752007,-0.0237222040715567,1.95308163811715e-57
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23322,-0.0515157250420511,0.00322165090252969,-0.0578301608110093,-0.0452012892730929,3.00321343676769e-57
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,28224,-0.0370220369634628,0.00231651508550846,-0.0415624065310594,-0.0324816673958662,3.05489980370667e-57
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,28404,-0.0457176870861383,0.00286726349983006,-0.0513375235458052,-0.0400978506264714,5.4842423443619e-57
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,28236,-0.0338901757302211,0.00215207644989878,-0.0381082455720227,-0.0296721058884195,1.23025481999441e-55
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,28176,-0.0429926152072551,0.00273054115694483,-0.048344475874867,-0.0376407545396432,1.28237517545688e-55
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,28187,-0.0438670413560955,0.00279178628886519,-0.0493389424822713,-0.0383951402299198,2.12233008947909e-55
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,28176,-0.0568652673107577,0.00362223248642228,-0.0639648429841453,-0.04976569163737,2.63954672325765e-55
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,28313,-0.0696105198137456,0.0044388428913426,-0.0783106518807771,-0.0609103877467141,3.42382290577542e-55
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,23337,-0.0303888267238931,0.00194227515453603,-0.0341956860267837,-0.0265819674210025,6.73050794937058e-55
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,23337,-0.0525767377808873,0.003363161549739,-0.0591685344183757,-0.0459849411433988,8.22012973092461e-55
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,27554,-0.0524433419275107,0.00336995606826192,-0.0590484558213041,-0.0458382280337174,2.24843956457727e-54
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,28044,-0.0784036983426274,0.00505340586868134,-0.0883083738452428,-0.068499022840012,4.60929936308055e-54
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,28553,-0.0530418396633157,0.00341969423891315,-0.0597444403715854,-0.0463392389550459,4.88263256855921e-54
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",28091,-0.0860433046462347,0.00555278313635555,-0.0969267595934916,-0.0751598496989778,6.22226402626687e-54
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,23337,0.0319021141356271,0.00207595241388527,0.027833247404412,0.0359709808668423,4.92442103919871e-53
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,23163,-0.0841866866062776,0.00550159603010492,-0.0949698148252832,-0.0734035583872719,1.33708602933854e-52
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,28367,0.028714602656841,0.00189248341903201,0.0250053351555382,0.0324238701581437,8.53430007447627e-52
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,23337,-0.0780139602323642,0.00514582325820081,-0.0880997738184378,-0.0679281466462906,1.13661164850801e-51
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,27702,-0.0819368044449741,0.0054206568136722,-0.0925612917997716,-0.0713123170901766,2.04887104069993e-51
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,27682,-0.0676389328157576,0.00450004905565558,-0.0764590289648426,-0.0588188366666727,7.33901010837807e-51
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,28428,-0.0242544031010359,0.00163638370371275,-0.0274617151603129,-0.0210470910417589,1.61838703521471e-49
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,28428,-0.140264312600816,0.00946503278946285,-0.158815776868163,-0.121712848333469,1.6853167487339e-49
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,28187,0.0271257762302805,0.00183349691052663,0.0235321222856483,0.0307194301749127,2.43372808631092e-49
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,23893,-0.0196112212528841,0.00132513477741011,-0.0222084854166079,-0.0170139570891603,2.44525280293925e-49
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27562,-0.0638468861930899,0.00432884375463916,-0.0723314199521827,-0.0553623524339972,4.793006114582e-49
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,27795,-0.0292593779446826,0.00198859500650287,-0.0331570241574282,-0.025361731731937,8.05330874811464e-49
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,27918,-0.0521733615495375,0.00356619641654543,-0.0591631065259666,-0.0451836165731085,2.73106805722603e-48
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,28135,-0.0500425300344127,0.00343248484078248,-0.0567702003223464,-0.0433148597464791,5.71100876538541e-48
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,28097,-0.0304010221452878,0.00210284200999854,-0.034522592484885,-0.0262794518056907,3.34149340134235e-47
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,28187,-0.0368981770441991,0.00255818393109081,-0.0419122175491371,-0.0318841365392612,5.40906831338708e-47
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,28452,-0.0279793603969823,0.00194205095604313,-0.0317857802708268,-0.0241729405231377,6.82927812189478e-47
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,28452,-0.0450143443534396,0.00313394856744549,-0.0511568835456328,-0.0388718051612465,1.27779968855313e-46
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,28176,-0.0269046468227542,0.00188074274817789,-0.0305909026091828,-0.0232183910363255,2.94469553952522e-46
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,28091,-0.054705752860291,0.00383506140589165,-0.0622224732158387,-0.0471890325047434,5.26492702697844e-46
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,27705,-0.0765033106009905,0.00536484247771568,-0.0870184018573132,-0.0659882193446678,5.64299312909801e-46
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,28145,-0.0191822763802131,0.00135581576049863,-0.0218396752707904,-0.0165248774896358,2.74278371164908e-45
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,28452,0.0343185628463718,0.00242661435183476,0.0295623987167756,0.0390747269759679,2.95592129395286e-45
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,27562,-0.0569533494892976,0.00404011022429391,-0.0648719655289137,-0.0490347334496815,5.68286955244664e-45
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,28187,0.0274829604204563,0.00195294872767667,0.02365518091421,0.0313107399267026,7.94814215885178e-45
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,28396,-0.029941804204987,0.00213561185713806,-0.0341276034449776,-0.0257560049649964,1.65036669694589e-44
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,28091,-0.0664606995615936,0.00474370563092469,-0.075758362598206,-0.0571630365249812,1.90397393618892e-44
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,27840,-0.0363142426739612,0.00259236800431995,-0.0413952839624283,-0.0312332013854941,1.96832779830702e-44
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,23198,-0.0608565897396291,0.00434407972071563,-0.0693709859922318,-0.0523421934870265,2.08165126410881e-44
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,27682,-0.0521521432290094,0.00373604064131463,-0.059474782885986,-0.0448295035720327,3.90431143893867e-44
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,28091,-0.0413463267114539,0.00296249040051125,-0.047152807896456,-0.0355398455264519,4.02757378269412e-44
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,23846,-0.0267473386338208,0.00192505958088994,-0.0305204554123651,-0.0229742218552766,1.01611667585553e-43
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,28091,-0.0747212216555589,0.00541652888266989,-0.0853376182655919,-0.0641048250455259,3.77619841312657e-43
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23188,-0.0418334355113206,0.00303965720507409,-0.0477911636332658,-0.0358757073893754,6.31730550156855e-43
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,27965,-0.0660201781600578,0.00485037847253398,-0.0755269199662244,-0.0565134363538912,4.66989776256527e-42
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,23775,0.0338314683659235,0.00250014946216104,0.0289311754200879,0.0387317613117592,1.44781309257045e-41
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,27965,-0.0385161796750589,0.00285176458734547,-0.044105638266256,-0.0329267210838618,1.94261317838527e-41
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,23521,-0.0238875103425526,0.00177905625922533,-0.0273744606106343,-0.020400560074471,5.94229448023156e-41
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,28176,-0.0300987887810504,0.00224422220285891,-0.0344974642986538,-0.0257001132634469,6.89770437466152e-41
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,28373,-0.0529786300590219,0.00396926039125535,-0.0607583804258824,-0.0451988796921614,1.62943204425816e-40
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,28363,-0.0440280861127495,0.00330708194791367,-0.0505099667306603,-0.0375462054948387,2.56167189000966e-40
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,27850,-0.0428869216471419,0.00323164460724099,-0.0492209450773343,-0.0365528982169496,4.51870385079732e-40
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,28224,0.0338538789901446,0.00255222104550977,0.0288515257409455,0.0388562322393438,4.90396710488447e-40
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,23775,-0.117670752630376,0.00888738426183004,-0.135090025783563,-0.100251479477189,7.11844636903621e-40
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,28384,-0.0275614384549251,0.00208372298156063,-0.0316455354987839,-0.0234773414110663,8.03994066853616e-40
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,28307,-0.0484163206976998,0.00366214423453813,-0.0555941233973945,-0.0412385179980051,8.73977920958595e-40
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,27785,-0.132145421516608,0.00999591071358095,-0.151737406515227,-0.11255343651799,8.87880596533027e-40
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,28307,-0.0197998531336013,0.00150782898478425,-0.0227551979437785,-0.0168445083234242,2.83664157658543e-39
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,23071,-0.0555942317536747,0.00423830508677769,-0.063901309723759,-0.0472871537835904,3.63080545624194e-39
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,28521,-0.0270494095995834,0.00206342653836173,-0.0310937256147724,-0.0230050935843944,3.79734566068477e-39
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,27562,-0.056270129906598,0.00429869823253079,-0.0646955784423583,-0.0478446813708376,4.9101053069337e-39
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,28091,-0.0605412673615443,0.00463283732342807,-0.0696216285154633,-0.0514609062076253,6.5290353556378e-39
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,28187,0.028142566675869,0.00217139400920012,0.0238866344178367,0.0323984989339012,2.63387840405836e-38
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,23846,-0.0259752256394648,0.00202962922257259,-0.029953298915707,-0.0219971523632225,2.23335322990245e-37
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,28326,-0.0593738005948476,0.00464572750965898,-0.0684794265137792,-0.050268174675916,2.67889474103449e-37
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,27544,-0.0531224510409548,0.00417217631436482,-0.0612999166171099,-0.0449449854647998,4.95969665692e-37
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,23846,-0.0569024163613081,0.00448603039797238,-0.0656950359413339,-0.0481097967812822,9.49329009595444e-37
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,23795,-0.0379609449091351,0.00300136094211222,-0.043843612355675,-0.0320782774625951,1.50676384957389e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,23846,-0.0301461993657788,0.00238896077132744,-0.0348285624775806,-0.0254638362539771,2.17049029996989e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,23893,0.0221876817604686,0.00177237445305877,0.0187138278324734,0.0256615356884638,7.65318855916959e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,23725,-0.0322788813838345,0.00258197094600552,-0.0373395444380053,-0.0272182183296636,9.48071179794765e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,27940,-0.0312571861886161,0.00252192588466999,-0.0362001609225693,-0.026314211454663,3.47816203548926e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,23337,-0.0327117279226717,0.00264502953981561,-0.0378959858207103,-0.0275274700246331,5.0619376182231e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,23738,-0.0933923539047357,0.00755470177178923,-0.108199569377443,-0.0785851384320288,5.3682056794056e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,28176,-0.0403894912662331,0.00326887444258171,-0.0467964851736933,-0.033982497358773,5.58633623294132e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,23337,-0.0277812222560149,0.00225967521849333,-0.0322101856842618,-0.023352258827768,1.24368356779246e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,28452,0.0384036445701435,0.00314234763061657,0.032244643214135,0.044562645926152,2.91541258999798e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,28091,0.0164581113315968,0.00134823091194527,0.013815578744184,0.0191006439190095,3.47428741866574e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,28224,-0.0529245828628041,0.00433839077934688,-0.061427828790324,-0.0444213369352843,3.83041621190849e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,28091,-0.0328206531380886,0.00269243298066535,-0.0380978217801926,-0.0275434844959845,4.28808641579773e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,23725,-0.0432696886340713,0.00356309911217001,-0.0502533628939245,-0.0362860143742181,7.79663273148873e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,28176,0.032312081031918,0.00267273058468996,0.0270735290859257,0.0375506329779103,1.45285270966126e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,23337,-0.0187705495979379,0.00155746929369805,-0.0218231894135861,-0.0157179097822897,2.37979844730596e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,28452,-0.0280369868060481,0.00233337421875188,-0.0326104002748018,-0.0234635733372944,3.53895990000249e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,28553,0.0202122288942338,0.00168224233928847,0.0169150339092284,0.0235094238792392,3.56181688206072e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,28553,0.023554302881719,0.00196580930606576,0.0197013166418301,0.0274072891216079,5.29999178582449e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,28452,-0.0203431818068913,0.00169833647742058,-0.0236719213026357,-0.017014442311147,5.54349170142421e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,28174,-0.0794267987282937,0.00665369962934764,-0.0924680500018151,-0.0663855474547724,9.08208911014063e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,28091,-0.0484342451248769,0.00405969949810181,-0.0563912561411565,-0.0404772341085974,9.84933272960821e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,28091,0.0331800815003036,0.00279238521540751,0.0277070064781049,0.0386531565225024,1.74940300759027e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,28276,0.0364710536915964,0.00307037350670766,0.0304531216184494,0.0424889857647434,1.83185193140863e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,28320,-0.0624259298375443,0.0052566858453192,-0.0727290340943699,-0.0521228255807186,1.89445831278325e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,28244,-0.0424043572053228,0.00357136000588701,-0.0494042228168614,-0.0354044915937843,1.9428971376254e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,23775,-0.0571078120022593,0.00480991610036073,-0.0665352475589664,-0.0476803764455523,2.02107582210539e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,28195,-0.0442648096504949,0.00373016821746457,-0.0515759393567255,-0.0369536799442644,2.10575736287692e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,23337,-0.021857074121366,0.00185372142904549,-0.0254903681222951,-0.0182237801204368,5.36020433433448e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,28452,-0.0213132021830445,0.00180889528133137,-0.024858636934454,-0.017767767431635,5.70639619642265e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,27965,-0.0290062465072398,0.00246820761135874,-0.0338439334255029,-0.0241685595889766,8.20020943685564e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,27965,-0.0471513336539343,0.00401942137476973,-0.055029399548483,-0.0392732677593857,1.05077874098985e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,28091,-0.0555579356189685,0.00475385149155024,-0.064875484542407,-0.04624038669553,1.75855347414901e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,23287,-0.029918108115504,0.00256644159168424,-0.0349483336352051,-0.0248878825958029,2.56991669358645e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,28122,-0.0427802787091238,0.0036711193361527,-0.0499756726079831,-0.0355848848102645,2.6088758741544e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,28307,-0.0317591609675257,0.00273278530615095,-0.0371154201675816,-0.0264029017674699,3.77053279884305e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,28452,-0.0267545320384236,0.00230531565743483,-0.0312729507269958,-0.0222361133498513,4.53635868971864e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,27562,-0.0648881513368818,0.00561789935134582,-0.0758992340655196,-0.053877068608244,8.66702642359592e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,28224,-0.0334197848760311,0.00290402938297834,-0.0391116824666686,-0.0277278872853935,1.40593070692779e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,28176,-0.0394777937695611,0.00343160464358233,-0.0462037388709825,-0.0327518486681398,1.47094611442842e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,28553,-0.0437549129173869,0.00380421815588928,-0.0512111805029299,-0.0362986453318439,1.51076993759961e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,28428,0.0292563475688493,0.00254859832656676,0.0242610948487784,0.0342516002889201,1.95464962019228e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,28176,0.0272206187082107,0.00238232890550257,0.0225512540534257,0.0318899833629958,3.6115541419756e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,28224,-0.027434406543598,0.00241133435454151,-0.0321606218784994,-0.0227081912086967,6.30737622878774e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23071,-0.0433699309987592,0.0038287232949261,-0.0508742286568144,-0.035865633340704,1.14864840685566e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,28521,-0.0289201956570809,0.00255787686623238,-0.0339336343148963,-0.0239067569992654,1.41159421282371e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,28091,-0.0666365099562584,0.00590041825761529,-0.0782013297411844,-0.0550716901713324,1.63573010426113e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,28224,-0.0468861933370285,0.00416389419549051,-0.0550474259601899,-0.038724960713867,2.38364192846038e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,28176,-0.0491715876742539,0.00436693490656564,-0.0577307800911225,-0.0406123952573852,2.38966251176041e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,28224,-0.0521845897065413,0.00463463987157182,-0.061268483854822,-0.0431006955582605,2.39694967581175e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,28091,-0.0553631694133841,0.00493785966614375,-0.0650413743590258,-0.0456849644677423,4.10699072297685e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,23862,-0.0413664902620357,0.00369779338072103,-0.0486141652882489,-0.0341188152358225,5.5874498779802e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,28291,0.0223488129310541,0.00201355396065732,0.0184022471681658,0.0262953786939425,1.4502424372537e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,23846,-0.0223504203793337,0.00201350753058064,-0.0262968951392718,-0.0184039456193957,1.47000533279785e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,28224,-0.0199339078507168,0.00179651760007417,-0.0234550823468622,-0.0164127333545715,1.50548107149651e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,23337,-0.0480597621668675,0.00435203049258993,-0.0565897419323437,-0.0395297824013912,2.78304219356396e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,28091,-0.0258308920711116,0.0023426749573508,-0.0304225349875191,-0.021239249154704,3.26308504372127e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,28521,-0.0340668485474691,0.00309143666738763,-0.0401260644155488,-0.0280076326793893,3.49907066792561e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,28452,-0.0959262076449757,0.00873351695119807,-0.113043900869324,-0.0788085144206275,5.21257062324654e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,28336,-0.0434014892200935,0.00395205282300308,-0.0511475127531795,-0.0356554656870074,5.31251659373973e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,28307,-0.0268499008113982,0.00244858115437947,-0.031649119873982,-0.0220506817488144,6.37362532549379e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,28127,-0.0219779551425628,0.00201643879850587,-0.0259301751876343,-0.0180257350974913,1.3177626252731e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,27544,-0.0381600320772355,0.00350496074373645,-0.0450297551349589,-0.031290309019512,1.50588689541111e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,22802,-0.0237962619356761,0.00218967136478066,-0.0280880178106462,-0.019504506060706,1.92261025485449e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",27682,-0.0680161379503524,0.00626641457936836,-0.0802983105259144,-0.0557339653747905,2.1659146165481e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,27965,-0.0544103009873509,0.00502240780439078,-0.0642542202839569,-0.044566381690745,2.70607947688619e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,28452,-0.0317246071095292,0.00293439400676879,-0.037476019362796,-0.0259731948562623,3.43759841116543e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,27965,-0.0384083430637855,0.00355288647736756,-0.0453720005594259,-0.031444685568145,3.47629062443098e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,23188,-0.0513284417870007,0.00475989382519272,-0.0606578336843784,-0.0419990498896229,4.77418392307693e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,27965,-0.0218608720824716,0.0020299837362538,-0.0258396402055291,-0.0178821039594142,5.44858095108961e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,23795,-0.0424120044838064,0.00394022651877503,-0.0501348484606055,-0.0346891605070073,5.88387493614021e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,23738,-0.0437243014967161,0.00406369564139944,-0.051689144953859,-0.0357594580395732,6.15311995995979e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,23198,-0.0392121363218004,0.00365446400589865,-0.0463748857733617,-0.032049386870239,8.51403167189544e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,23862,-0.0544369345934824,0.00510015090672738,-0.064433230370668,-0.0444406388162967,1.55311704745748e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,28428,-0.0316057735919175,0.00296707578927491,-0.0374212421388963,-0.0257903050449386,1.91116530956283e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,28320,0.014840710126943,0.00139839792754384,0.0120998501889571,0.0175815700649289,2.91600156864164e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,28176,-0.0393658293333325,0.00371801266757918,-0.0466531341617877,-0.0320785245048773,3.79903064561099e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,23893,0.018617875017697,0.00175936624708312,0.0151695171734141,0.0220662328619799,4.11972433014463e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,23337,0.0163900780101695,0.00154890299248656,0.0133542281448958,0.0194259278754432,4.15106929214804e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,28428,-0.0267331988551718,0.00253163972617391,-0.0316952127184727,-0.021771184991871,5.12275029325698e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,28091,-0.0376442135170719,0.00357135204054386,-0.0446440635165379,-0.0306443635176059,6.27633790427857e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23337,-0.0156727926923634,0.00148906451549532,-0.0185913591427343,-0.0127542262419926,7.55148809950263e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,28086,0.0451675744283778,0.00430447627503548,0.0367308009293083,0.0536043479274474,1.03626146807054e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,28182,-0.082077851127872,0.00782393245865483,-0.0974127587468355,-0.0667429435089086,1.06410917465093e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,28187,-0.022996404743227,0.00219313485359379,-0.0272949490562708,-0.0186978604301831,1.12145581614582e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,28521,-0.029336276480294,0.00281733288291848,-0.0348582489308142,-0.0238143040297738,2.40724803250506e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,23337,-0.026495847474192,0.00255020791461276,-0.031494254986833,-0.0214974399615509,3.13629099441101e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,23775,-0.0266051810436489,0.0025781170111353,-0.031658290385474,-0.0215520717018237,6.48540442819711e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,23893,-0.0503901716824204,0.00491428624415929,-0.0600221727209727,-0.0407581706438682,1.27960373985593e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,28176,-0.0528342904276743,0.00515735835624742,-0.0629427128059193,-0.0427258680494294,1.38434795987473e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,23862,-0.0260841706864599,0.00254594626241594,-0.0310742253607951,-0.0210941160121246,1.39602289862114e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,22764,0.0300969415249521,0.00294757425775718,0.024319695979748,0.0358741870701562,2.00391257407331e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,28144,-0.0586538055464936,0.00575057646556737,-0.0699249354190056,-0.0473826756739816,2.19454060698697e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,23893,-0.0246679358424188,0.00242206002251422,-0.0294151734865467,-0.0199206981982909,2.60243371167503e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,28553,-0.036092118453024,0.00355760334544842,-0.0430650210101029,-0.029119215895945,3.83036749219129e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,28553,-0.0407073551816739,0.00402487703767287,-0.0485961141755128,-0.0328185961878351,5.26007191824511e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,27544,-0.0392437552834518,0.00388137454248031,-0.0468512493867132,-0.0316362611801904,5.44985559625068e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,23530,-0.036707041328015,0.00363973974192464,-0.0438409312221873,-0.0295731514338427,7.19258177829231e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,23393,-0.0372624445420102,0.00369481130092751,-0.0445042746918281,-0.0300206143921923,7.19723252069371e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,28091,0.05280802067293,0.00524230036379698,0.0425331119598879,0.0630829293859721,7.9474105760652e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,27833,-0.0247862638521086,0.00246104386869338,-0.0296099098347476,-0.0199626178694696,8.11719417347568e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,28091,-0.0311113478294923,0.00310103831647187,-0.0371893829297772,-0.0250333127292074,1.20176232348289e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,23725,-0.0388867794594137,0.00388501684025117,-0.046501412466306,-0.0312721464525214,1.54303281372575e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,28336,0.0298563514959587,0.00298437200063023,0.0240069823747235,0.035705720617194,1.59765617273825e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,27544,-0.0190971143237733,0.00191217178546407,-0.0228449710232829,-0.0153492576242637,1.90235595711797e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,28277,-0.0225777710794162,0.0022631205113336,-0.02701348728163,-0.0181420548772023,2.11410939809867e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,23198,-0.0409291444132284,0.00410488348482668,-0.0489747160434887,-0.0328835727829681,2.27901997113251e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23198,-0.025013014172014,0.00250981627592112,-0.0299322540728194,-0.0200937742712086,2.39059194004775e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,23846,-0.0554123603401289,0.00556688650793745,-0.0663234578956863,-0.0445012627845715,2.69208865275725e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,27544,-0.0347011870788867,0.00349426212559008,-0.0415499408450432,-0.0278524333127301,3.34201024041825e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,27544,-0.0243118540281575,0.00245004096824526,-0.0291139343259182,-0.0195097737303968,3.61521443637488e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,28452,-0.043898062304757,0.0044295841511717,-0.0525800472410535,-0.0352160773684605,4.09782353742927e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",27544,-0.0355059926892103,0.00358631032210807,-0.0425351609205421,-0.0284768244578785,4.5301063100465e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,27376,-0.0584424822309905,0.00591676051704939,-0.0700393328444073,-0.0468456316175737,5.69722032007341e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,23832,0.0231084812793872,0.00234938213255843,0.0185036922995727,0.0277132702592017,8.70813485832002e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",28187,0.0162759299300726,0.00165643302475183,0.0130293212015591,0.0195225386585862,9.4754972020769e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27965,-0.0219961935738634,0.00224329332249273,-0.0263930484859491,-0.0175993386617776,1.16198158152602e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,23337,-0.0275086574225081,0.00281262966885592,-0.0330214115734657,-0.0219959032715505,1.5101275488655e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,28182,-0.0323090209294262,0.00330410271164165,-0.0387850622442438,-0.0258329796146085,1.513243052542e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,28233,-0.0430584311882335,0.00440855548219002,-0.051699199933326,-0.0344176624431411,1.69328069855455e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,23795,-0.0292155991957354,0.00299530535744123,-0.0350863976963202,-0.0233448006951506,1.95772761304854e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,23775,-0.05038954959299,0.00518424626187531,-0.0605506722662656,-0.0402284269197144,2.73332225809247e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,28224,-0.0512055080884118,0.00527125676815695,-0.0615371713539994,-0.0408738448228242,2.84543213432377e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,28176,-0.0339412484829667,0.00349668067821049,-0.0407947426122592,-0.0270877543536741,3.05918571102269e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,23775,-0.0209503739474535,0.00217281724102555,-0.0252090957398636,-0.0166916521550435,5.82826609619835e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,27562,-0.0421763384773317,0.00437602300828968,-0.0507533435735795,-0.033599333381084,5.981393176345e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,28553,0.0156380091319011,0.00162343110147019,0.0124560841730195,0.0188199340907826,6.28350462414352e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,28428,0.0301329049578299,0.00312944793117081,0.0239991870127351,0.0362666229029246,6.52582353578803e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,27562,-0.0376012066819792,0.0039068804570205,-0.0452586923777394,-0.029943720986219,6.83129822797536e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,28187,0.0245562809968887,0.00255221140598199,0.019553946641164,0.0295586153526134,7.00593091303818e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,27373,-0.0129097083315546,0.00134322601691214,-0.0155424313247024,-0.0102769853384068,7.78111753481827e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,28224,-0.0183509553208188,0.0019150845721655,-0.0221045210822632,-0.0145973895593744,1.02398284545461e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,28224,-0.0414557736183527,0.00433096119093163,-0.0499444575525787,-0.0329670896841267,1.1316699291604e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,27562,-0.046602599518756,0.00489359182176239,-0.0561940394894103,-0.0370111595481017,1.81226448614587e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,23589,-0.0175960291369279,0.00184788806262719,-0.0212178897396772,-0.0139741685341786,1.852421853925e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,23846,-0.0385760713383142,0.00405284930514846,-0.0465196559764052,-0.0306324867002232,1.92259210363045e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,27682,-0.0244834493530441,0.00257376527379988,-0.0295280292896918,-0.0194388694163963,2.00342582334846e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,28187,-0.0421829850036954,0.00443913641789427,-0.0508836923827682,-0.0334822776246227,2.20559727901306e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,28336,0.0377120143047041,0.00397661805141073,0.0299178429239391,0.0455061856854691,2.64623926004174e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,23862,-0.0728951714335548,0.00769060386712082,-0.0879687550131116,-0.057821587853998,2.81284051786383e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,28192,-0.0280486025620684,0.00296261558802027,-0.0338553291145882,-0.0222418760095487,3.08198471092197e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,27544,-0.0224696108837617,0.00238204565575631,-0.0271384203690441,-0.0178008013984793,4.29241917147017e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,28422,-0.0364282895971655,0.00386459870599403,-0.0440029030609138,-0.0288536761334173,4.56665346898886e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27682,-0.0226651437881032,0.00240984997105958,-0.0273884497313799,-0.0179418378448264,5.58110896205889e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,23738,-0.0541352045456937,0.00576140701939516,-0.0654275623037083,-0.0428428467876792,6.15261196463827e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,28132,0.0308232352272326,0.00328106075228078,0.0243923561527623,0.0372541143017029,6.18229882214932e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,27562,-0.0356941898329886,0.00380313465806325,-0.0431483337627925,-0.0282400459031846,6.73055615111224e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,27544,-0.0414345970474715,0.00442038084873411,-0.0500985435109904,-0.0327706505839527,7.53446167453467e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,23775,-0.0394041663725856,0.00420347961740481,-0.047642986422699,-0.0311653463224722,7.57414325033837e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,28521,-0.0209484881646522,0.00223633617527717,-0.0253317070681955,-0.016565269261109,7.97014055712912e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,27702,-0.0336745990709441,0.00359596051736717,-0.0407226816849837,-0.0266265164569044,8.19735820065145e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,27562,-0.0376181228088908,0.00402281058191972,-0.0455028315494534,-0.0297334140683281,9.30153131174348e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,28091,-0.0349305393749474,0.00373813353573814,-0.0422572811049941,-0.0276037976449006,9.90613138500451e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,28113,-0.0435830760850737,0.00467771017766896,-0.0527513880333049,-0.0344147641368426,1.27934929593576e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,23585,-0.0202142528448988,0.00217152793134543,-0.0244704475903358,-0.0159580580994617,1.40270832340681e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,28137,-0.0527099833232085,0.00566494310294467,-0.06381327180498,-0.0416066948414369,1.43975824045066e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,23738,-0.0633142330652393,0.0068139469158039,-0.0766695690202149,-0.0499588971102637,1.64272462612933e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,23198,-0.0328883498280056,0.00354141357202554,-0.0398295204291757,-0.0259471792268356,1.72581632835435e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,28336,-0.0338821108415551,0.00365408863326253,-0.0410441245627497,-0.0267200971203606,1.94573167358797e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,28176,-0.0444518049218563,0.00479452589475542,-0.0538490756755769,-0.0350545341681357,1.9650670997508e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,27641,-0.0377703419067114,0.00407509557827597,-0.0457575292401323,-0.0297831545732905,2.0195565456773e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,28485,0.0342140222259385,0.00369220787925916,0.0269772947825905,0.0414507496692864,2.05408515611981e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,23862,0.0238850294768135,0.00257822277930613,0.0188317128293735,0.0289383461242535,2.1277311269149e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23071,-0.0429525119041375,0.00464702688821794,-0.0520606846050447,-0.0338443392032304,2.59824655540687e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,23846,-0.0355478766412656,0.00385285392974885,-0.0430994703435733,-0.0279962829389578,3.02536159207911e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,23893,0.0172281197451541,0.00186843067594737,0.0135659956202973,0.020890243870011,3.1906695196437e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,28553,-0.0381861131576092,0.00414293759204578,-0.0463062708380189,-0.0300659554771994,3.25428240931287e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,28470,-0.0314841220514362,0.00341994071148885,-0.0381872058459544,-0.0247810382569181,3.60897045756774e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,28304,0.0196675130242834,0.00214016803267573,0.015472783680239,0.0238622423683278,4.20115558353651e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,28237,-0.0166664712512924,0.00181634183615558,-0.0202265012501574,-0.0131064412524275,4.77730932045111e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,23820,0.045757180970601,0.00498961497600783,0.0359775356176256,0.0555368263235763,5.0801072416988e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,27969,-0.0452919350745888,0.00494210127323218,-0.0549784535701239,-0.0356054165790537,5.30861671150749e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,28286,-0.0191376550196613,0.00209099946167265,-0.0232360139645397,-0.0150392960747829,5.93290540252248e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,28224,-0.0418615496091478,0.00457612047495948,-0.0508307457400684,-0.0328923534782273,6.18941294185069e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,23862,-0.0254104594829369,0.00277741324067512,-0.0308541894346601,-0.0199667295312137,6.19590350617445e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,27965,-0.0328915531710988,0.00359778787665637,-0.0399432174093453,-0.0258398889328523,6.5252601517329e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,23071,-0.0422485612345013,0.00462191328088914,-0.0513075112650441,-0.0331896112039586,6.6898013652691e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,27702,-0.0438187760567752,0.00479872920623284,-0.0532242853009916,-0.0344132668125589,7.21457929349083e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",28224,0.0488158502435713,0.00535852487556442,0.038313141487465,0.0593185589996776,8.77315286751107e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,28091,-0.0656687633538083,0.00720982967588408,-0.0798000295185411,-0.0515374971890755,8.91515067390087e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,28411,-0.0390842396649556,0.00429963177968651,-0.0475115179531411,-0.03065696137677,1.05182593137632e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,23738,-0.0496350294767014,0.00546680613247107,-0.0603499694963447,-0.0389200894570581,1.17520000718689e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,28439,0.0222667039193643,0.00245369957117735,0.0174574527598567,0.0270759550788719,1.21104474158767e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,23198,-0.0187612532366354,0.00206822770449231,-0.0228149795374403,-0.0147075269358305,1.26861387572472e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,23377,-0.027047980057373,0.00299376696403971,-0.0329157633068908,-0.0211801968078552,1.76778833825863e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,28452,-0.0200881450093592,0.00222460861447372,-0.0244483778937277,-0.0157279121249908,1.822970548547e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23393,-0.0271828957873131,0.00301269333261061,-0.0330877747192299,-0.0212780168553963,1.97135696851964e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,27562,-0.0344439204643014,0.00382536460178748,-0.0419416350838049,-0.026946205844798,2.31142158798357e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,28237,-0.0182179550077105,0.00202660340429083,-0.0221900976801205,-0.0142458123353004,2.63724990132832e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,27965,0.0208212301213685,0.00232513553744734,0.0162639644679717,0.0253784957747653,3.60825493816055e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,28553,0.0159733375887488,0.00178468671342968,0.0124753516304266,0.0194713235470709,3.75774703750982e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,28553,0.0208149247573281,0.00232630675108919,0.0162553635251933,0.0253744859894629,3.84678195941433e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,28452,-0.0231433696722455,0.00259055245143094,-0.0282208524770502,-0.0180658868674409,4.36054476129137e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,28336,-0.0259141536665558,0.00290079077633665,-0.0315997035881756,-0.020228603744936,4.37256561355873e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,23561,0.0254796559940658,0.00285305126214937,0.019887675520253,0.0310716364678785,4.53719722422448e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,28336,-0.0256541345040944,0.00287701799659214,-0.031293089777415,-0.0200151792307738,5.07613232338552e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,28176,-0.0555598959189707,0.00625087720102887,-0.0678116152329873,-0.0433081766049542,6.56494182955457e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,23846,-0.027188804415191,0.00306367950525229,-0.0331936162454855,-0.0211839925848965,7.50437407440094e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,28176,-0.0346938255187622,0.00391132542203575,-0.0423600233459522,-0.0270276276915721,7.73117824906235e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,23775,-0.0382085076408012,0.00430737341010825,-0.0466509595246133,-0.029766055756989,7.7844180410687e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,23493,-0.0372207001180968,0.00419989590744011,-0.0454524960966794,-0.0289889041395142,8.38348427848407e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,23216,-0.0168486735867173,0.00190320565339348,-0.0205789566673685,-0.0131183905060661,9.13405822996574e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,27544,-0.0312202046468329,0.0035345782272921,-0.0381479779723254,-0.0242924313213404,1.08034699712958e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,28521,0.0172168408287039,0.00195138095439044,0.0133921341580986,0.0210415474993091,1.17767487732475e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,23725,-0.0216139728549627,0.00246419226848532,-0.026443789701194,-0.0167841560087315,1.88399497966414e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,28288,0.0185142286266795,0.00211809627527667,0.0143627599271372,0.0226656973262217,2.43651389426517e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,28224,-0.031702342147459,0.00363563148739701,-0.0388281798627571,-0.0245765044321608,2.93452229376036e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,23775,-0.0177140848919764,0.00203213050753058,-0.0216970606867363,-0.0137311090972164,3.04001000180905e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,28224,0.0183716815430923,0.00210821373337833,0.0142395826256708,0.0225037804605139,3.0818821793947e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,23846,-0.0186995949545947,0.00214675085825512,-0.0229072266367747,-0.0144919632724146,3.21413117504853e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,28187,0.0342899751894198,0.00393944105738776,0.0265686707169398,0.0420112796618998,3.36734039907347e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,27268,-0.0238859198866415,0.00274795138587348,-0.0292719046029535,-0.0184999351703294,3.74865778835992e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,28307,-0.0157760363329145,0.00181552252742329,-0.0193344604866642,-0.0122176121791649,3.83221722175109e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,28521,0.0150352765377465,0.00173149700021079,0.0116415424173334,0.0184290106581597,4.04251840595971e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23337,0.0242435560269231,0.00279387674330056,0.018767557610054,0.0297195544437922,4.30964654315989e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,28404,-0.0166860729700665,0.00192994602391769,-0.0204687671769452,-0.0129033787631878,5.61558148507542e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,27965,-0.0137793760399818,0.00159434066431145,-0.0169042837420322,-0.0106544683379313,5.77908088118956e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,23795,-0.0311535208613866,0.00360694229789399,-0.0382231277652588,-0.0240839139575144,6.12195466610133e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,23872,-0.0371406074042882,0.00430108428135851,-0.0455707325957508,-0.0287104822128255,6.22449902211063e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,28224,0.0272876927445947,0.00316459098855201,0.0210850944070327,0.0334902910821566,6.86902499364773e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,23812,0.00869658446659263,0.00100934307007166,0.00671827204925217,0.0106748968839331,7.35174602262902e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,27965,0.0205705662792584,0.00238846375651416,0.0158891773164907,0.0252519552420262,7.52038356149995e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,23775,-0.0223769644700975,0.00260436600327244,-0.0274815218365115,-0.0172724071036835,9.05651942269732e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,28521,-0.0446711576232428,0.00523480167315797,-0.0549313689026324,-0.0344109463438532,1.48926818090432e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,28553,-0.0256185753275423,0.00300519325381985,-0.0315087541050292,-0.0197283965500554,1.60556572456865e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,27965,-0.0310809432541508,0.00364645513224263,-0.0382279953133464,-0.0239338911949553,1.62335190445074e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,23502,-0.0138645395805017,0.00162926856151547,-0.017057905961072,-0.0106711731999314,1.84700974128535e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,28176,-0.0427333788669904,0.00503101384496853,-0.0525941660031287,-0.032872591730852,2.093544528073e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,23198,-0.0138617105893976,0.00163251778416112,-0.0170614454463534,-0.0106619757324418,2.16984571332552e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",28237,0.0195368470473413,0.00230312874904657,0.01502271469921,0.0240509793954726,2.30544372993623e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,27562,-0.03858492266622,0.00455623315262403,-0.0475151396453631,-0.0296547056870769,2.6053938719028e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,27682,-0.030403880034589,0.00359207357737247,-0.037444344246239,-0.023363415822939,2.70581960984511e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,28307,0.0230927414130193,0.00273072218370913,0.0177405259329494,0.0284449568930892,2.88246471524068e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,28195,0.0197257500525587,0.00233354678925792,0.0151519983456131,0.0242995017595042,2.97113893649755e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,27562,-0.0352040263920238,0.00416741579278527,-0.0433721613458829,-0.0270358914381646,3.12198671949851e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,23775,-0.0382561260404299,0.00452832405825311,-0.047131641194606,-0.0293806108862538,3.12584158573961e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,27702,0.0231162457994668,0.00273755754677914,0.0177506330077797,0.0284818585911539,3.21138606990293e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",28091,-0.0559467358444615,0.0066508812162414,-0.0689824630282946,-0.0429110086606283,4.22208958910709e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",27562,-0.0473921550814449,0.00564231557629714,-0.0584510936109873,-0.0363332165519025,4.69998258432914e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,28187,-0.0256492540334559,0.00305414094679168,-0.0316353702891676,-0.0196631377777442,4.74432559803449e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,28521,-0.0283038876840347,0.00337124080422035,-0.0349115196603066,-0.0216962557077628,4.84359025132968e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,28521,0.0148451969564456,0.00176888622911375,0.0113781799473826,0.0183122139655085,4.9808016837101e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,28428,-0.0382062080522131,0.00455347789333206,-0.0471310247231439,-0.0292813913812822,5.06003485271611e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,23862,-0.0132905657627129,0.00158551247385729,-0.0163981702114732,-0.0101829613139526,5.46397900710378e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,23775,-0.0399695575187736,0.00477880035801985,-0.0493360062204925,-0.0306031088170547,6.39544566466749e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,28044,-0.0147191475938903,0.00176418895561565,-0.018176957946897,-0.0112613372408836,7.55276384536499e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,23725,-0.0274641508236139,0.00329266533623949,-0.0339177748826433,-0.0210105267645845,7.76212850741634e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",23056,-0.0420359726840002,0.00504578660854651,-0.0519257144367514,-0.032146230931249,8.46480059080612e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,28307,0.0159114141872394,0.00191213324597449,0.0121636330251294,0.0196591953493494,9.08810892563242e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,27702,-0.0269861659983086,0.00324373261702857,-0.0333438819276846,-0.0206284500689326,9.23639461110897e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,23188,-0.0188393669644963,0.0022642244653787,-0.0232772469166385,-0.014401487012354,9.24071641550769e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,23337,-0.0396320093534572,0.00477749519037832,-0.0489958999265987,-0.0302681187803157,1.13855494919457e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,23815,0.0276352422999663,0.00333492216673066,0.0210987948531742,0.0341716897467584,1.22588817930723e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,23163,-0.0256428641823305,0.003096499727306,-0.0317120036478503,-0.0195737247168108,1.28423964220575e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,28182,-0.0210578514963681,0.00254346153615169,-0.0260430361072254,-0.0160726668855108,1.29422788183766e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,23337,-0.030240873775869,0.00365339242176794,-0.0374015229225342,-0.0230802246292039,1.3248468043985e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,28266,-0.0255945772703109,0.00309301883777918,-0.0316568941923581,-0.0195322603482638,1.34105484109142e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,23862,-0.0158282983307014,0.00191353238935793,-0.019578821813843,-0.0120777748475599,1.38809100335772e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',23775,-0.0234780911309782,0.00284788879473559,-0.0290599531686599,-0.0178962290932964,1.75023963688753e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27702,-0.0336739391741711,0.00408599555617349,-0.0416824904642712,-0.0256653878840711,1.77790117011583e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,28176,-0.0343873402998417,0.00417756919208514,-0.0425753759163285,-0.0261993046833548,1.92914968775711e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,23337,-0.0257618939714005,0.00313015539201707,-0.031896998539754,-0.0196267894030471,1.96540648809351e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,28176,0.0245264136790925,0.00298047213217639,0.0186846883000268,0.0303681390581582,1.9678824131368e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,27562,-0.0278063304922668,0.00338673379582878,-0.0344443287320912,-0.0211683322524423,2.30059060358946e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,23725,-0.0119363952602954,0.00145434857232899,-0.0147869184620602,-0.00908587205853056,2.37453245007843e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,28182,0.0252476519831915,0.00307758319184172,0.0192155889271818,0.0312797150392013,2.42878821994066e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,27562,-0.0379570880706106,0.00463567998160638,-0.0470430208345591,-0.0288711553066621,2.76907363273583e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,23862,-0.02613532165107,0.00319183989376361,-0.0323913278428466,-0.0198793154592933,2.78393336419982e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,27910,-0.0346903485723445,0.0042385283695871,-0.0429978641767352,-0.0263828329679537,2.84914300090766e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",23795,-0.0348885227369073,0.00426623678865832,-0.0432503468426776,-0.026526698631137,3.03331353208676e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,23188,-0.0292179505432123,0.0035769209089728,-0.0362287155247989,-0.0222071855616256,3.28145388456959e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,28182,-0.041620106635656,0.00510039460155293,-0.0516168800546997,-0.0316233332166123,3.48357318399993e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,27969,-0.0287761781205137,0.00353266236486765,-0.0357001963556542,-0.0218521598853731,3.92518947417503e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,23687,-0.024146306978735,0.00296584197703924,-0.0299593572537319,-0.0183332567037381,4.09593328129349e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,23720,-0.0238353200086056,0.00293158838368818,-0.0295812332406344,-0.0180894067765768,4.48216422694119e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,23775,-0.0440318249203107,0.00541951179686198,-0.0546540680421602,-0.0334095817984612,4.70175951026246e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,28224,-0.0168890241820642,0.00208010901238713,-0.020966037846343,-0.0128120105177854,4.87836019739542e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,27910,-0.013052204448685,0.00160762415183706,-0.0162031477862857,-0.00990126111108439,4.89488956876857e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,23071,-0.021807601952661,0.00269639016975774,-0.0270925266853861,-0.0165226772199358,6.37717649608848e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,28091,0.0161968108291432,0.00200473177224756,0.012267536555538,0.0201260851027485,6.77376228531065e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,27500,-0.0392445245720967,0.00486001227272916,-0.0487701486266458,-0.0297189005175475,7.02243214434466e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23198,-0.0204574595962509,0.00253374328612859,-0.0254235964370629,-0.0154913227554388,7.13115166368628e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,23198,-0.0464285785620146,0.00575446876757352,-0.0577073373464587,-0.0351498197775705,7.47356693014649e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,28091,-0.0297076409959275,0.00368718573713597,-0.036934525040714,-0.022480756951141,8.12702562142449e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,28044,-0.0308519581627433,0.00382922463270237,-0.03835723844284,-0.0233466778826467,8.1291036992581e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,23733,-0.0176268441364574,0.00219040033179131,-0.0219200287867683,-0.0133336594861464,8.85667825696204e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",23188,-0.0197487591909645,0.00245805841210892,-0.0245665536786979,-0.014930964703231,9.85758627297365e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,23872,-0.0398959636245069,0.0049659145128539,-0.0496291560697006,-0.0301627711793133,9.87108888846192e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,28291,-0.00996294400170346,0.00124377070465213,-0.0124007345828216,-0.00752515342058527,1.18823184991944e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,28184,0.017300510369575,0.00216064551215291,0.0130656451657552,0.0215353755733947,1.21936714232778e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",28176,-0.0531184078190292,0.00666018068761589,-0.0661723619667563,-0.0400644536713021,1.57456981152634e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,28496,-0.028636245553745,0.00359081062879996,-0.0356742343861929,-0.0215982567212971,1.58221879403277e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",23846,-0.0408430801249247,0.00512227162222553,-0.0508827325044868,-0.0308034277453627,1.6095983584299e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,28291,0.0150901573947766,0.00189396318044508,0.0113779895611043,0.018802325228449,1.6796312062882e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,23198,-0.0322566074444952,0.00405110911626183,-0.0401967813123683,-0.024316433576622,1.76413791248925e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,23846,-0.0204542636510651,0.00256969186857807,-0.0254908597134782,-0.0154176675886521,1.79935434995682e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",23795,-0.022874278776149,0.00287379376539063,-0.0285069145563146,-0.0172416429959834,1.80244472191881e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,27544,0.040171910818841,0.00505013930319028,0.030273637784588,0.0500701838530939,1.86545978162267e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,23775,-0.0256022470691884,0.00323993328492489,-0.0319525163076412,-0.0192519778307356,2.86100994513585e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,23725,-0.0320851374895003,0.00406544285370654,-0.0400534054827651,-0.0241168694962355,3.09774990527106e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,23846,-0.0142516575960422,0.00180902682229387,-0.0177973501677382,-0.0107059650243462,3.46582009304283e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,28336,-0.0322156498471171,0.00409522319252022,-0.0402422873044568,-0.0241890123897775,3.7720578064441e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,23738,-0.0522674105878085,0.00666106401065701,-0.0653230960486963,-0.0392117251269208,4.45056426713779e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,22706,-0.0263971390256109,0.00337484351984527,-0.0330118323245077,-0.0197824457267142,5.43611812787029e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,23872,0.0140778804912492,0.00180186423290938,0.0105462265947468,0.0176095343877516,5.81576459927247e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,23337,-0.0407596372530738,0.00522520231142016,-0.0510010337834573,-0.0305182407226903,6.41939739701518e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,27544,-0.0237148825945082,0.00304333132743015,-0.0296798119962713,-0.0177499531927451,6.80530672149196e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,23815,-0.0247943692437027,0.00318412052886241,-0.0310352454802731,-0.0185534930071324,7.14731983334557e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,23846,-0.048354537549616,0.00622781149131165,-0.0605610480725868,-0.0361480270266451,8.53955236834276e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,28182,-0.0159249586354141,0.00205239040751603,-0.0199476438341455,-0.0119022734366826,8.83332255660613e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,27965,-0.0296987493638582,0.00383212091384655,-0.0372097063549974,-0.022187792372719,9.50392948582181e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",28091,-0.0233537934484927,0.00301603003624669,-0.0292652123195362,-0.0174423745774492,1.0018198180739e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,23893,0.0122178028943103,0.00157860706675071,0.00912373304347892,0.0153118727451417,1.03662098014892e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,27918,-0.0241123552295999,0.00311784667438097,-0.0302233347113866,-0.0180013757478132,1.08013923054005e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,28367,-0.0248644659991304,0.00322188516183094,-0.031179360916319,-0.0185495710819417,1.22653914502393e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,28187,-0.029590265045209,0.00383600518147063,-0.0371088352008915,-0.0220716948895266,1.26127428605109e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,27562,-0.024722892735022,0.00321150610952475,-0.0310174447096905,-0.0184283407603535,1.42584319901422e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,28173,-0.0388254136741113,0.005045592016382,-0.04871477402622,-0.0289360533220026,1.46208068525579e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,28224,0.0368619265595274,0.00480235049552385,0.0274493195883007,0.0462745335307542,1.69681259462815e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,23846,-0.0357631656808765,0.00466022796253182,-0.0448972124874389,-0.0266291188743142,1.72925923652077e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,28428,-0.0339831273814828,0.00443232259958461,-0.0426704796766687,-0.025295775086297,1.8151694372326e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,28521,-0.0177881630855202,0.00232159552741765,-0.0223384903192588,-0.0132378358517816,1.88799806160868e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,23198,-0.0384174599307089,0.00502114471825669,-0.048258903578492,-0.0285760162829257,2.06957155292721e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,23056,-0.020819427230476,0.00272575596098317,-0.026161908914003,-0.015476945546949,2.29126916044747e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,28340,-0.0536763243708981,0.00703989264159686,-0.0674745139484279,-0.0398781347933682,2.52461690677553e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,27532,-0.0206033738168934,0.00270374207691373,-0.0259027082876443,-0.0153040393461425,2.61185966623337e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,28176,-0.039993532733934,0.00525341783299806,-0.0502902316866102,-0.0296968337812577,2.76481739223275e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,28223,0.0271384524481891,0.0035661297829312,0.0201488380736439,0.0341280668227343,2.82515836723459e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,28187,0.0140048926141368,0.00184072841335031,0.0103970649239702,0.0176127203043034,2.86292016938526e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,28091,-0.0281101020834807,0.0036961355285633,-0.0353545277194647,-0.0208656764474966,2.93197549229743e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,27562,-0.0265176582515891,0.00348976695809784,-0.0333576014894609,-0.0196777150137174,3.08639279436937e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,28091,-0.0641136742765106,0.00847195189711134,-0.0807186999948488,-0.0475086485581724,3.91356425675086e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,23337,-0.0208756806560936,0.00276058060732029,-0.0262864186464414,-0.0154649426657459,4.11359267652459e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,23738,-0.0154754962061188,0.00204814375298837,-0.019489857961976,-0.0114611344502616,4.31117331807545e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,28452,0.0302502059204988,0.00400448605144446,0.0224014132596677,0.03809899858133,4.34497924919523e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,27829,0.014195048398056,0.00188403046274139,0.0105023486910828,0.0178877481050291,5.05474440503705e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,23071,-0.0187146050761945,0.00248503965990881,-0.0235852828096157,-0.0138439273427732,5.2237692843704e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,23507,-0.0287692954746803,0.00382924326790745,-0.0362746122797789,-0.0212639786695817,5.98256074029503e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,28224,-0.0185062358493915,0.00246813693764022,-0.0233437842471663,-0.0136686874516167,6.66731337085248e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27682,-0.02919791451955,0.00390079077024053,-0.0368434644292215,-0.0215523646098786,7.36053598784487e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,23775,-0.0345845102496974,0.00462424300781561,-0.043648026545016,-0.0255209939543788,7.75088153107744e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,28176,-0.0335315820739953,0.00448762884629134,-0.0423273346127263,-0.0247358295352643,8.12753121720475e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,27918,-0.0235627001139273,0.0031547432705443,-0.0297459969241942,-0.0173794033036605,8.31860378848923e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,27324,-0.0390541491521619,0.0052301385981826,-0.0493052208045998,-0.028803077499724,8.4408073770928e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,27965,0.0131160002563306,0.00175656313985974,0.00967313650220553,0.0165588640104557,8.45309510611283e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,28521,-0.0193528169016251,0.00259210545810971,-0.0244333435995201,-0.0142722902037301,8.49930984644721e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,23846,-0.0368589815148225,0.0049388802754761,-0.0465391868547557,-0.0271787761748894,8.74527410382794e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,23071,-0.0244477000779753,0.00328051487206322,-0.0308775092272192,-0.0180178909287314,9.48846259489557e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,23775,-0.0159228717334045,0.0021396910404826,-0.0201166661727504,-0.0117290772940586,1.02795179132851e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,23198,0.0307613142427943,0.00413393619280116,0.0226587993049041,0.0388638291806846,1.03270139143827e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,28521,-0.0201152955140552,0.00270383276669603,-0.0254148077367795,-0.014815783291331,1.03877031440837e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,28336,0.0168885129448997,0.00227298245025532,0.0124334673423992,0.0213435585474001,1.11568779950912e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,27877,-0.0183439055979606,0.00247009407090787,-0.02318528997694,-0.0135025212189812,1.14789431926557e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,23846,-0.0278569846373543,0.00375084024350524,-0.0352086315146245,-0.020505337760084,1.14934014909987e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,28428,0.0148468194643023,0.00200028027848018,0.0109262701184811,0.0187673688101234,1.18266284855822e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,22492,-0.0622509689882266,0.00841229262369753,-0.0787390625306738,-0.0457628754457794,1.40964944302716e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,23071,-0.0399457324454775,0.005415749041127,-0.0505606005660865,-0.0293308643248686,1.6881868071948e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,28176,-0.0534476033641824,0.00724886896358091,-0.067655386532801,-0.0392398201955638,1.7112352000718e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,28091,-0.0678787526496259,0.00921056180636523,-0.0859314537901018,-0.0498260515091501,1.75772496142248e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,27965,-0.0444759506420393,0.00604309068673776,-0.0563204083880453,-0.0326314928960333,1.89255952494901e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,23198,-0.0145773587660205,0.00198736153955594,-0.0184725873835502,-0.0106821301484909,2.28950470120223e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,22885,-0.0266871023101212,0.00364565261386372,-0.0338325814332941,-0.0195416231869483,2.55678255521799e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,23337,0.0179804963482382,0.00245741772909572,0.0131639575992106,0.0227970350972658,2.62113031566184e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,28224,-0.0269698497096822,0.00369427559831734,-0.0342106298823842,-0.0197290695369802,2.94398947070305e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,23467,-0.0139118020244233,0.00190759009150905,-0.017650678603781,-0.0101729254450655,3.13052061244247e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,23725,-0.0346075003163018,0.0047460400173054,-0.0439097387502204,-0.0253052618823832,3.15270468593005e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,28307,-0.0412083097231554,0.00565873540523465,-0.0522994311174153,-0.0301171883288955,3.36867676563085e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,28096,-0.0158714695194819,0.00218155278828184,-0.0201473129845143,-0.0115956260544495,3.54678484810012e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,28336,0.0237567473687096,0.00326550010317395,0.0173563671664887,0.0301571275709305,3.55222319146805e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,23775,-0.0274886070173791,0.00379011171526058,-0.0349172259792898,-0.0200599880554684,4.21003937847941e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,28307,0.0136069569453717,0.00188489451631751,0.00991256369338936,0.017301350197354,5.37108267028499e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,23163,-0.0165179768076638,0.00228881600511759,-0.0210040561776943,-0.0120318974376333,5.48574404907174e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,28553,-0.0219477552720102,0.00304223242271817,-0.0279105308205378,-0.0159849797234825,5.55386472719092e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,23775,-0.0433859025308332,0.00602470836995116,-0.0551943309359374,-0.0315774741257289,6.1403982816049e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,28500,-0.0294458446213297,0.00409590684318926,-0.0374738220339807,-0.0214178672086788,6.68296055804399e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23188,-0.0240139595666727,0.00334112377790957,-0.0305625621713755,-0.0174653569619699,6.80426446146436e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,23725,-0.033395019633489,0.00465707106237817,-0.0425228789157502,-0.0242671603512278,7.67365616211498e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,27682,-0.0283203301783319,0.00395146290847481,-0.0360651974789426,-0.0205754628777213,7.85501485404631e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,27965,-0.0326448582992909,0.00456518798201054,-0.0415926267440315,-0.0236970898545502,8.83767731333855e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,27965,-0.0230494400135518,0.00323352172464211,-0.0293871425938503,-0.0167117374332532,1.04097852986572e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,27702,-0.0291390264681112,0.00409090082145248,-0.0371571920781581,-0.0211208608580644,1.08269398922496e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",28044,-0.0366875311089442,0.0051605930390013,-0.0468022934653868,-0.0265727687525017,1.19536835648314e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,23795,-0.0293197722079153,0.00412785288629146,-0.0374103638650466,-0.0212291805507841,1.25595885197385e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,23738,-0.0274781580249041,0.00387524585680724,-0.0350736399042463,-0.0198826761455619,1.37188524688146e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,27544,-0.0185117665689131,0.00261271777814658,-0.0236326934140804,-0.0133908397237458,1.4212769763072e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,27562,-0.0249678720371547,0.00352793839456295,-0.0318826312904981,-0.0180531127838114,1.50631323985676e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,23393,-0.0271997453446673,0.00384498893129059,-0.0347359236499969,-0.0196635670393377,1.54688636441e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,23844,-0.0177519351764178,0.00251286131543525,-0.0226771433546709,-0.0128267269981647,1.6571079396527e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,28237,0.0115370348170768,0.00163438635842377,0.00833363755456616,0.0147404320795874,1.71654294392609e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,28176,-0.0413808672733968,0.00587024344066713,-0.0528865444171043,-0.0298751901296892,1.8401531405312e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,27544,-0.032273851413433,0.00457988176422752,-0.041250419671319,-0.0232972831555471,1.87287373167429e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,23795,-0.0265689523269819,0.0037773785585144,-0.0339726143016701,-0.0191652903522937,2.06573012866779e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,28521,-0.0164683956866687,0.00234308725518378,-0.0210608467068289,-0.0118759446665085,2.13454952434144e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,27562,-0.0138326012393904,0.00196927086466559,-0.0176923721341349,-0.00997283034464579,2.20255960160508e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,28521,-0.0235407759303919,0.00335292189026426,-0.0301125028353098,-0.0169690490254739,2.25260346329264e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,28091,-0.0543633551813377,0.00776494289230156,-0.0695826432502487,-0.0391440671124266,2.59618930449441e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,28274,0.0185127613651403,0.00265110394958702,0.0133165976239498,0.0237089251063309,2.95248544949382e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,27519,0.0221149580791457,0.00316952447240792,0.0159026901132262,0.0283272260450652,3.07558827483113e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,27562,-0.0305042375415609,0.00437896042745042,-0.0390869999793637,-0.021921475103758,3.33188937793379e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,23775,-0.0299906189491231,0.00430492772078639,-0.0384282772818644,-0.0215529606163817,3.33214796397209e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,23198,-0.0108011036313649,0.00155135818795329,-0.0138417656797534,-0.00776044158297646,3.43565976579118e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,27607,-0.0209419616282243,0.00300993804632986,-0.0268414401990309,-0.0150424830574178,3.53829983273523e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,28091,-0.00997240925911497,0.00143437373299292,-0.0127837817757811,-0.00716103674244885,3.66850948316493e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,28471,-0.0326421341639393,0.0047056213817593,-0.0418651520721875,-0.0234191162556911,4.09546160047332e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,23725,-0.0192232567634043,0.00277610230063979,-0.0246644172726583,-0.0137820962541503,4.48532293677379e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,28452,-0.0150018272893952,0.00216798244999469,-0.0192510728913848,-0.0107525816874056,4.62131887953009e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,23775,-0.0220144322783111,0.00318167168264067,-0.0282505087762869,-0.0157783557803354,4.6593338968789e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,23775,-0.0312822594230152,0.00452845080346498,-0.0401580229978065,-0.0224064958482238,5.04156118019033e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,23738,-0.0241232927291108,0.00349663286367043,-0.0309766931419048,-0.0172698923163168,5.36842522438512e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",28553,-0.0234885308698728,0.0034110922095327,-0.0301742716005568,-0.0168027901391887,5.86013969165821e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,28411,-0.0161467575872747,0.00235151386451502,-0.0207557247617241,-0.0115377904128253,6.71327626952037e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,28176,-0.0263065493135056,0.00383249829742651,-0.0338182459764616,-0.0187948526505497,6.83112153934343e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,28091,-0.044231133214731,0.00644970008059393,-0.0568725453726951,-0.0315897210567669,7.13481024138635e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,23198,-0.0239634048779467,0.00349802572022224,-0.0308195352895823,-0.0171072744663111,7.54070534774631e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,23775,-0.0403779926667845,0.00589475074778124,-0.0519317041324357,-0.0288242812011332,7.57463864327713e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,28144,-0.0429654484074176,0.00627324138591842,-0.0552610015238177,-0.0306698952910175,7.58960962776782e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,28281,0.0239082739860693,0.00351237501027356,0.0170240189659331,0.0307925290062055,1.0173854110773e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,23188,-0.0370708043554443,0.00544992795788577,-0.0477526631529004,-0.0263889455579882,1.05635160454887e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,28428,-0.0242235654257213,0.00356234588642165,-0.0312057633631077,-0.0172413674883349,1.06769915258852e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,23862,-0.0130226380365953,0.00191577059609328,-0.0167775484049381,-0.0092677276682525,1.08886996808399e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,28437,-0.0110783857481771,0.00163078060525441,-0.0142747157344757,-0.00788205576187845,1.11755192536425e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,23188,0.0149954951221771,0.00220921279641771,0.0106654380411984,0.0193255522031558,1.16677831811182e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,27918,-0.0413222073829755,0.00608960515516954,-0.0532578334871078,-0.0293865812788432,1.17837693703002e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,23893,0.0243994299560652,0.00360314522715247,0.0173372653108463,0.031461594601284,1.30228115906674e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,28363,-0.0274729771291013,0.0040597781549801,-0.0354301423128623,-0.0195158119453403,1.33934155227347e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,27597,-0.0178352850451541,0.002644112238372,-0.0230177450323632,-0.012652825057945,1.5574573270699e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,28452,-0.0177000885602604,0.0026249077265322,-0.0228449077042635,-0.0125552694162573,1.57977727238401e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,28277,-0.0234913417205019,0.00348527700309983,-0.0303224846465776,-0.0166601987944263,1.61246794448672e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,28091,-0.0150341283678262,0.00223110397641876,-0.019407092161607,-0.0106611645740454,1.63205714636322e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,23301,-0.0264987655255448,0.00393603378546863,-0.0342133917450633,-0.0187841393060263,1.70824250709055e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",23846,-0.0321177919072249,0.00477336086763348,-0.0414735792077865,-0.0227620046066633,1.75247774600351e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,28176,-0.0476504542801058,0.00708381423463248,-0.0615347301799855,-0.0337661783802262,1.76915380583284e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,27562,-0.0207835804157205,0.00309782932922035,-0.0268553259009923,-0.0147118349304486,1.99649014447806e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,28307,-0.0260510164188583,0.00388429530777096,-0.0336642352220894,-0.0184377976156272,2.02745418093953e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,28091,-0.0310681525321234,0.00463262273740819,-0.0401480930974434,-0.0219882119668034,2.03287738580646e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,23736,-0.0370150330049584,0.00552942152880925,-0.0478526992014245,-0.0261773668084922,2.21699796809156e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,28031,-0.0208036507767131,0.00312885713808568,-0.026936210767361,-0.0146710907860652,3.00589935854973e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,28091,-0.0270688204449357,0.00407686586524333,-0.0350594775408126,-0.0190781633490587,3.20235797814571e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,28553,0.0144108112035811,0.00217258137837457,0.0101525517019669,0.0186690707051952,3.34724146884367e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,28522,0.0194316433666245,0.00293317748239927,0.0136826155011219,0.025180671232127,3.5396308849158e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,28187,0.0153791906162428,0.0023227065936275,0.0108266856927329,0.0199316955397527,3.626055934333e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23188,-0.0152690202649898,0.00231034862699985,-0.0197973035739095,-0.01074073695607,3.95414211270682e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,23775,-0.0283826387619371,0.00429972246840343,-0.0368100948000078,-0.0199551827238664,4.16890230355799e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,27682,-0.0241092323603163,0.00365462154341447,-0.0312722905854086,-0.0169461741352239,4.27368273667481e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,27702,-0.0198524542292683,0.0030115353535996,-0.0257550635223235,-0.0139498449362131,4.41330095094309e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,27084,-0.0169760714540068,0.00257568624920385,-0.0220244165024464,-0.0119277264055673,4.45220900433837e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,28411,-0.00904806814504718,0.00137432652204339,-0.0117417481282522,-0.00635438816184213,4.6707537031184e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,23738,-0.0479875898810992,0.00729989374233713,-0.0622953816160799,-0.0336797981461184,5.00865722838667e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,23198,-0.0179428337007705,0.00273211437157762,-0.0232977778690626,-0.0125878895324784,5.22925802122821e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,27682,-0.0185441849063958,0.00283287679242371,-0.0240966234195463,-0.0129917463932453,6.01076814707927e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,23747,-0.0487488760355273,0.00744686740627414,-0.0633447361518246,-0.0341530159192299,6.02142722401209e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,28199,-0.0433302067772986,0.0066217645426843,-0.0563088652809599,-0.0303515482736374,6.10830747401172e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,28176,0.0234878744218787,0.0035949948235655,0.0164416845676903,0.0305340642760671,6.5348784745653e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,28187,-0.0247378818025579,0.0037868514701425,-0.0321601106840372,-0.0173156529210786,6.57508889281516e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,27965,-0.019587582221921,0.00300167503042461,-0.0254708652815532,-0.0137042991622887,6.89107718950335e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",28121,-0.0292630904534593,0.00448794259120771,-0.0380594579322264,-0.0204667229746922,7.13183704038029e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,28553,-0.0135501283501502,0.0020808892753569,-0.0176286713298497,-0.00947158537045067,7.55384944714852e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,28176,-0.0190627252453845,0.00292879616897638,-0.0248031657365782,-0.0133222847541908,7.70651971891489e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",28091,-0.0460075909022925,0.00707126256851082,-0.0598672655365737,-0.0321479162680113,7.83324536828587e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,28276,-0.0255646684368662,0.00392949164910202,-0.0332664720691061,-0.0178628648046262,7.8548213084369e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,23725,-0.0505155402465445,0.00777242111256965,-0.065749485627181,-0.035281594865908,8.22805993038006e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",23738,0.0455421495577949,0.00701150810871247,0.0317995936647184,0.0592847054508713,8.44854551985999e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,28224,-0.0338390000104518,0.00521575660703473,-0.0440618829602399,-0.0236161170606638,8.8516964107531e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,23795,0.0205568165032711,0.00317031196132656,0.014343005059071,0.0267706279474712,9.09774389047309e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,23337,-0.0246804046264027,0.00380658765977688,-0.0321413164395654,-0.0172194928132401,9.13493259384276e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,23188,-0.0248160295350943,0.00383299288303249,-0.032328695585838,-0.0173033634843506,9.71457901572304e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,23348,-0.0287557656052688,0.00444684492651733,-0.0374715816612428,-0.0200399495492949,1.02246967661307e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",28155,0.0246204379138526,0.00381204000426496,0.0171488395054932,0.0320920363222119,1.07400010713777e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,23738,-0.0121040912030019,0.00187755792411608,-0.0157841047342694,-0.0084240776717344,1.16494086976404e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,28251,0.0216800211341885,0.00336799878356324,0.0150787435184045,0.0282812987499724,1.23760889026321e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",28091,0.0186042243282217,0.00289210030744057,0.0129357077256382,0.0242727409308052,1.27312725690663e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,23769,0.00839481990001601,0.00130573972180939,0.00583557004526961,0.0109540697547624,1.30741930765363e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,23337,0.0226505818966738,0.00353351561726946,0.0157248912868257,0.029576272506522,1.48097864603495e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,28428,0.00947627757441288,0.00147843203057409,0.00657855079448766,0.0123740043543381,1.48110053748855e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,23862,0.0226248163098014,0.00353204872433813,0.0157020008100987,0.0295476318095042,1.52594006064289e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,23198,-0.0205055237918402,0.0032072179797047,-0.0267916710320615,-0.014219376551619,1.65160143481499e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,23725,-0.0431974668851873,0.00677409400066202,-0.0564746911264849,-0.0299202426438898,1.84083844043528e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,27374,0.0166982792658345,0.00262815508118747,0.011547095306707,0.0218494632249619,2.13623892172764e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,23725,-0.0312608662482924,0.00492771317383865,-0.0409191840690162,-0.0216025484275687,2.28081666511088e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,23337,-0.0337814063086165,0.00532946182887044,-0.0442271514932026,-0.0233356611240305,2.36082708367194e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,28176,-0.0104990447797016,0.00166076602539823,-0.0137541461894822,-0.0072439433699211,2.62391796184669e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,23795,-0.016649378166073,0.00263376189736027,-0.0218115514848992,-0.0114872048472469,2.63601830128178e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,28320,-0.0148897772440523,0.00235578115981262,-0.019507108317285,-0.0102724461708195,2.64554961459621e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,28176,0.0134739619944573,0.00213384792289331,0.00929162006558638,0.0176563039233282,2.75261301334832e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,28176,-0.0350269521787139,0.00554887570178238,-0.0459027485542074,-0.0241511558032204,2.78757753094321e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",23862,-0.017979108953023,0.00285015221199804,-0.0235654072885391,-0.0123928106175068,2.87399967253406e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,27562,-0.0189445313337341,0.00300443103399469,-0.0248332161603637,-0.0130558465071045,2.91562556445843e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,28181,0.0253939753373355,0.00402783184678986,0.0174994249176274,0.0332885257570436,2.93169936370002e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,28176,-0.0409688199247056,0.00649917372075311,-0.0537072004173817,-0.0282304394320295,2.94933218316214e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,27965,0.0145300005228363,0.00230589461684382,0.0100104470738224,0.0190495539718502,2.99668992994406e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,23163,-0.0269378927623165,0.0042882867188917,-0.0353429347313442,-0.0185328507932888,3.40767518033991e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,28091,-0.0119784527996258,0.00190731514189266,-0.0157167904777354,-0.00824011512151623,3.42934895463521e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,23337,-0.0295527507701282,0.00472086797367002,-0.0388056519985214,-0.0202998495417349,3.91622665148005e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,27965,-0.0246032993328117,0.00393501366765268,-0.0323159261214109,-0.0168906725442124,4.10020235230459e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,28224,-0.0268536865443491,0.00430057901796794,-0.0352828214195662,-0.0184245516691319,4.32035029543712e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,28187,-0.00999341725138536,0.00160196702742847,-0.0131332726251452,-0.00685356187762556,4.48876329645427e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,28195,-0.0168313645717291,0.00270856584345405,-0.0221401536248991,-0.0115225755185592,5.23337654569574e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,23766,0.0200620491739433,0.00323021638190959,0.0137308250654005,0.0263932732824861,5.36085629513083e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,28496,-0.0162033679298367,0.00261197344380583,-0.0213228358796962,-0.0110838999799773,5.59815451417554e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,28204,-0.0246036862918332,0.00396754640911213,-0.032380077253693,-0.0168272953299735,5.67990678751705e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,23775,-0.029259877675925,0.0047334106820098,-0.0385373626126643,-0.0199823927391858,6.45026899409768e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",28224,-0.0309342865278326,0.00500531489675245,-0.0407447037254674,-0.0211238693301978,6.48601327078638e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,27702,-0.0128361963509991,0.00207928871298583,-0.0169116022284513,-0.00876079047354682,6.77818158274302e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,28091,-0.0134003584680455,0.00217102398784448,-0.0176555654842207,-0.00914515145187032,6.81948160938364e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,27682,-0.0153916191010197,0.00249382462637328,-0.0202795153687113,-0.010503722833328,6.84133344703933e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,23725,-0.024907236886044,0.00404246661150838,-0.0328304714446005,-0.0169840023274876,7.32673019652275e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,23198,-0.0227708912474272,0.00370473329510486,-0.0300321685058328,-0.0155096139890217,8.0537788924699e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,28428,0.0191127188445227,0.0031181087479109,0.0130012256986173,0.0252242119904281,8.92659699796976e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,23725,-0.018522716293393,0.00302797170755443,-0.0244575408401997,-0.0125878917465864,9.67226093618929e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,23738,0.0474910800656344,0.00779731036470545,0.0322083517508117,0.0627738083804571,1.14146444364983e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,27951,0.0117491457187864,0.00193320287607829,0.00796006808167296,0.0155382233558999,1.23607629338955e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,23725,-0.0199226865212073,0.00328039662059169,-0.026352263897567,-0.0134931091448476,1.27249623813566e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,28521,-0.0390870327525324,0.00643648620507704,-0.0517025457144834,-0.0264715197905814,1.27343927446492e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,28452,-0.0189937417303852,0.0031314922628622,-0.0251314665655951,-0.0128560168951752,1.33287929729989e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,23738,-0.0124640827169021,0.00205867707555261,-0.0164990897849852,-0.00842907564881894,1.43046714835197e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,28553,0.00676521458859836,0.00112060432397371,0.0045688301136099,0.00896159906358682,1.58831139124453e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,28176,-0.0346696249328668,0.00574365850986607,-0.0459271956122043,-0.0234120542535293,1.59799077751408e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,23738,-0.0126999508073994,0.00210401305643055,-0.0168238163980033,-0.00857608521679556,1.60265574226625e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,23393,-0.0219863976704526,0.0036480392329097,-0.0291365545669557,-0.0148362407739496,1.69628169093979e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,23862,0.00883080237436556,0.00146524734762429,0.00595891757302195,0.0117026871757092,1.69656511095875e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,28140,-0.0100336024368529,0.00166847653544464,-0.0133038164463244,-0.00676338842738137,1.83649007804459e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,23188,-0.0343093788154998,0.00570607978845833,-0.0454932952008781,-0.0231254624301214,1.85102790138418e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,23071,-0.0305794185869179,0.00509146937965836,-0.0405586985710483,-0.0206001386027875,1.92991783889434e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,28428,-0.0123612455559037,0.00205888023305309,-0.0163966508126878,-0.0083258402991197,1.95006723709304e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,27562,-0.0166206963145983,0.00276876307067174,-0.0220474719331149,-0.0111939206960817,1.96207719422747e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,27562,-0.0403135446485918,0.00672141098184884,-0.0534875101730156,-0.0271395791241681,2.02524765263477e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,28091,-0.0159246550012622,0.0026585036181584,-0.0211353220928526,-0.0107139879096717,2.12285155005355e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,23872,0.0106608946046233,0.00177998809084034,0.00717211794657625,0.0141496712626704,2.13754014278081e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,27910,-0.0260815955368306,0.00435700728343476,-0.0346213298123627,-0.0175418612612985,2.17520691288375e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,28320,-0.015852539817021,0.00264854362799606,-0.0210436853278933,-0.0106613943061488,2.18480847586204e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,23738,-0.0200065043839141,0.00334634929435204,-0.0265653490008441,-0.0134476597669841,2.2827217862218e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,23198,-0.0213200565830127,0.00356832694071372,-0.0283139773868116,-0.0143261357792138,2.33727894446718e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,27965,-0.0212222110264689,0.00355500487834809,-0.0281900205880312,-0.0142544014649067,2.40596843902506e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,28428,0.0122147005249532,0.00204687269454426,0.00820283004364647,0.01622657100626,2.43776974268365e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,27887,0.0254689893657001,0.00427425449219171,0.0170914505610043,0.0338465281703958,2.57306978067002e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,23644,-0.0101966384387339,0.00172367344992933,-0.0135750384005953,-0.00681823847687237,3.35131325545099e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",28187,-0.0185956674067562,0.00315127607144891,-0.0247721685067961,-0.0124191663067164,3.65442185012247e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",23777,-0.0161573346848188,0.00273929643910805,-0.0215263557054706,-0.010788313664167,3.72119490308951e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,27881,-0.012091524471853,0.00205129315097918,-0.0161120590477722,-0.00807098989593376,3.79942164948251e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,27544,0.0134675861433247,0.0022930155505132,0.0089732756643188,0.0179618966223305,4.32088782009149e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,28091,-0.0219345896006751,0.00373898377319871,-0.0292629977961446,-0.0146061814052056,4.50192733748153e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,28320,-0.0116485926574104,0.00198766233029562,-0.0155444108247898,-0.00775277449003095,4.66728697820428e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,28176,-0.0226015659541979,0.00385938570713049,-0.0301659619401737,-0.0150371699682222,4.78659648314583e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,23738,-0.0433124602505449,0.0074038696112816,-0.0578240446886568,-0.0288008758124329,4.98097608349634e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,23813,-0.0176935051939077,0.00303133901701263,-0.0236349296672525,-0.011752080720563,5.38833443224334e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,23795,-0.0191701375491428,0.00328557039533894,-0.0256098555240072,-0.0127304195742785,5.46038546194135e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,23337,-0.0214802616658291,0.00369172230620622,-0.0287160373859933,-0.0142444859456649,6.01568293241101e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,23846,-0.0100688154604202,0.00173174808884279,-0.0134630417145521,-0.00667458920628834,6.16835519381315e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,23775,-0.0162052651977981,0.0027881320912336,-0.021670004096616,-0.0107405262989803,6.24337960538894e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,27702,-0.0275620634064283,0.0047440025787589,-0.0368603084607958,-0.0182638183520609,6.32033918869466e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,23188,-0.0338910453208471,0.00583497584250207,-0.0453275979721511,-0.022454492669543,6.395118893736e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,28224,-0.0139966969382684,0.00241068506331769,-0.0187216396623711,-0.00927175421416576,6.46266866817562e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,28521,-0.0166474707267691,0.0028680147096277,-0.0222687795576393,-0.0110261618958988,6.52310485305519e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,27965,-0.0155795541815835,0.00268420915328608,-0.0208406041220242,-0.0103185042411428,6.5391503094232e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,23893,-0.00784661002020039,0.00135370269541475,-0.0104998673032133,-0.00519335273718747,6.860358887572e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,23893,-0.0119935896482181,0.00207224476787767,-0.0160551893932584,-0.00793198990317791,7.22369926788137e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,28428,-0.0228258543972755,0.00395106985412322,-0.0305699513113571,-0.015081757483194,7.67766909403949e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,23795,-0.0155393653089032,0.00269344178642055,-0.0208185112102875,-0.0102602194075189,8.05725438680651e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,23100,-0.0197558087143887,0.00342551401154492,-0.0264698161770168,-0.0130418012517607,8.16018391545921e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",28121,-0.0267298891481903,0.00463516793500633,-0.0358148183008027,-0.0176449599955779,8.16571228328289e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,28176,-0.036048987718585,0.00625507128688205,-0.0483089274408738,-0.0237890479962962,8.34129231019446e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,23846,-0.0134243169166865,0.00232942894839733,-0.0179899976555453,-0.00885863617782779,8.36888290762729e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,28091,0.0177829386503571,0.00308672788329985,0.0117329519990894,0.0238329253016248,8.44413523549651e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,22875,-0.0279186580563129,0.00484600415498186,-0.0374168262000774,-0.0184204899125485,8.46044568440629e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,23862,0.019552453167432,0.00339624757311064,0.0128958079241351,0.0262090984107288,8.66334701686222e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,28134,-0.0254695058780657,0.00442565807063339,-0.0341437956965071,-0.0167952160596242,8.75593801547193e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,28521,-0.0103247193643661,0.00179447633626685,-0.0138418929834491,-0.00680754574528309,8.82503955904213e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,28266,-0.0139250253691187,0.00242253409470515,-0.0186731921947408,-0.0091768585434966,9.11671753817167e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,27682,0.00842968627397607,0.00146737958039277,0.00555362229640624,0.0113057502515459,9.30372700701837e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,28553,0.0118332055322912,0.00206020853940754,0.00779519679505244,0.01587121426953,9.35736926232597e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,23188,-0.0179674456931515,0.00313125635468913,-0.0241047081483422,-0.0118301832379609,9.6940788908272e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,23738,-0.0186888183413729,0.00326418190420039,-0.0250866148736056,-0.0122910218091401,1.04422111349976e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,23163,-0.0191620574498504,0.00335134312046203,-0.025730689965956,-0.0125934249337448,1.09288150036629e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,23198,-0.028909065816409,0.00507015520704503,-0.0388465700222173,-0.0189715616106008,1.19981853408862e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,23846,-0.0107102592350704,0.00187959347407805,-0.0143942624442634,-0.00702625602587747,1.22521945965713e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,23846,-0.0246845383097003,0.00434295626425708,-0.0331967325876441,-0.0161723440317564,1.33264480703308e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,23841,-0.0216921369443376,0.00381693598938344,-0.0291733314835292,-0.0142109424051461,1.33796598027579e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,23893,-0.00799040914907846,0.00140614719144091,-0.0107464576443026,-0.00523436065385428,1.34297581967855e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,28428,-0.0253122777620942,0.00445935527940513,-0.0340526141097282,-0.0165719414144601,1.39044690959157e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,23071,-0.0138984159468686,0.00244847066099492,-0.0186974184424187,-0.00909941345131858,1.39238196557404e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,27562,-0.032872080230842,0.00580369511235542,-0.0442473226510586,-0.0214968378106253,1.49364158626669e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,28176,0.0165883722765961,0.00292984326109349,0.0108458794848528,0.0223308650683393,1.51194115904342e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",23893,-0.00642296213357017,0.00113480785293455,-0.00864718552532189,-0.00419873874181844,1.53147564264437e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,23353,0.0119033833453175,0.00210489212438666,0.00777779478151967,0.0160289719091154,1.57572762441379e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,28521,-0.0134096209890096,0.00238194213831813,-0.0180782275801132,-0.0087410143979061,1.82218759571736e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,23775,-0.0116887660599985,0.00207957976256025,-0.0157647423946166,-0.00761278972538042,1.92278755657386e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,23775,-0.00856834064095077,0.00152625016454363,-0.0115597909634563,-0.00557689031844525,1.99929214730154e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,23663,0.0103853825502651,0.00185142570359389,0.00675658817122107,0.0140141769293091,2.05301271749081e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,23725,-0.0239645997552962,0.00428306804618836,-0.0323594131258254,-0.015569786384767,2.22806400178633e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",23795,0.0349119058335016,0.00623966664075468,0.0226821592176224,0.0471416524493808,2.22849379470478e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,28096,-0.0164724551757314,0.00294743740710304,-0.0222494324936534,-0.0106954778578095,2.30846133986583e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,23846,-0.0292912949086766,0.00526315589170809,-0.0396070804564245,-0.0189755093609287,2.64442900675051e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,23738,-0.0395588666204286,0.00711775039964383,-0.0535096574037305,-0.0256080758371267,2.76168732376766e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,27544,-0.0232841510419034,0.00418988866484685,-0.0314963328250032,-0.0150719692588036,2.76633978886632e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,28135,0.0107366263097289,0.00193565221178278,0.00694274797463465,0.0145305046448231,2.9360336053899e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,27562,-0.022607991042242,0.00407590497968613,-0.0305967648024268,-0.0146192172820572,2.93713409683791e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,28091,-0.0169291080660828,0.00305516284165063,-0.022917227235718,-0.0109409888964475,3.03190644478506e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,23188,-0.0132680853647099,0.00239715392359776,-0.0179665070549615,-0.00856966367445831,3.14718778965002e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,23872,0.0239459756394183,0.00433784714505448,0.0154437952351116,0.0324481560437251,3.42051568109825e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23188,-0.0168146452976425,0.00305248481101794,-0.0227975155272376,-0.0108317750680473,3.6572758646138e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,23846,-0.0279917365163346,0.00510615011453776,-0.0379997907408286,-0.0179836822918406,4.24891950111366e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,28307,-0.0209952011350761,0.00383308273007325,-0.0285080432860196,-0.0134823589841325,4.35373400812609e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,28176,0.0210355619713398,0.00384255544341151,0.0135041533022533,0.0285669706404264,4.42820664602475e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,27562,-0.0198698572804844,0.0036337255129689,-0.0269919592859034,-0.0127477552750653,4.58632537598451e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,28553,-0.0102726359445416,0.00188007903496891,-0.0139575908530806,-0.0065876810360025,4.69575121610504e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,28428,-0.0174047082935947,0.00319757952668948,-0.0236719641659061,-0.0111374524212833,5.27974566051712e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,23845,-0.0104675021733239,0.00192362185564207,-0.0142378010103824,-0.00669720333626549,5.33365426069371e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],27601,-0.0178393869372005,0.00329339833596736,-0.0242944476756965,-0.0113843261987045,6.12125466439173e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,27965,-0.0225670876073887,0.00417428699964119,-0.0307486901266854,-0.0143854850880919,6.48977928073403e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,28521,-0.0208057756831735,0.00384999279402824,-0.0283517615594688,-0.0132597898068781,6.56536167623622e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,28187,-0.0110982166082473,0.00205647064770356,-0.0151288990777462,-0.0070675341387483,6.84137129129e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,23862,0.0147585054569632,0.00273954440495914,0.00938899842324333,0.0201280124906831,7.22366080431518e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,23198,-0.0116036716809285,0.00215725896586512,-0.0158318992540241,-0.00737544410783284,7.56694914337934e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,23188,0.00964416701253729,0.00179349738123709,0.00612891214531259,0.013159421879762,7.63441032364897e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23170,-0.0292254006342816,0.00543535651601631,-0.0398786994056735,-0.0185721018628896,7.65101572784712e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,28553,-0.0149690801506755,0.00278512286116324,-0.0204279209585554,-0.0095102393427955,7.73297125319982e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,28307,0.0101254310711982,0.00188429636211794,0.00643221020144708,0.0138186519409494,7.77948953367646e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",28091,-0.0122443093236249,0.00228146017970913,-0.0167159712758548,-0.00777264737139505,8.07473934078219e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,27544,-0.0151412617756723,0.00282340621308715,-0.0206751379533231,-0.00960738559802148,8.26179574585984e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,28215,0.0143138760467893,0.00266983369372731,0.00908100200708377,0.0195467500864948,8.32572875733331e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,28224,0.0188746065551956,0.00352141668659942,0.0119726298494608,0.0257765832609305,8.38992265345867e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,23198,-0.0116969248648257,0.00218310172108631,-0.0159758042381549,-0.00741804549149658,8.4979478363709e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,27544,-0.0288571760575115,0.00539330376915888,-0.0394280514450629,-0.0182863006699601,8.83840934321286e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,23725,-0.015353409223802,0.00287408368700579,-0.0209866132503334,-0.00972020519727066,9.27641048327167e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,23862,0.00880754510838342,0.0016505781769045,0.00557241188165061,0.0120426783351162,9.58669677843035e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,23163,-0.0248972966809344,0.0046679806947169,-0.0340465388425795,-0.0157480545192892,9.71700806217965e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,28091,0.0102705357754519,0.00192614150854528,0.00649529841870311,0.0140457731322006,9.77893018347645e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,28496,-0.00748774974521237,0.00140550867903628,-0.0102425467561235,-0.00473295273430126,1.00367497885438e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,27481,-0.0253554156467299,0.00476318315830946,-0.0346912546370164,-0.0160195766564434,1.02752502778399e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23194,-0.0141711908907356,0.00266465367838189,-0.0193939121003641,-0.00894846968110705,1.05763274112853e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,27657,-0.0201696780082247,0.00379417709706148,-0.0276062651184652,-0.0127330908979842,1.06921258113469e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23139,-0.0100746663224111,0.00189510062455389,-0.0137890635465367,-0.00636026909828547,1.06960159340883e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,28176,-0.0283615698045394,0.00533594537686307,-0.038820022743191,-0.0179031168658877,1.07355538797008e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,28452,0.0119721996984664,0.0022536542251218,0.0075550374172277,0.0163893619797052,1.09033753592202e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,27965,-0.0103144057445462,0.00195007367064565,-0.0141365501390116,-0.00649226135008068,1.23749584174272e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,28452,-0.0165341326667806,0.00312914847305002,-0.0226672636739586,-0.0104010016596026,1.27387366717887e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,28276,0.0321321392003432,0.00608601371605269,0.0202035523168799,0.0440607260838065,1.30372668310966e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",28276,-0.0310792825154419,0.00588912947891198,-0.0426219762941093,-0.0195365887367744,1.31996452499931e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,28187,0.0140068365591976,0.00265503362500613,0.00880297065418555,0.0192107024642096,1.3331548565736e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",23738,0.0315803587604709,0.00599098918866091,0.0198380199506955,0.0433226975702463,1.3663831958207e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,27562,-0.0396742579596651,0.00754178779003295,-0.0544561620281297,-0.0248923538912005,1.44665807676597e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,23738,-0.0273520344126517,0.00520266401013838,-0.0375492558725229,-0.0171548129527805,1.47440393561003e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,23738,-0.0306160259892852,0.0058311645427499,-0.042045108493075,-0.0191869434854954,1.53064842779057e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,28307,-0.011791009172978,0.00224629515637444,-0.0161937476794719,-0.00738827066648405,1.53952982255615e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,23198,-0.0155345020438615,0.00296804894049007,-0.021351877967222,-0.00971712612050095,1.67405742174628e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,28277,-0.0231652814746311,0.00442758724977862,-0.0318433524841972,-0.014487210465065,1.68850847593256e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,23163,-0.0241824549341351,0.00463129235621873,-0.0332597879523238,-0.0151051219159464,1.78979062999791e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,23188,-0.016139119067975,0.0030981091921442,-0.0222114130845777,-0.0100668250513724,1.91129236289951e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,27562,-0.0184409285169601,0.00354384042331642,-0.0253868557466603,-0.0114950012872599,1.96803955191374e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,23893,0.00655603780990501,0.00126139645321642,0.00408370076160082,0.00902837485820921,2.03708879125846e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,28428,-0.0122944493451962,0.00236643935356276,-0.0169326704781792,-0.00765622821221317,2.0575912565177e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,27970,-0.0240888778922243,0.00463875169746767,-0.0331808312192609,-0.0149969245651876,2.08418964798272e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,27562,-0.0141056386334365,0.00272446156016099,-0.0194455832913521,-0.00876569397552098,2.26573997618315e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,28224,-0.0100359296778456,0.00194190123504533,-0.0138420560985344,-0.00622980325715673,2.38102278154412e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,23337,-0.0292412499386318,0.00567169830792581,-0.0403577786221664,-0.0181247212550973,2.54825522722839e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",23775,-0.014079351053453,0.00273291221714668,-0.0194358589990605,-0.00872284310784551,2.60092487648058e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,23872,0.0185788670731711,0.00360885634499534,0.0115055086369803,0.025652225509362,2.65181249493256e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,23735,-0.0205861186581042,0.00400220615496368,-0.028430442721833,-0.0127417945943754,2.71532421034466e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,23188,-0.0156920150317687,0.00305160623912115,-0.0216731632604462,-0.00971086680309128,2.73726295228147e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,27528,0.0197358334583985,0.00384102240334753,0.0122074295478373,0.0272642373689596,2.79317410510002e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,28126,0.0115463398898686,0.00224720333742274,0.00714182134852,0.0159508584312172,2.79394099677767e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,27562,-0.021019521910221,0.00409420853583522,-0.029044170640458,-0.012994873179984,2.85629106104791e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,23198,-0.025335718787792,0.00493970374205557,-0.0350175381222209,-0.0156538994533631,2.93636400727205e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,23795,-0.0103405454749055,0.00201687604005747,-0.0142936225134182,-0.00638746843639291,2.96684426240318e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,28176,-0.0311017086820351,0.00606874913665564,-0.0429964569898801,-0.01920696037419,2.99667005776122e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,23872,-0.00967039876206066,0.00188732618558227,-0.0133695580858019,-0.0059712394383194,3.01671931218665e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,27544,-0.0201913025212171,0.00394190483603471,-0.0279174359998451,-0.0124651690425891,3.03994784148598e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,23795,-0.0272755740856169,0.00532843338287127,-0.0377193035160446,-0.0168318446551892,3.09759687229075e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,23071,-0.0128180275554788,0.002504345710196,-0.017726545147463,-0.00790950996349463,3.10753754847111e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,27872,0.0089322876980877,0.00174743170965224,0.00550732154716931,0.0123572538490061,3.2143933284528e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,23738,-0.0139960204709725,0.0027411351406895,-0.0193686453467239,-0.00862339559522111,3.31730469282275e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,28428,-0.00814850205315602,0.00159639873491439,-0.0112774435735882,-0.00501956053272382,3.34155342887099e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,28336,-0.0160223276734126,0.00314362742206832,-0.0221838374206665,-0.0098608179261587,3.47728199222625e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,28232,-0.0138086332022442,0.00271649509977932,-0.0191329635978117,-0.00848430280667675,3.73392228127635e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,23846,0.00958295118535887,0.00188523299723911,0.00588789451077021,0.0132780078599475,3.74002662968778e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,28176,0.0118872528330861,0.0023442838160604,0.00729245655360774,0.0164820491125645,3.98782984641952e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,23188,-0.0153412304189183,0.0030287630002853,-0.0212776058994774,-0.00940485493835908,4.11143672510291e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,28336,0.0104686342014968,0.00207229268770708,0.0064069405335909,0.0145303278694026,4.40576594410833e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,23188,-0.0171162472184387,0.00339136574139682,-0.0237633240715765,-0.010469170365301,4.52179149055446e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",28363,-0.0244906722683021,0.00486179800421088,-0.0340197963565554,-0.0149615481800488,4.74868725245851e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,27777,-0.0257370229623794,0.00511032862906816,-0.035753267075353,-0.0157207788494058,4.7764812775125e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,28452,0.02164842764529,0.00430163851894069,0.0132172161481663,0.0300796391424138,4.8681917971085e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,23549,0.0371486646752056,0.00738363703062503,0.0226767360951805,0.0516205932552306,4.90967560187651e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,23198,-0.0250216314665505,0.00498653020159591,-0.0347952306616785,-0.0152480322714225,5.26408593773609e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,28553,0.0101074008815885,0.00201487470577349,0.00615824645827247,0.0140565553049046,5.29666001903576e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,28553,-0.0193389112639678,0.00385673108766869,-0.0268981041957984,-0.0117797183321372,5.35379660922397e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",28452,0.0251141494697188,0.0050117421866022,0.0152911347839785,0.0349371641554591,5.44549219753131e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,23700,-0.0139913851085526,0.00279244148322559,-0.0194645704156747,-0.00851819980143041,5.46939424723564e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23198,0.0312291908914848,0.00623768868187606,0.0190033210750077,0.0434550607079618,5.58254774335926e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,28091,0.00815657387177503,0.00163697851993005,0.00494809597271212,0.0113650517708379,6.30752573713787e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,23893,-0.0110219689358744,0.00221606848976054,-0.0153654631758051,-0.00667847469594373,6.61565441783339e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,28174,0.0224928292316042,0.00452556789830973,0.0136227161509171,0.0313629423122913,6.72873954378119e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,23198,-0.0144223575911981,0.00290578048795033,-0.0201176873475808,-0.00872702783481547,6.9784555365738e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,28553,-0.013330726983337,0.00268609926445872,-0.0185954815416761,-0.00806597242499796,6.98632394664241e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,28452,-0.013541566603762,0.00273000459556592,-0.0188923756110712,-0.00819075759645282,7.07999260047504e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,28521,-0.0206703178788839,0.00417342702594802,-0.028850234849742,-0.0124904009080258,7.3555875762731e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,28091,-0.0285462961021202,0.00577767591109111,-0.0398705408878588,-0.0172220513163817,7.82529702763652e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,28363,0.0116545794807955,0.00235909870207493,0.00703074602472861,0.0162784129368623,7.84592129128797e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,27385,0.0235779142689843,0.00477285268847278,0.0142231229995776,0.0329327055383909,7.85810362047716e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23198,0.0259769104558131,0.00526127953070459,0.0156648025756321,0.0362890183359941,7.97310130630202e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,27412,-0.0376098560349718,0.00762216584059484,-0.0525493010825377,-0.0226704109874059,8.0920812209259e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,23738,-0.0280987231944524,0.00569932621355171,-0.0392694025730138,-0.0169280438158911,8.27068810144365e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,28422,-0.0193746648219652,0.00393430581718526,-0.0270859042236483,-0.0116634254202821,8.50312350675718e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,28091,-0.0258353833092463,0.00525037213670239,-0.036126112697183,-0.0155446539213096,8.6733473897255e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,27544,-0.0285921028475209,0.00581402045621945,-0.0399875829417111,-0.0171966227533308,8.80328615394433e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,23393,-0.0114218872447637,0.00232540002375589,-0.0159796712913252,-0.0068641031982021,9.08557530108081e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,28033,-0.0202135940018479,0.00412829312521071,-0.0283050485272609,-0.0121221394764349,9.81729891841965e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,28307,-0.0305317115342279,0.00624004846082129,-0.0427622065174377,-0.0183012165510182,9.99246937891104e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,28428,0.0100235834415515,0.00205015478352708,0.00600528006583839,0.0140418868172645,1.01807135963981e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,23188,-0.0146936392369994,0.00300575541854869,-0.0205849198573548,-0.00880235861664392,1.02285893150656e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,28237,-0.0166393865738428,0.00340433849007473,-0.0233118900143893,-0.00996688313329636,1.025801084719e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,28117,0.0140236923193018,0.00286966991340855,0.00839913928902103,0.0196482453495826,1.03017662639407e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,28224,-0.0120478795140595,0.00247020527281372,-0.0168894818487743,-0.00720627717934457,1.08144708697777e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,23337,-0.0223080406484723,0.00458011248644373,-0.031285061121902,-0.0133310201750426,1.11970722510045e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,28270,-0.0163458114990078,0.00336286328729016,-0.0229370235420965,-0.00975459945591908,1.17608823664356e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,28452,0.0112957571441174,0.00232567034502408,0.00673744326787021,0.0158540710203646,1.19816796636706e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,23488,0.00269228704094191,0.000555294888079885,0.00160390906030533,0.00378066502157848,1.25262378058047e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,23725,-0.026297733823438,0.00542823756555305,-0.036937079451922,-0.015658388194954,1.27656502776377e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,28307,0.0099165692337613,0.00204767492000906,0.00590312639054354,0.0139300120769791,1.28669792655217e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,28224,0.011395717949143,0.00235498517407283,0.00677994700796022,0.0160114888903257,1.31198362736658e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23198,-0.0228596880027979,0.00472437180852195,-0.0321194567475009,-0.0135999192580949,1.31548915743256e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,22978,-0.0168059249198606,0.00347863565402962,-0.0236240508017587,-0.00998779903796256,1.36599330954976e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,23862,-0.0166011453337362,0.00343869992748735,-0.0233409971916114,-0.00986129347586096,1.38946871919671e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,27918,-0.0101454109813473,0.00210498384728851,-0.0142711793220328,-0.00601964264066179,1.44522803623714e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,28291,0.00769823448483477,0.00159909734497093,0.00456400368869175,0.0108324652809778,1.48618811495264e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,23188,0.0141343652634273,0.0029394524549358,0.00837303845175311,0.0198956920751014,1.53018948059683e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,28224,-0.00578905787871531,0.00120438970476515,-0.008149661700055,-0.00342845405737561,1.54283834709888e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,23071,-0.0141681327819647,0.00294880322779604,-0.0199477871084449,-0.00838847845548446,1.55953286126762e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,27531,-0.0104374793334956,0.00217379535896104,-0.0146981182370592,-0.00617684042993191,1.58308261579964e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",27544,-0.0166858737810144,0.0034870644219789,-0.0235205200480931,-0.0098512275139358,1.71806781298417e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,23545,-0.0104150091558714,0.00217828462269034,-0.0146844470163445,-0.00614557129539833,1.75227245070621e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23198,0.0227597248722009,0.00476117670231302,0.0134278185356674,0.0320916312087344,1.76130399964416e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,27508,-0.0190552540544916,0.0039886917929832,-0.0268730899687387,-0.0112374181402445,1.78563409893691e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,27702,-0.013877963327615,0.0029087560430784,-0.0195791251720487,-0.00817680148318137,1.84156573098347e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,23846,-0.0237950813433634,0.00499052193716411,-0.0335765043402051,-0.0140136583465217,1.87111691301454e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,23775,0.0100028279769056,0.00209847491069145,0.00588981715195031,0.0141158388018608,1.88363409619021e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,28194,0.0306363975373644,0.00643108298646449,0.0180314748838939,0.0432413201908348,1.90925274125159e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",28050,-0.0340248183700559,0.00716630619569409,-0.0480707785136163,-0.0199788582264955,2.06566598624196e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,27562,-0.0312320656507826,0.00658656477583297,-0.0441417326114152,-0.01832239869015,2.12903757519464e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,27136,0.0102476560302807,0.00216218093937651,0.00600978138910277,0.0144855306714587,2.15332389090552e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,23872,0.0193055654569772,0.00407676935062001,0.011315097529762,0.0272960333841925,2.19764586617664e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,28176,0.0151534978844825,0.00320025483993393,0.00888099839821204,0.0214259973707531,2.20021721295716e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,27968,0.0189062549581323,0.00399327771442117,0.0110794306378668,0.0267330792783978,2.20648991824358e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,23188,-0.031527837199039,0.00665982929391225,-0.044581102615107,-0.018474571782971,2.21404557626998e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,23071,0.00889877497968739,0.00188886715905564,0.00519659534793833,0.0126009546114364,2.47733659186308e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,23795,0.012157449084877,0.00258322317784452,0.00709433165630176,0.0172205665134523,2.53660408846438e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,28187,0.0101341249402055,0.00215539370444198,0.00590955327949925,0.0143586966009118,2.59160029736895e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,23725,-0.0126709064463653,0.00270603831061381,-0.0179747415351683,-0.00736707135756219,2.85026452587069e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",28091,-0.0193442152685778,0.00413591549464474,-0.0274506096380815,-0.0112378208990741,2.9227103865814e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,28187,-0.00751910650301175,0.00160772941174386,-0.0106702561500297,-0.00436795685599379,2.92668060637687e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,28452,0.00907208042605089,0.00194079294858797,0.00526812624681846,0.0128760346052833,2.9613724237322e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,28307,0.0087570077435298,0.00187343632271697,0.00508507255100454,0.0124289429360551,2.96313189949101e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,28187,-0.013633937410924,0.00292326636475081,-0.0193635394858356,-0.00790433533601241,3.11635440698173e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,28307,0.0117671227193458,0.00252853193313496,0.0068112001304013,0.0167230453082903,3.27448713384419e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,28438,-0.0084563324205221,0.00181748348496129,-0.0120186000510462,-0.00489406478999797,3.28980834009464e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,23337,-0.0119473763791543,0.00256859425557757,-0.0169818211200863,-0.00691293163822228,3.31611985646284e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,23163,-0.015366806513678,0.00330880012848698,-0.0218520547655125,-0.0088815582618435,3.43233646450731e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,23337,-0.0133747430498148,0.00288048675176276,-0.0190204970832698,-0.00772898901635979,3.44884203590627e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,28307,0.0132099290221927,0.00284635110269285,0.00763108086091466,0.0187887771834707,3.48272892157177e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,23198,-0.0193756938492696,0.00417652447950174,-0.027561681829093,-0.0111897058694462,3.51686790592716e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,27871,0.0136817995137514,0.00295355155628399,0.00789283846343477,0.019470760564068,3.63222565229382e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,27489,-0.0145650408259357,0.00314683802380795,-0.0207328433525993,-0.00839723829927211,3.70062281238504e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,28091,-0.0187422129745065,0.00405301999547538,-0.0266861321656382,-0.0107982937833747,3.77614713632429e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",23675,-0.0344075120078679,0.00745069478722311,-0.0490108737908252,-0.0198041502249106,3.89442700265862e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,28176,-0.0126542784398795,0.00274614080865317,-0.0180367144248397,-0.00727184245491929,4.08297580786559e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,23256,-0.0206272071552525,0.00448349555375209,-0.0294148584406066,-0.0118395558698984,4.23300584312334e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,23852,0.00612397524817222,0.00133304316005745,0.00351121065445961,0.00873673984188483,4.37093480483016e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,28307,-0.00845288819927294,0.00184537062452193,-0.0120698146233359,-0.00483596177520996,4.65639524191037e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,28187,0.023724441110097,0.00518425141633681,0.0135633083340768,0.0338855738861171,4.75398711581155e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,23198,-0.01029099495481,0.00226039598051533,-0.0147213710766201,-0.00586061883299999,5.32208263384642e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,23893,0.00609470084045295,0.00133916901642553,0.00346992956825891,0.00871947211264698,5.36274490903067e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,23766,-0.00800781282153553,0.00175986000197122,-0.0114571384253991,-0.00455848721767195,5.38460073976242e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,27832,-0.0146268673211016,0.00322497531555321,-0.0209478189395858,-0.00830591570261727,5.77076786162019e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,28404,-0.0177217598721764,0.00391637861567042,-0.0253978619588904,-0.0100456577854624,6.06295315378616e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,23509,-0.0338264639486432,0.00748715662369724,-0.0485012909310898,-0.0191516369661966,6.27506116609667e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,28176,0.00820179992202529,0.00181747610051246,0.00463954676502088,0.0117640530790297,6.42537230769033e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,23198,-0.0141251334729645,0.00313194800668952,-0.020263751566076,-0.00798651537985309,6.51406743573831e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,28415,-0.0287987057108462,0.00638806803791761,-0.0413193190651648,-0.0162780923565277,6.56401906257099e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,23738,-0.0315982946260816,0.00701085325340899,-0.0453395670027632,-0.0178570222494,6.6047944354136e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,23615,-0.0185943221239031,0.00412642716255392,-0.0266821193625088,-0.0105065248852975,6.63295355102114e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,23198,-0.0158476303028729,0.00353226841533648,-0.0227708763969324,-0.00892438420881335,7.27401260058756e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,23738,-0.0216720957943206,0.00483339694053375,-0.0311455537977668,-0.0121986377908745,7.36609422012127e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23393,-0.0345692519769139,0.00771469652057088,-0.0496900571572329,-0.019448446796595,7.46601293433318e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,23337,-0.0354455893881034,0.0079112807949362,-0.0509516997461784,-0.0199394790300285,7.48622338548351e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,28187,0.00602869917993255,0.00134607117478784,0.00339039967734838,0.00866699868251671,7.5380661194902e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,23795,-0.0202155811218989,0.00452209401995438,-0.0290788854010095,-0.0113522768427883,7.84331164265917e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,28320,0.0131569084706092,0.00294392499801639,0.00738681547449713,0.0189270014667214,7.88271412254079e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,23163,0.00970939856961812,0.00217342512539832,0.00544948532383741,0.0139693118153988,7.9578271286893e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,23795,-0.0147718959197482,0.00331697329768752,-0.0212731635832158,-0.0082706282562807,8.48954862500992e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,23795,-0.020021149418994,0.00449598100082963,-0.02883327218062,-0.0112090266573679,8.50160359604725e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,23665,-0.0151166832589959,0.0034041441876444,-0.0217888058667789,-0.00844456065121287,9.00849767168645e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,27562,-0.0159701691436796,0.003596786208341,-0.023019870112028,-0.00892046817533125,9.02571759976042e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23071,0.00621185354908527,0.00140040659829448,0.00346705661642808,0.00895665048174246,9.2176618935977e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,28238,-0.0197533907232395,0.00445671309995597,-0.0284885483991532,-0.0110182330473259,9.35938694258545e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,28176,-0.0246534400593314,0.0055694822115975,-0.0355696251940625,-0.0137372549246003,9.6123870835207e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,27623,-0.0221322240098743,0.00500313475443651,-0.0319383681285699,-0.0123260798911788,9.74083761286733e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,27544,0.0135725652295693,0.00307164439465502,0.00755214221604551,0.0195929882430932,9.96917225623526e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,28182,-0.00899415223628663,0.00204036732180893,-0.0129932721870321,-0.00499503228554112,1.04664571905743e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,28070,-0.023743064274253,0.00539060670204855,-0.0343086534102681,-0.0131774751382379,1.06407777362533e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,28521,-0.0296872120389742,0.00674041833683216,-0.0428984319791652,-0.0164759920987831,1.06483957097584e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,27562,-0.0171406913822409,0.00389677629681014,-0.0247783729239888,-0.00950300984049304,1.09316905179965e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,28224,-0.0200963408895061,0.00457543008647678,-0.0290641838590006,-0.0111284979200116,1.12602224762238e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,28553,-0.0105177154978927,0.00239862932903474,-0.0152190289828008,-0.00581640201298463,1.16461429129507e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,23198,-0.0269705477652734,0.00615374104364923,-0.0390318802108259,-0.014909215319721,1.17684351400087e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",23795,0.012662185853976,0.00289137425365681,0.00699509231680863,0.0183292793911433,1.19571227811021e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,28440,-0.0244003775461646,0.00557502962421568,-0.0353274356096273,-0.0134733194827019,1.20904442772286e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23188,-0.0107282891448914,0.00245312789828263,-0.0155364198255253,-0.0059201584642574,1.22910041351018e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,23738,-0.0127956075453628,0.00292686824388514,-0.0185322693033776,-0.0070589457873479,1.23764818844211e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,28176,-0.0112713535890649,0.00258485419641507,-0.0163376678140385,-0.00620503936409141,1.30203376277896e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,28191,-0.0169163051920528,0.0038849076052331,-0.0245307240983097,-0.00930188628579591,1.33923637951566e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,28187,0.0119836430902283,0.00275306251030167,0.00658764057003703,0.0173796456104196,1.34857761386507e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,23393,-0.0157996612824992,0.00363517926389623,-0.0229246126397358,-0.0086747099252626,1.39023102161031e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,28138,0.0233933300133475,0.00538899417497405,0.0128309014303984,0.0339557585962967,1.42366018558158e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,23795,-0.0225035786906066,0.00518645183600351,-0.0326690242891735,-0.0123381330920398,1.43777299188934e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,23071,0.00966635381234049,0.00222992614802663,0.00529569856220829,0.0140370090624727,1.46489686379761e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,28176,-0.0253131548533665,0.00584102447647905,-0.0367615628272654,-0.0138647468794676,1.47142334495587e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,23075,-0.0122455186736883,0.002827011110566,-0.0177864604503976,-0.00670457689697889,1.48645805753685e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,28187,-0.00814191934840362,0.00188065122316427,-0.0118279957458056,-0.00445584295100166,1.50094046547843e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,23795,-0.00754933037551086,0.00174432799336098,-0.0109682132424984,-0.00413044750852335,1.51131196431645e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,23738,0.0335884174074785,0.00776195594316184,0.0183749837588813,0.0488018510560757,1.51556134519533e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,27935,-0.00841244216439265,0.00194415344581172,-0.0122229829181836,-0.00460190141060168,1.51646901698871e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,28553,-0.0197540815973302,0.00457227571293286,-0.0287157419946786,-0.0107924211999818,1.56269280167023e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,28111,0.010011905415079,0.00231784452475843,0.00546893014655252,0.0145548806836056,1.5692651190372e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,28494,0.0135919942189383,0.00314913862102803,0.0074196825217234,0.0197643059161533,1.59346159920031e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23188,-0.0102878627790027,0.00238710235718822,-0.0149665833990916,-0.00560914215891375,1.6409776049521e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,28142,0.00861045265605525,0.00199923376849827,0.00469195446979865,0.0125289508423119,1.66136725866681e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,28452,-0.0176548258639769,0.00410301199047194,-0.0256967293653019,-0.00961292236265194,1.69144066399799e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,28320,-0.00758069728472179,0.0017627891004119,-0.0110357639215291,-0.00412563064791447,1.71060862195245e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,28521,0.0228230965469416,0.0053074676363006,0.0124204599797925,0.0332257331140908,1.71221792000107e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,23188,-0.0128296958775253,0.00298612232783075,-0.0186824956400735,-0.006976896114977,1.74269711485513e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,23725,-0.0132685503318813,0.00308887832991459,-0.0193227518585139,-0.00721434880524869,1.74923500773105e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,23188,0.0170947899373443,0.00398005896693698,0.0092938743621478,0.0248957055125408,1.75317290249009e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,23775,0.0198588016381947,0.0046307733968395,0.0107824857803893,0.0289351174960002,1.80640686187141e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,23188,-0.0159957791089817,0.00375027861675151,-0.0233463251978147,-0.00864523302014876,2.00492624208685e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28553,0.00848443478287322,0.00199196176853901,0.00458018971653676,0.0123886798492097,2.05690783201231e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,23775,-0.00786713856365964,0.0018489242600326,-0.0114910301133235,-0.00424324701399574,2.09866572700159e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,23163,-0.0201206670458968,0.00473247627200163,-0.02939632053902,-0.0108450135527736,2.13065911356033e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,28428,0.0228593113863287,0.00538233817069434,0.0123099285717678,0.0334086942008896,2.17246560174426e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,28411,0.0122524475938858,0.00288895994884596,0.00659008609414775,0.0179148090936239,2.23103096675916e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,28187,-0.00721146702413809,0.0017087003080641,-0.0105605196279437,-0.00386241442033245,2.445889549062e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,27682,-0.026983827777176,0.00639763907033322,-0.0395232003550291,-0.0144444551993229,2.47504660104286e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,28206,0.0111127316683748,0.00263607602369238,0.00594602266193777,0.0162794406748119,2.49852932709642e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,23893,0.00873715557214976,0.00207304931061283,0.00467397892334862,0.0128003322209509,2.51096392438564e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,28428,-0.0174086712549921,0.00413267980400242,-0.0255087236708369,-0.00930861883914738,2.53403451389058e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,23893,0.00648693468233159,0.00154156905239121,0.00346545933964482,0.00950841002501835,2.58572580790375e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,23725,-0.0193913621434088,0.0046114363671812,-0.0284297774230839,-0.0103529468637336,2.6197124175781e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,27562,-0.028087705394521,0.00670008841453018,-0.0412198786870001,-0.0149555321020418,2.77197899389349e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,28187,-0.0146156415085667,0.00349289380853201,-0.0214617133732895,-0.00776956964384399,2.86794617905496e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23071,0.00739970477352882,0.0017716315260382,0.00392730698249395,0.0108721025645637,2.96759153767875e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,28174,-0.0175045232411039,0.00419215498213776,-0.0257211470060939,-0.00928789947611395,2.98169622934671e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,23163,-0.0123704024410469,0.00296766621197783,-0.0181870282165235,-0.0065537766655704,3.07867690895743e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,23893,0.00891184523423556,0.00214226088786399,0.00471301389402214,0.013110676574449,3.19333867975897e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,23337,-0.0165000881036549,0.00396934669229238,-0.024280007620548,-0.00872016858676182,3.23778068807238e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,28344,-0.00927500453538648,0.0022336329524232,-0.013652925122136,-0.004897083948637,3.2992560909791e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,28091,-0.0127318231349518,0.00307169368016084,-0.018752342748067,-0.0067113035218365,3.40977890213132e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,23198,0.0120174903489126,0.00290302648961195,0.00632755842927321,0.017707422268552,3.49077373202883e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,28176,-0.0265363841238878,0.00642093240130131,-0.0391214116304384,-0.0139513566173373,3.59417277439569e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,23337,-0.00908355887968624,0.00219786010105673,-0.0133913646777574,-0.00477575308161505,3.59448763920876e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,27977,0.0114126648586807,0.00276466812207003,0.0059939153394234,0.0168314143779379,3.66926266424941e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,23795,0.0126538272691036,0.00306894904106788,0.00663868714861059,0.0186689673895967,3.7494638831786e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,28428,-0.00754270186416152,0.00182955853412112,-0.0111286365910389,-0.00395676713728412,3.75536915545344e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,23775,-0.0211593166467587,0.00514464171514552,-0.0312428144084439,-0.0110758188850735,3.92060406907679e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,28336,0.00970854931816511,0.00236059867733845,0.00508177591058175,0.0143353227257485,3.92078747109481e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,28080,-0.00960586215276408,0.00234063081080673,-0.0141934985419453,-0.00501822576358288,4.07279338026076e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,23337,-0.00801090151203048,0.00195227870681332,-0.0118373677773846,-0.00418443524667638,4.08576817766313e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,23744,-0.0207292015412732,0.00507722824434933,-0.0306805689001979,-0.0107778341823485,4.46460649938419e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,28176,0.0164046580564225,0.00401813626668534,0.00852911097371922,0.0242802051391258,4.46472303522731e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,27562,-0.0217388569465529,0.00532553305011863,-0.0321769017247854,-0.0113008121683204,4.47745370887795e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,23738,-0.00995544049870908,0.00244061303978119,-0.0147390420566802,-0.00517183894073794,4.53631225107005e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,28091,-0.0105845422297269,0.00259729166222908,-0.0156752338876959,-0.00549385057175792,4.60966518912028e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,27562,0.0130886795308979,0.00321362508734927,0.00678997435969329,0.0193873847021024,4.65669956056487e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,28428,0.0356266826785527,0.00875662201754705,0.0184637035241605,0.052789661832945,4.74359530843351e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,27651,-0.0114356826098252,0.00281318249276629,-0.0169495202956471,-0.00592184492400324,4.81582760504562e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,28224,-0.0240880869660821,0.00592883011006052,-0.0357085939818007,-0.0124675799503635,4.86033635573417e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,23188,-0.0156120413157764,0.00384801952654656,-0.0231541595878076,-0.00806992304374512,4.98351465597347e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,27562,-0.0175703008800175,0.00433325255475654,-0.0260634758873403,-0.00907712587269471,5.03236336858065e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,23071,-0.0211387429604653,0.0052174698812516,-0.0313649839277185,-0.0109125019932122,5.10500995960882e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,27544,-0.0143824911634027,0.0035503456552382,-0.0213411686476696,-0.00742381367913584,5.11364425525536e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,28187,-0.0112608710603013,0.00278473772757232,-0.016718957006343,-0.00580278511425955,5.27358118437691e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,23795,-0.0184514010267415,0.00456830590213173,-0.0274052805949197,-0.00949752145856332,5.38472948280742e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,28224,-0.0298576640906976,0.00740182166543834,-0.0443652345549567,-0.0153500936264384,5.50202531849358e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,23071,0.0104138362803624,0.00258200517398793,0.00535310613934604,0.0154745664213787,5.51910313669029e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,27682,0.0137547589517724,0.0034157534147485,0.00705988225886531,0.0204496356446794,5.66774674479603e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,27562,-0.0122651981960374,0.00304609988417902,-0.0182355539690283,-0.00629484242304654,5.67586514677891e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,23071,-0.017288528364814,0.00429699931012688,-0.0257106470126626,-0.00886640971696529,5.75479265056758e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,23188,-0.00896068380247431,0.00222720119818744,-0.0133259981509217,-0.00459536945402694,5.7571995510703e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,23738,-0.0109072906579068,0.00271269365188895,-0.0162241702156092,-0.00559041110020449,5.81717643160312e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,27639,0.0154796181770322,0.00385262252537374,0.00792847802729969,0.0230307583267648,5.88637817567409e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,23235,0.00939608365760298,0.00234233925551413,0.00480509871679529,0.0139870685984107,6.05460787960423e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,28521,0.0200196177186094,0.00500131128502566,0.0102170475999591,0.0298221878372597,6.27359583326375e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,27965,0.0115390739908961,0.00288424768456911,0.00588594852914063,0.0171921994526515,6.33119914963979e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,28082,-0.0125543468191882,0.00313849446497903,-0.0187057959705471,-0.00640289766782928,6.34732244403324e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,28320,-0.0093641273683036,0.00234167118182283,-0.0139538028846763,-0.00477445185193085,6.37969105946641e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,23240,-0.0116682146801327,0.00291882903392637,-0.0173891195866284,-0.00594730977363707,6.41945710303449e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,28120,0.010105073804623,0.0025335264508875,0.00513936196088346,0.0150707856483625,6.6649182040079e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,23893,0.00455266550199777,0.00114235630102098,0.00231364715199665,0.00679168385199889,6.75868705861833e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,23163,-0.0329897653876622,0.00828029684446132,-0.0492191472028064,-0.016760383572518,6.79355205689107e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,23170,-0.0154332154428621,0.00387568633278512,-0.023029560655121,-0.00783687023060331,6.85291285888999e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,28187,0.014181202975925,0.00356168004325456,0.0072003100911461,0.021162095860704,6.86231487495525e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,23198,-0.0107466834770996,0.00270053963848521,-0.0160397411685306,-0.0054536257856686,6.92827418936078e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,27562,-0.0146117803281634,0.00367745294282028,-0.0218195880960912,-0.00740397256023568,7.10513574735917e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,23747,-0.0174660711978814,0.00440117284163774,-0.0260923699674914,-0.00883977242827147,7.25379860666032e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,28452,0.0169899780361128,0.00428717865002573,0.00858710788206237,0.0253928481901632,7.42024819743377e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,27544,-0.0222181342533923,0.00560691295257661,-0.0332076836404424,-0.0112285848663421,7.43147549882591e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,27905,-0.00760830937731466,0.00192396372643724,-0.0113792782811317,-0.00383734047349767,7.6885068951667e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,28144,0.0237292228427951,0.00600565088584563,0.0119581471065377,0.0355002985790526,7.79665675533375e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,28176,-0.0160285178577908,0.00405696241309707,-0.0239801641874611,-0.00807687152812057,7.80583931467852e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,28277,-0.0191113350574162,0.00484670008446162,-0.0286108672229609,-0.00961180289187138,8.06072836563384e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,28276,0.0220906196992664,0.00560783402114514,0.0110992650178219,0.0330819743807109,8.19354248086792e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,27508,-0.00771753798636896,0.00196063990498468,-0.0115603922001389,-0.00387468377259899,8.2973859761726e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,28336,-0.00801591185534336,0.0020369997243238,-0.012008431315018,-0.00402339239566871,8.33410530155677e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,27544,-0.0172549211483178,0.00438807906444501,-0.0258555561146301,-0.00865428618200563,8.4368723713984e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,27682,-0.0143257851053997,0.00365251019266259,-0.0214847050830184,-0.007166865127781,8.79648256415255e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",23071,0.0151286830199161,0.00385959423511419,0.00756387831909229,0.0226934877207399,8.88932444292318e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,23775,0.0105849671358209,0.0027063576251282,0.0052805061905696,0.0158894280810721,9.21135362985038e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,23163,-0.0135654570851756,0.00347080370084159,-0.0203682323388252,-0.00676268183152614,9.31551510702641e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,23738,-0.0218560675881178,0.00559753410145347,-0.0328272344269666,-0.010884900749269,9.4646947801735e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,23738,-0.015733297771693,0.004043393783832,-0.0236583495880037,-0.00780824595538226,0.000100058363859634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,23198,-0.00847819754711599,0.00218051342627776,-0.0127520038626204,-0.00420439123161158,0.000101286087073947
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,28176,0.016228643625544,0.00417502514232239,0.00804559434659212,0.0244116929044959,0.000101691073440913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,28182,0.00852471715146573,0.00219317572271313,0.004226092734948,0.0128233415679835,0.000101753151107919
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,23795,-0.0119948140203632,0.00308862390725333,-0.0180485168785798,-0.00594111116214672,0.000103222279557022
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,28187,-0.0151899049228953,0.00391276513611652,-0.0228589245896837,-0.00752088525610693,0.000103776901702415
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,23725,-0.00770464207003344,0.00198532447883006,-0.0115958780485404,-0.00381340609152652,0.000104396161646981
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,23163,-0.0213384507747046,0.00550068479129637,-0.0321197929656455,-0.0105571085837637,0.000105075220439309
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,27682,-0.0306675475819581,0.00792258236722518,-0.0461958090217195,-0.0151392861421968,0.000108681855377027
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,23846,-0.0283505733046625,0.00732434001517517,-0.0427062797344058,-0.0139948668749191,0.000108797216478212
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,23056,0.0126012493648401,0.00325751132577431,0.00621652716632249,0.0189859715633578,0.000109867966502863
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,27196,-0.024236768989766,0.00627226493211083,-0.0365304082567032,-0.0119431297228288,0.000111750309857343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,23188,-0.0152591887397007,0.00395670428388923,-0.0230143291361236,-0.00750404834327786,0.000115314073399823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,28091,-0.0269241221123758,0.00699113515348232,-0.0406267470132011,-0.0132214972115504,0.000117810724016263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,22829,-0.00861058365153431,0.00223686348392723,-0.0129948360800317,-0.00422633122303694,0.00011873002783452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,28091,-0.0360368556263485,0.00937558876615184,-0.0544130096080061,-0.0176607016446908,0.000121465093639802
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,23872,-0.0187419693344813,0.00488288903816252,-0.0283124318492798,-0.00917150681968271,0.000124210988174488
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,27544,-0.0111830168193477,0.00291870458359637,-0.0169036778031966,-0.00546235583549881,0.000127647036640469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,27237,-0.0156862036286676,0.00410321733011544,-0.0237285095956939,-0.00764389766164135,0.000132182989800395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23198,-0.0198853700427334,0.00522350267847924,-0.0301234352925527,-0.00964730479291404,0.000141079726027793
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,27965,0.00925636318721817,0.00243641035596218,0.0044809988895323,0.014031727484904,0.000145482621522514
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,27544,-0.018504067901288,0.00487709336910468,-0.0280631709047332,-0.00894496489784285,0.000148510653639763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,23775,-0.0108889496105793,0.00287164011651146,-0.0165173642389418,-0.00526053498221685,0.00014987359472346
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,28187,0.00931289504265822,0.00245631980686546,0.00449850822120193,0.0141272818641145,0.000150111720485981
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,23738,-0.00877189046224417,0.00231383429405619,-0.0133070056785943,-0.00423677524589404,0.000150375449021845
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23071,0.0112487626780818,0.00296844601991586,0.00543060847904673,0.0170669168771169,0.000151368175179411
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,23188,-0.0123046247806259,0.00325582670941403,-0.0186860451310774,-0.00592320443017443,0.000157687243718618
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,23026,-0.025431936882013,0.00673793267488219,-0.0386382849247821,-0.0122255888392439,0.000160768618032357
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,27910,-0.0287339165365402,0.00761894697816684,-0.0436670526137472,-0.0138007804593332,0.000162684639080118
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,28452,-0.0115001927741386,0.00305034503491816,-0.0174788690425782,-0.00552151650569901,0.000163493402702885
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",27682,-0.0227471582714978,0.00603423524375992,-0.0345742593492673,-0.0109200571937284,0.000163794095001544
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,23738,-0.0292050707568322,0.0077487915639318,-0.0443927022221385,-0.0140174392915258,0.000164310310222565
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,23775,-0.00854964014499222,0.00227039941698138,-0.0129996230022757,-0.00409965728770871,0.000166484149267301
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,23337,-0.0177620300216365,0.00471867491648937,-0.0270106328579557,-0.00851342718531737,0.000167493520153984
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,23738,-0.0176866375454381,0.00470291990603516,-0.026904360561267,-0.00846891452960918,0.000169792493044504
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,28452,-0.00863225776163169,0.00229831345430753,-0.0131369521320744,-0.00412756339118894,0.000173057243636633
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,27638,-0.012867802507899,0.00342803601578059,-0.019586753098829,-0.00614885191696907,0.000174603465402164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,28553,0.00406477648195896,0.00108427653480764,0.00193959447373599,0.00618995849018193,0.000178006553518322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,28053,0.017045229083242,0.00455641953985053,0.00811464678513494,0.025975811381349,0.000183708510298346
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,23795,0.0119201659748419,0.0031952346121322,0.00565750613506276,0.018182825814621,0.000191462618509098
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,23188,-0.0219996852280781,0.00590519822065857,-0.0335738737405689,-0.0104254967155873,0.000195408114945704
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,23163,-0.0174645403264275,0.00468875969944303,-0.0266545093373358,-0.00827457131551913,0.000195959242776558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,28452,-0.00997290572537748,0.00267757770077511,-0.0152209580188967,-0.00472485343185827,0.000196003062511749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,23198,-0.00780116295643366,0.00209741293836979,-0.0119120923156385,-0.00369023359722886,0.000200150216437578
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,23071,0.0105147383595941,0.00283484978012673,0.00495843279054571,0.0160710439286425,0.00020848600983347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,28031,0.00975256913996416,0.00263181084349388,0.00459421988671615,0.0149109183932122,0.000211255059403934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,23795,-0.0170671544077677,0.0046072226577902,-0.0260973108170365,-0.00803699799849886,0.000212342400285853
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,28260,0.0124437127890784,0.00336011454173577,0.00585788828727627,0.0190295372908805,0.000213167822527491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,20725,-0.0266981044636555,0.0072107808156458,-0.0408312348623213,-0.0125649740649897,0.000214017118432658
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,23872,-0.00560214043638285,0.00151583257352082,-0.00857317228048366,-0.00263110859228204,0.000219727649863019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,28253,0.00936308469290102,0.00253426210307635,0.00439593097087138,0.0143302384149307,0.000220648796122351
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,28237,0.00852154011457187,0.00230815276543092,0.00399756069432727,0.0130455195348165,0.00022297714026261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28553,-0.0068563550525096,0.00185811609900543,-0.0104982626065602,-0.00321444749845896,0.000224715150482856
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,27928,0.0121281655323849,0.00329309119782037,0.00567370678465699,0.0185826242801128,0.000231019611961759
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,23846,-0.0120011842327598,0.00326093352253711,-0.0183926139369325,-0.00560975452858707,0.000233481361432509
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,28291,-0.00829046463554466,0.00225443222892134,-0.0127091518042305,-0.00387177746685884,0.000236053313312247
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,28224,-0.0293052891346665,0.00799120325255068,-0.0449680475096658,-0.0136425307596671,0.000245677594147783
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,28404,0.00774365758938779,0.00211441832839346,0.00359939766573661,0.011887917513039,0.000250404031754331
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,22978,-0.0140698454891151,0.00384837625401608,-0.0216126629469867,-0.00652702803124361,0.000256705603145576
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,28274,-0.00708807817662905,0.00193887924064349,-0.0108882814882903,-0.00328787486496782,0.000256885334741452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,23725,-0.00812337695558472,0.00222246178808423,-0.0124794020602298,-0.00376735185093963,0.000257611015398337
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,23843,0.00624623528652898,0.00170907205904833,0.00289645405079426,0.0095960165222637,0.000257983002257688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,27713,0.010343645614327,0.0028305914228811,0.00479568642548003,0.0158916048031739,0.000258426335114403
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27562,-0.0144393311296766,0.00395426533327543,-0.0221896911828964,-0.00668897107645672,0.000261110500190516
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,28553,0.00756392822056987,0.00207365249524102,0.00349956932989748,0.0116282871112423,0.000265135843424298
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,23795,-0.0154465564792166,0.00424285037507306,-0.0237625432143598,-0.00713056974407341,0.000272571372857778
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,23893,-0.00536684059127205,0.00147446763719942,-0.00825679716018292,-0.00247688402236118,0.000273372851702818
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,27562,-0.018491576673117,0.00508641272271632,-0.028460945609641,-0.008522207736593,0.000277963404949635
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,23725,-0.00870514365024459,0.00239607173454332,-0.0134014442499495,-0.00400884305053969,0.000280638541844183
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,28187,0.00710699104103516,0.00195635593172781,0.00327253341484865,0.0109414486672217,0.000280892768724459
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,28235,0.00681819918368085,0.00188312045085516,0.00312728310000473,0.010509115267357,0.000294330362032115
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,23738,-0.0159925633347599,0.0044179310791924,-0.024651708249977,-0.00733341841954277,0.000295305645410432
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,28176,0.0122136730798493,0.00337699021908817,0.00559477225043646,0.0188325739092621,0.000298865528559879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23071,-0.00695676468956161,0.00192405432974434,-0.0107279111758605,-0.0031856182032627,0.000300198785877046
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,28320,0.0294303352211121,0.00814640713496013,0.0134633772365903,0.045397293205634,0.000303576924290304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,28320,0.015957161451494,0.00442071759878299,0.00729255495787936,0.0246217679451087,0.000307161295139016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,23725,-0.0204549228744439,0.00566760812476952,-0.0315634347989922,-0.00934641094989567,0.000307902377732621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,23795,-0.0144683402456274,0.00401861366110773,-0.0223448230213986,-0.00659185746985628,0.000318458456648749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,23396,-0.00616841945288799,0.0017145305521043,-0.00952889933501243,-0.00280793957076356,0.000321667790320772
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,27702,-0.0117064331923813,0.00325802355959543,-0.0180921593691884,-0.00532070701557431,0.000327322517613451
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,28452,0.00407699065420107,0.00113578295101331,0.00185085607021497,0.00630312523818716,0.000331760453651482
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,27965,-0.00936287037544718,0.00261236501798589,-0.0144831058106995,-0.00424263494019483,0.000338871105896951
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,28411,-0.007309815519901,0.00204252723915803,-0.0113131689086507,-0.00330646213115126,0.000345737973832405
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,28176,0.0159554045217031,0.00446423493262481,0.00720550405375843,0.0247053049896477,0.000352087363374755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,28144,0.0172878981550726,0.00484443208160233,0.00779281127513205,0.0267829850350132,0.000359474424784792
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,27702,-0.00770900399949178,0.00216167182295064,-0.011945880772475,-0.00347212722650853,0.000362773541562077
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,28237,-0.00588894740441855,0.0016525873087767,-0.00912801852962089,-0.00264987627921621,0.000366586211979567
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,27879,0.025414051770877,0.0071355787411315,0.0114283174382593,0.0393997861034948,0.000369221057053003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,28521,-0.0213100896367684,0.00598358844656686,-0.0330379229920395,-0.00958225628149737,0.000369451081109709
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,23393,0.0083769180763858,0.00235227789689908,0.00376645339846361,0.012987382754308,0.000369905252738112
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,28156,0.0147297710047659,0.00413807095037907,0.00661915194202295,0.0228403900675089,0.000372068165526154
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,28330,0.0273064708529353,0.0076716177320396,0.0122701000981377,0.0423428416077329,0.000372290112468758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,28063,0.00848032846790136,0.00238324272517813,0.00380917272655223,0.0131514842092505,0.000373857355630189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,27965,0.00878582163474582,0.00247011518777967,0.00394439586669767,0.013627247402794,0.000375953258703834
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,28095,-0.0450669216761748,0.0126719426069228,-0.0699039291857434,-0.0202299141666062,0.000376541917676018
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,27910,-0.0084744703611666,0.00238820901421583,-0.0131553600290296,-0.00379358069330358,0.000388123309222843
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,27965,-0.0228814600270711,0.0064636590466661,-0.0355502317585367,-0.0102126882956056,0.00040075182402633
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23071,0.00767066408578889,0.00216706468579152,0.00342321730163751,0.0119181108699403,0.000401437198760705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,23795,-0.016144872317197,0.00456284907386305,-0.0250880565019686,-0.00720168813242544,0.000403431727373753
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,28452,-0.0134355745814441,0.00379893120993598,-0.0208814797529186,-0.00598966940996957,0.000405846793635838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,27562,-0.00925394939579898,0.00261791686127971,-0.0143850664439072,-0.00412283234769074,0.000408671938492078
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,23846,-0.0111410118152782,0.00315447782800105,-0.0173237883581603,-0.00495823527239615,0.000413507570093199
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,27702,-0.0103999012211034,0.00294569279435472,-0.0161734590980386,-0.00462634334416816,0.000415377567549885
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",28109,-0.0160593984107148,0.00455293804835902,-0.0249831569854985,-0.0071356398359311,0.000420552913738814
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,27965,0.0275840432102365,0.00782481616928063,0.0122474035184465,0.0429206829020265,0.000423839584331438
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,28521,-0.00843503150209437,0.00239570388832021,-0.013130611123202,-0.00373945188098676,0.000430757593486856
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,27562,-0.0105192953864205,0.00299000695158409,-0.0163797090115254,-0.00465888176131572,0.00043526513297545
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,27682,-0.0175405891016116,0.00498688006520434,-0.0273148740294121,-0.00776630417381113,0.000436581369469076
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,27562,-0.00861032061863918,0.00244867012149002,-0.0134097140567596,-0.00381092718051874,0.00043826785013688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,23846,-0.00659888788676227,0.00187681981530182,-0.0102774547247538,-0.0029203210487707,0.00043892402392862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,27489,-0.0159382652463921,0.0045338664153654,-0.0248246434205082,-0.00705188707227588,0.000439831415050563
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,28176,0.00798133322138697,0.00227084221050681,0.00353048248879363,0.0124321839539803,0.000440938995601837
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,23056,0.00695114546351917,0.00197901127033688,0.00307228337365888,0.0108300075533795,0.000444872911943431
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,28553,0.00545937267302538,0.00155496907262122,0.00241163329068778,0.00850711205536297,0.000447246890348838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,28187,0.012124427578755,0.00347306425430791,0.00531722164031153,0.0189316335171985,0.000481973030096131
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",23846,-0.00721448740934776,0.002066625255816,-0.0112650729107471,-0.0031639019079484,0.000482175027631103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,28452,-0.0142599322074354,0.00408672289826893,-0.0222699090880424,-0.00624995532682826,0.00048496221740052
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",27544,-0.0129233840237721,0.00370554864951214,-0.0201862593768158,-0.00566050867072826,0.000488179915619989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,23738,0.0120111137507579,0.00344772943810042,0.00525356405208108,0.0187686634494347,0.000495286162929915
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28521,-0.00925135565696469,0.00265848915707333,-0.0144619944048284,-0.00404071690910095,0.000502294494330862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,23795,-0.0253871339903273,0.00729989227602159,-0.0396949228513296,-0.0110793451293249,0.000506562000726046
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",23393,-0.0108703155593778,0.00313060689464459,-0.0170063050728812,-0.00473432604587435,0.000517007633375971
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,28023,0.00546737197412419,0.00157637737394822,0.00237767232118568,0.0085570716270627,0.000524521152137174
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,23163,-0.0183385964538209,0.00528797724534243,-0.0287030318546921,-0.00797416105294974,0.00052533997170855
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,23846,-0.009311710062111,0.00268747791043531,-0.0145791667665642,-0.00404425335765779,0.000531458634309392
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,23725,-0.0204091311764667,0.0058964265720222,-0.0319661272576302,-0.00885213509530316,0.000538577646848896
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,23198,-0.0125806927125073,0.00363708133746512,-0.019709372133939,-0.00545201329107568,0.000543143169171177
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,28291,0.00647196310731426,0.00187239325785455,0.00280207232191935,0.0101418538927092,0.000548004086791016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,23071,-0.0147198914307006,0.00425919754228568,-0.0230679186135806,-0.00637186424782069,0.000549192368442879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,23846,0.0079530541359707,0.00230730251184371,0.00343074121275704,0.0124753670591844,0.000568024597756781
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,23775,-0.0252425045907172,0.00733754105687784,-0.0396240850621978,-0.0108609241192366,0.000582313368647136
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23056,0.0144647385220043,0.00420883694225765,0.00621541811517929,0.0227140589288293,0.000589768217849592
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,22663,-0.00548028970169847,0.00159592577807216,-0.0086083042267199,-0.00235227517667704,0.000595973110301965
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,23198,0.0133991236798379,0.00390303612765372,0.00574917286963665,0.0210490744900392,0.000597984365635786
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,23587,-0.010275699819409,0.00299557783826526,-0.0161470323824089,-0.00440436725640906,0.000603969812046669
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,28092,-0.0254694965429048,0.00743634103156126,-0.0400447249647649,-0.0108942681210447,0.000615669646650032
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,28553,0.00958241211558237,0.00279980967882347,0.00409478514508837,0.0150700390860764,0.000621299503286023
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,23738,0.0164556479028718,0.00481342538339844,0.00702133415141089,0.0258899616543328,0.000630272538789714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,23071,-0.0155633703425231,0.00455688476527977,-0.0244948644824715,-0.00663187620257477,0.000638091340267152
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,23337,0.00653569129264376,0.00191547370621057,0.00278136282847104,0.0102900197568165,0.000645858040637259
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,28428,-0.0115125283924907,0.00337961024228809,-0.0181365644673754,-0.00488849231760605,0.000659007850240873
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",23795,-0.0186055675364615,0.00546286101994785,-0.0293127751355593,-0.0078983599373637,0.000660726599009872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,23276,-0.0125552283614097,0.00368741530689102,-0.0197825623629161,-0.00532789435990333,0.00066303458473635
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,28195,-0.0064527466979135,0.00189719880222403,-0.0101712563502726,-0.00273423704555441,0.000671845979689461
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,23795,-0.0082745492012729,0.00243499709291092,-0.0130471435033783,-0.0035019548991675,0.000679479209100607
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,28264,0.0128056000545061,0.00376963712513697,0.00541711128923765,0.0201940888197746,0.000682134236999661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,27885,0.00685702432145499,0.00201900677161827,0.00289977104908319,0.0108142775938268,0.00068414678951297
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,23198,-0.0237511170235058,0.00699540280069695,-0.0374621065128718,-0.0100401275341397,0.00068681766543681
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27702,-0.0101659157296541,0.00299856010098137,-0.0160430935275776,-0.00428873793173058,0.000699223524794291
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,22978,-0.00982457771851904,0.00290162715786134,-0.0155117669479273,-0.00413738848911082,0.000710677863673117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,27786,-0.00983103872871548,0.00291022973776387,-0.0155350890147327,-0.0041269884426983,0.000730895179568328
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,28091,-0.0127330965857587,0.00377163194564924,-0.0201254951992312,-0.00534069797228617,0.000736428192929161
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,28428,0.0164295501923144,0.00486841398137946,0.00688745878881064,0.0259716415958181,0.000739887371984081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,28151,-0.00812217511812211,0.00241823249767306,-0.0128619108135613,-0.00338243942268291,0.000784071616089137
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,27910,0.0111160277766521,0.00331221275296047,0.00462409078084962,0.0176079647724547,0.000791631797901885
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,23188,-0.0206869885980879,0.00616478948894751,-0.0327699759964251,-0.00860400119975081,0.000793005825872398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,28553,0.00625056833765258,0.00186313419721255,0.002598825311116,0.00990231136418917,0.000795064266362668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,28521,-0.0124689131445892,0.00371933822359759,-0.0197588160628405,-0.00517901022633797,0.000802024896887343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,23071,0.00966496728011217,0.00288318386663494,0.00401392690150769,0.0153160076587167,0.000803051442136524
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,28187,0.0112406548994423,0.00335538890892139,0.00466409263795638,0.0178172171609282,0.000809087242800076
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,23795,-0.0213004306142112,0.00638087643016887,-0.0338069484173422,-0.00879391281108022,0.00084462476053363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,28187,0.00996187018420076,0.00299916630353266,0.00408350422927675,0.0158402361391248,0.000896338964166899
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,28378,0.0164030447658219,0.00494740990811008,0.00670612134592613,0.0260999681857176,0.00091600230547003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,23393,-0.0170977424255957,0.00515727332982588,-0.0272059981520544,-0.00698948669913695,0.000916946577689638
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23393,0.00827851393383417,0.00249754501484805,0.00338332570473199,0.0131737021629363,0.000918939834777589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,23775,-0.0131772279315435,0.00397603676480273,-0.0209702599905568,-0.00538419587253013,0.000920558389738404
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,23393,-0.0150510600207757,0.00454903427004042,-0.0239671671900549,-0.00613495285149646,0.000938960685297307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,27682,-0.0217023943451855,0.00656094425459212,-0.034561845084186,-0.00884294360618494,0.000941465437555459
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,28224,-0.00580547822374955,0.00175643600298283,-0.0092480927895959,-0.00236286365790319,0.000950065315697689
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,28239,-0.0105402253368536,0.00318894233352551,-0.0167905523105636,-0.00428989836314362,0.000950127616206667
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,23071,0.0135982888929818,0.0041146572156715,0.00553356075026566,0.0216630170356979,0.000951751200159621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,27942,-0.0221180258779026,0.00670725919241306,-0.0352642538950322,-0.00897179786077298,0.000976280016842575
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,23337,-0.00903717037955511,0.00274577257953877,-0.0144188846354511,-0.00365545612365911,0.000998723920251536
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,23163,-0.0163252944961307,0.0049625954001488,-0.0260519814804224,-0.00659860751183908,0.00100455199066945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,23846,0.0219712027188894,0.00668044752788404,0.00887752556423671,0.0350648798735422,0.0010073198952503
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,23198,-0.0140642568442982,0.00427876548583781,-0.0224506371965403,-0.00567787649205606,0.00101415163013331
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,23795,0.0133849707306379,0.00407515682029212,0.00539766336286529,0.0213722780984104,0.00102300605861717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,23636,-0.00679065449785848,0.00207045589454899,-0.0108487480511745,-0.00273256094454247,0.00104035783641143
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,28091,-0.00451450243805922,0.0013796576903234,-0.00721863151109309,-0.00181037336502535,0.00106846544081824
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",23846,-0.0113182073476198,0.00346136903699936,-0.0181024906601385,-0.00453392403510105,0.00107751663742686
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,28404,-0.0115464866930516,0.00353346756688843,-0.0184720831241529,-0.00462089026195027,0.0010853503979458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,23826,-0.0080023562109325,0.00245081306214877,-0.0128059498127441,-0.0031987626091209,0.00109547356359924
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,23163,-0.010980205208337,0.003364461801583,-0.0175745503394397,-0.00438586007723433,0.00110171893026309
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,28174,0.00497354979186918,0.00152584885495521,0.00198288603615696,0.0079642135475814,0.00111729447525987
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,27781,-0.00499260250403209,0.0015347230096246,-0.0080006596028963,-0.00198454540516789,0.0011429094241097
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,28224,0.01712983416618,0.00526853392884106,0.00680350766565149,0.0274561606667085,0.00114994167407578
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,28428,-0.00514828735168745,0.00158358209740147,-0.00825210826259432,-0.00204446644078057,0.00115117921404561
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,23893,0.00337031175188052,0.0010367993979078,0.00133818493198124,0.0054024385717798,0.00115285428934687
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",28176,0.0183054764661256,0.00563654801520282,0.00725784235632806,0.0293531105759231,0.00116502752188081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,28266,0.00841801786794614,0.00259402641907463,0.00333372608655986,0.0135023096493324,0.00117523251530253
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,28320,-0.0277567226480586,0.00855604481865662,-0.0445265704926256,-0.0109868748034916,0.00117956217387884
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,28470,-0.00612451488200558,0.00188905969872054,-0.00982707189149784,-0.00242195787251333,0.00118790167341356
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,23163,-0.00994249663863939,0.00307066304381572,-0.0159609962045182,-0.00392399707276058,0.00120583008476092
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,23795,-0.0215145300168245,0.00666604955024674,-0.0345799871353081,-0.0084490728983409,0.00125055683976224
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,23872,-0.0152146810726174,0.00471979015739958,-0.0244654697811206,-0.0059638923641142,0.00126763473490665
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,27682,-0.00763057985531121,0.002370288540129,-0.0122763453939641,-0.00298481431665837,0.00128669205952714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,27562,-0.0128144191283246,0.00398214967646265,-0.0206194324941914,-0.00500940576245783,0.0012925278602626
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,27562,0.0117989934029445,0.00367054949831295,0.00460471638625116,0.0189932704196379,0.00130820945943895
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,27965,-0.0171746335744157,0.00535144915226986,-0.0276634739128646,-0.00668579323596677,0.00133189029228202
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,23725,-0.00958303364636513,0.00298737941360008,-0.0154382972970213,-0.00372776999570897,0.00133913746464737
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,28320,-0.0089159743347495,0.00278551412770274,-0.0143755820250469,-0.00345636664445214,0.00137180652387363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,23738,-0.0305182984833342,0.00953797395016948,-0.0492127274256664,-0.011823869541002,0.00137769491121923
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,23100,-0.00864031930913448,0.00270194698718052,-0.0139361354040083,-0.00334450321426066,0.00138661117513752
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,23056,0.0199581403626063,0.00624480800617231,0.00771831667050862,0.0321979640547041,0.00139555585116106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23188,-0.00682824211344085,0.00213924467609566,-0.0110211616785884,-0.00263532254829334,0.00141531812908343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,27562,-0.00733041954778508,0.00229696262572333,-0.0118324662942028,-0.00282837280136735,0.00141766774765874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,23795,-0.0105834860548849,0.00331633395091895,-0.017083500598686,-0.00408347151108372,0.00141807872331263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,27918,0.00699952131191351,0.00219395595657763,0.00269936763702135,0.0112996749868057,0.00142250146368906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,28320,-0.022688136878973,0.00712086110566153,-0.0366450246460696,-0.00873124911187637,0.00144335897174884
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,28224,0.00590488562629036,0.00185524943544245,0.00226859673282315,0.00954117451975757,0.00146017134571154
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,28184,-0.00731973297175259,0.00230096570482207,-0.0118296257532038,-0.00280984019030134,0.00146847164262773
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,23337,-0.0110163174657926,0.00346460029068834,-0.0178069340355418,-0.00422570089604349,0.00147630900676286
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,28048,-0.00672431112459552,0.00211646651791905,-0.0108725854997169,-0.00257603674947418,0.00148896311968904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,28224,-0.00528962255276944,0.00166565827924732,-0.00855431278009418,-0.0020249323254447,0.00149638842585848
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,28176,0.0132205837664655,0.00416533870575796,0.00505651990317989,0.0213846476297511,0.0015054042844179
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,27940,-0.0102827987905778,0.00324704545261715,-0.0166470078777074,-0.0039185897034482,0.0015428300706725
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,28176,-0.0156669703710397,0.00494814722702707,-0.0253653389360128,-0.00596860180606666,0.00154593407357088
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,28428,-0.0207297209085259,0.00654863889015722,-0.033565053133234,-0.00789438868381772,0.00154979682805324
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,23198,0.00821144473261617,0.00259474036247501,0.00312575362216516,0.0132971358430672,0.0015547032370645
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,23725,-0.00863734914659744,0.0027317365314951,-0.0139915527483278,-0.00328314554486705,0.00156966155870642
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,27965,-0.013181429695607,0.00417080184553971,-0.0213562013128648,-0.00500665807834916,0.0015771713341424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,27702,-0.0118405255716624,0.00375049787235751,-0.0191915014014831,-0.00448954974184166,0.00159542562995106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,23703,0.0188524499931048,0.00598372620966046,0.00712434662217034,0.0305805533640393,0.00163126784086332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,28176,0.0112484863944911,0.00357039908766941,0.00425050418265907,0.0182464686063231,0.00163170550906634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,28091,0.018429917860965,0.00585141390658767,0.00696114660405316,0.0298986891178768,0.00163636407526327
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,28336,-0.0122268224196007,0.00388805514090578,-0.019847410495776,-0.00460623434342536,0.00166420933650247
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,28470,-0.00999072937585098,0.00317701411359697,-0.016217677038501,-0.00376378171320092,0.00166433045223463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,28224,0.0224978966551922,0.00715580110668724,0.00847252648608516,0.0365232668242991,0.00166823589880281
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,28520,-0.0050633942121107,0.00161086146289373,-0.0082206826793824,-0.001906105744839,0.00167235213680858
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,28122,0.0127772376889186,0.0040726058051634,0.00479493031079833,0.0207595450670388,0.00170651643806371
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,28521,0.0100492395057821,0.0032066113756811,0.00376428120944715,0.0163341978021171,0.00172667154230177
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,28176,-0.00755741342689351,0.00241269496245411,-0.0122862955533036,-0.00282853130048346,0.00173588603370948
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,27176,-0.0137209976554865,0.00438310569891849,-0.0223118848253668,-0.0051301104856063,0.00174736639571012
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,28521,-0.0143938330176577,0.00460459471406696,-0.0234188386572289,-0.00536882737808643,0.00177396573354304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,27682,0.00729627381217942,0.00234070910579244,0.00270848396482625,0.0118840636595326,0.00182813557151046
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,28087,0.00611779332630166,0.00196278269755064,0.00227073923910242,0.00996484741350091,0.00182949269629271
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,28129,-0.00870224843282972,0.00279553580221509,-0.0141814986051713,-0.00322299826048815,0.00185438943898572
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,27556,-0.0167443935710867,0.00538090153219124,-0.0272909605741815,-0.00619782656799185,0.00186128345819506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,23056,0.00914488372260197,0.00294074214618175,0.00338102911608573,0.0149087383291182,0.00187493279075045
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,23198,-0.0129689427477499,0.0041726761279197,-0.0211473879584725,-0.0047904975370273,0.00188545279796265
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,28111,-0.0057402376390363,0.00184949122362498,-0.00936524043734126,-0.00211523484073133,0.00191316609514029
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",23795,-0.0100572802659763,0.00324288823997946,-0.016413341216336,-0.00370121931561655,0.00192876039358698
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,28524,-0.0121824730379885,0.00393028094152055,-0.0198858236833688,-0.00447912239260828,0.00193941791165614
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,23071,0.00759191839325216,0.00244951416729902,0.00279087062534609,0.0123929661611582,0.00194174718962602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,28218,0.00459667204609424,0.0014867905812132,0.00168256250691637,0.0075107815852721,0.0019922521799033
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,28452,-0.0113579661365297,0.00367861358839117,-0.0185680487697764,-0.00414788350328301,0.00201996407901383
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,28307,-0.00460007815544526,0.0014930066296753,-0.00752637114960886,-0.00167378516128167,0.00206446708597457
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,28199,0.0106960399647192,0.00347919086586862,0.00387682586761673,0.0175152540618217,0.0021120620335886
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",23071,0.0100439266349997,0.00326834800678827,0.00363796454169474,0.0164498887283048,0.00212101926769652
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",23287,-0.0179949021256981,0.00585703166439447,-0.0294746841879113,-0.00651512006348494,0.00212619591750229
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,28031,0.00601970857836553,0.00196163313867777,0.00217490762655711,0.00986450953017395,0.00215181171974429
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,23795,-0.0185782881490904,0.00605399385649253,-0.0304441161078158,-0.00671246019036509,0.00215187017012641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,27682,0.00688019860859746,0.00224503091079206,0.00247993802344502,0.0112804591937499,0.00218146067364082
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,23188,-0.0120379424237338,0.00393310211857372,-0.0197468225761383,-0.0043290622713293,0.00221092128291546
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,22978,-0.0117223868129962,0.00383307551523838,-0.0192352148228634,-0.00420955880312894,0.00222912515468572
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,27544,-0.00974522774008704,0.0031905649637079,-0.0159987350689545,-0.00349172041121956,0.00225734618718086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,28176,0.0250093978282721,0.00819139254891289,0.00895426843240283,0.0410645272241414,0.00226677929898804
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,28195,-0.0061836016051631,0.00202787341680751,-0.0101582335021058,-0.00220896970822038,0.00229585361938144
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,28224,0.0168617710527447,0.00553628850990922,0.00601064557332264,0.0277128965321668,0.00232367867814811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,23071,-0.0093427073762035,0.00307471585852011,-0.0153691504589029,-0.00331626429350408,0.00237978146110301
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,23337,-0.0139373499620499,0.00459421419021061,-0.0229420097748627,-0.00493269014923715,0.00241860783329597
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,23071,0.00651917610591539,0.00215003681666044,0.00230510394526094,0.0107332482665699,0.00243109924377449
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23071,0.010323055683288,0.00340887757305439,0.00364165564010141,0.0170044557264746,0.00246217223397139
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",23795,-0.0159928459474531,0.00528356798386882,-0.026348639195836,-0.00563705269907021,0.00247337891020142
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,23775,-0.00792828966583945,0.00261972740813646,-0.0130629553857869,-0.00279362394589199,0.00247766233894093
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,28276,0.0118627242782419,0.00392036895481929,0.00417880112679608,0.0195466474296877,0.00248100483571707
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,28176,0.00969533673901238,0.00321159363021052,0.00340061322379976,0.015990060254225,0.00253958649011931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,28091,-0.0160388580593349,0.00531304230015769,-0.026452420967644,-0.00562529515102581,0.00254030052974053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,23893,-0.00550872950352111,0.00182485257637185,-0.00908544055320994,-0.00193201845383227,0.00254108026808375
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,28470,-0.00674209971261607,0.0022334891155381,-0.0111197383790707,-0.00236446104616139,0.00254136797204766
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,23071,0.0137388896443106,0.00456136032442457,0.00479862340843839,0.0226791558801827,0.00259800340521411
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,23795,-0.0108223276557437,0.00360304163232566,-0.017884289255102,-0.00376036605638541,0.00267026950384745
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,28224,-0.0138832172768085,0.00462292876845645,-0.0229441576629831,-0.00482227689063384,0.00267459818376709
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,28210,0.0194310364129115,0.00647285827878515,0.00674423418649264,0.0321178386393304,0.00268512970814728
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,23056,0.0185181112033671,0.00617400965620277,0.00641705227720969,0.0306191701295246,0.00270831561991744
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,28112,-0.00398989007183965,0.00133119237471675,-0.00659902712628448,-0.00138075301739482,0.00272682846266268
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,23872,-0.0082150107452178,0.00274303206318895,-0.0135913535890681,-0.00283866790136746,0.00274848008638486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,23056,-0.0112297739138453,0.00375082269271075,-0.0185813863915584,-0.00387816143613222,0.00275683688847158
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,23549,0.013197263206487,0.00440845408800659,0.00455669319399404,0.0218378332189799,0.00275969843009736
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,23775,0.00747065818225236,0.0025028081124251,0.00256515428189915,0.0123761620826056,0.00283949993601326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,28091,0.00741110989541247,0.002483474770306,0.00254349934561272,0.0122787204452122,0.00284593778182551
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,23795,-0.00982083599477625,0.00329254104315602,-0.0162742164393621,-0.00336745555019044,0.00285958334788034
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,23056,-0.00894444209583764,0.00300070412708244,-0.0148258221849192,-0.00306306200675606,0.00287814455052729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,28187,0.00746637637109014,0.00251071210703751,0.00254538064129662,0.0123873721008837,0.00294377850685352
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,23393,0.0107212128968721,0.00360740366236238,0.00365070171864179,0.0177917240751023,0.00296165439479759
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,23846,-0.0166222546370153,0.00559340498148085,-0.0275853284007178,-0.00565918087331285,0.00296394120701643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,23738,-0.00956694649769308,0.00322056206346508,-0.0158792481420846,-0.00325464485330152,0.00297532891190681
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23188,-0.0113454557756643,0.00382485769322546,-0.0188421768543862,-0.00384873469694245,0.00301770052188774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,28187,0.0106211690754032,0.00358158091460033,0.00360127048278655,0.0176410676680199,0.0030244711480871
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,23775,-0.011221604808739,0.00379199199600115,-0.0186539091209012,-0.00378930049657674,0.00308652655564268
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23198,-0.00850811332391124,0.00288589289618762,-0.014164463400439,-0.00285176324738351,0.00319976168887425
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,27682,0.00775111865339498,0.00263321660910958,0.0025900140995402,0.0129122232072498,0.00324695552536952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,28470,-0.00408742720511863,0.00139600417559423,-0.00682359538928332,-0.00135125902095395,0.00341477728515854
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23071,0.00737832128735005,0.00252746984045866,0.00242448040005107,0.012332162174649,0.00351211850991569
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",23198,-0.0169393491567786,0.00580291424656752,-0.028313061080051,-0.00556563723350626,0.00351369111255347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,28428,-0.0113107747925022,0.00388171482483141,-0.0189189358491718,-0.00370261373583266,0.00357267884475167
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,28091,-0.00836485206164054,0.00287193147552098,-0.0139938377536617,-0.00273586636961942,0.00358689968240609
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,27544,-0.0134516217811963,0.00462176931077189,-0.0225102896303092,-0.00439295393208337,0.00361149529616101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,28176,0.0128160063151723,0.00440484500723785,0.00418251010098616,0.0214495025293585,0.00362261691780632
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,23110,-0.0134471423901473,0.00463053335708892,-0.0225229877700416,-0.00437129701025305,0.00368758488877594
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,23775,-0.0178534002332007,0.00616021152074366,-0.0299274148138583,-0.00577938565254311,0.0037567852282556
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,27562,-0.018173541104744,0.00627131421941385,-0.0304653169747952,-0.00588176523469288,0.00375985619299947
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,27126,-0.00624297721848162,0.00215458995805293,-0.0104659735362654,-0.00201998090069788,0.00376421415027041
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,28187,0.00712070801326679,0.00245775091210722,0.00230351622553664,0.011937899800997,0.00376744806154838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,23056,0.00559256853241897,0.00193078836996019,0.00180822332729699,0.00937691373754095,0.00377680667404686
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,23755,-0.00604907117967615,0.00209167001998679,-0.0101487444188503,-0.00194939794050204,0.00383167915421672
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,28428,-0.00621967049461788,0.00215217144641903,-0.0104379265295992,-0.00200141445963659,0.00385593113616961
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,27918,-0.00790367823028615,0.00273568471551098,-0.0132656202726877,-0.00254173618788463,0.00386638332393029
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,28428,-0.00444551850651157,0.00154379938115819,-0.00747136529358163,-0.00141967171944151,0.00398482417301129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,28428,-0.0124704284609305,0.00433258975102233,-0.0209623043729343,-0.00397855254892674,0.00400141718993639
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,27373,-0.016544609264905,0.00574884230290989,-0.0278123401786084,-0.0052768783512016,0.00400638310659921
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,23845,0.0036883407969114,0.00128207300890508,0.00117547769945744,0.00620120389436537,0.0040201389376388
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,23393,0.00665421977620106,0.00231870351844994,0.00210956088003917,0.0111988786723629,0.00411097241111854
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,28237,-0.00643724138278081,0.00224616734017643,-0.0108397293695266,-0.002034753396035,0.00416161864935697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23198,-0.00936432799521744,0.0032725764404517,-0.0157785778185028,-0.00295007817193211,0.00422079499037249
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,23738,-0.0103600593371231,0.00362217722248958,-0.0174595266932027,-0.00326059198104351,0.00423777340997602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",28176,-0.00845504439757377,0.00295778686852522,-0.0142523066598832,-0.00265778213526435,0.00425865810704089
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,28553,0.00434098443816222,0.00152229419055645,0.00135728782467157,0.00732468105165287,0.0043530090247263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,23738,0.0186373119625832,0.00654135186133737,0.00581626231436197,0.0314583616108045,0.00438735281938465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,28091,-0.00594266088129279,0.00208587899857045,-0.0100309837184909,-0.00185433804409471,0.00438893209614847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,28494,0.00583696476975159,0.00204969711545881,0.00181955842345231,0.00985437111605087,0.00440650698390161
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,23163,-0.00916310072507244,0.00322136847085909,-0.0154769829279563,-0.00284921852218863,0.00445237395043465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,23738,-0.0148975586082935,0.00523951168015051,-0.0251670015013885,-0.0046281157151985,0.00446856912689323
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",23198,-0.0187745079965191,0.00660986780962171,-0.0317298489033777,-0.00581916708966057,0.00450996719130501
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,27544,-0.00991202092792503,0.00349256411409243,-0.0167574465915462,-0.00306659526430387,0.00454253261705831
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,28452,-0.00411765466194303,0.00145174241239476,-0.00696306979023675,-0.00127223953364931,0.00456641412847038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,23393,-0.00565488668413864,0.0019990809245895,-0.00957308529633406,-0.00173668807194321,0.00467709366616236
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,28093,0.0139311930514384,0.00492972114606804,0.004268939605145,0.0235934464977317,0.00471724795983825
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,27965,0.0111067585669554,0.00393028137935026,0.00340340706342893,0.018810110070482,0.00471748057698486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,23872,0.00434429693186568,0.00153983958353576,0.00132621134813559,0.00736238251559576,0.00478740403148297
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,27702,0.011833302375672,0.00419599306080211,0.0036091559764999,0.0200574487748442,0.00480362955290984
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,23198,-0.0131846260115489,0.00467650942324992,-0.0223505844811188,-0.0040186675419791,0.00481647282983371
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,23893,-0.00797169577809056,0.00283144187946963,-0.013521321861851,-0.00242206969433008,0.0048753544977375
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,27500,-0.00694733852193148,0.00246917316938405,-0.0117869179339242,-0.00210775910993875,0.00490204219289216
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,27965,0.00975904650362846,0.00346876600415795,0.00296026513547889,0.016557827871778,0.00490539509996786
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,28336,-0.00893562048210021,0.00318247374888972,-0.015173269029924,-0.00269797193427636,0.00499215991660035
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,23198,0.0182929077468793,0.00652011751727243,0.00551347741302529,0.0310723380807332,0.0050263251095146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,27965,-0.00681287618662918,0.00243155038428729,-0.0115787149398323,-0.00204703743342609,0.00508430477779285
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,27442,0.0172775251694361,0.00616711344604501,0.0051899828151879,0.0293650675236843,0.00508921412703358
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,28187,0.0227493574722434,0.00813419636177553,0.00680633260316331,0.0386923823413234,0.00516535795992302
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,23337,0.0100903876281965,0.00361299976971037,0.00300890807956421,0.0171718671768289,0.00522964647075639
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,28529,-0.00647910647760499,0.00232053533863085,-0.0110273557413215,-0.00193085721388852,0.00524062257871142
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,23163,-0.011518674520476,0.00412636146943335,-0.0196063430005654,-0.00343100604038665,0.00525098345921649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,28029,-0.00500736701349985,0.00179655187699041,-0.00852860869240105,-0.00148612533459865,0.00531998341977765
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,23775,-0.0156364354879606,0.00562013264931557,-0.0266518954806191,-0.00462097549530205,0.00540312992124895
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,23725,-0.010485786170307,0.0037759518749161,-0.0178866518451426,-0.00308492049547148,0.00549076820425517
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",23795,0.0134876251400529,0.00486139799084292,0.00395928507800075,0.023015965202105,0.00553410818286113
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,23795,0.00678149103018136,0.00244685009082734,0.00198566485215977,0.011577317208203,0.0055838806751682
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,27562,-0.0116176597675678,0.00419695460822359,-0.019843690799686,-0.00339162873544954,0.00564189312523386
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,27562,-0.00624640418338113,0.00225722900343364,-0.0106705730301111,-0.0018222353366512,0.00565623925698474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,23337,0.0120076962606899,0.00434644145614046,0.00348867100665457,0.0205267215147252,0.00573791257843784
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,28336,-0.00808644626586375,0.0029332224441231,-0.013835562256345,-0.00233733027538248,0.00583989630668999
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,27702,-0.0214293531258451,0.00777462613439279,-0.036667620349255,-0.00619108590243528,0.0058494126036865
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,27831,0.00718035070346505,0.00260642661416745,0.00207175453969684,0.0122889468672333,0.00587547146275878
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,23188,0.00622586123994116,0.00226217477084206,0.00179199868909072,0.0106597237907916,0.00592500753401124
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,23071,-0.00857247324463212,0.00312626255203419,-0.0146999478466191,-0.00244499864264511,0.00610978887550733
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,23893,-0.00476693980050682,0.00173848928463365,-0.00817437879838877,-0.00135950080262487,0.00611115794235245
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,28452,0.0107911775061507,0.00393590480719234,0.00307680408405373,0.0185055509282477,0.00611552643132888
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,23071,0.00707552045489576,0.00258077205425461,0.00201720722855674,0.0121338336812348,0.00611824040967827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,27734,-0.00818165392062644,0.00300690320434262,-0.014075184201138,-0.00228812364011491,0.00651338672695674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,27842,-0.0110111758486839,0.00404792364341208,-0.0189451061897715,-0.00307724550759618,0.00652822694502865
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,28331,0.00450881695346767,0.00165858435103487,0.00125799162543932,0.00775964228149602,0.00656239121012028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",23725,-0.00954600063175031,0.00351698128579895,-0.0164392839519163,-0.00265271731158436,0.00664720923047069
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23071,0.00752657565483616,0.00277383431416738,0.00208986039906808,0.0129632909106042,0.00666422368271671
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,27918,-0.00949102649639442,0.00349855050662226,-0.0163481854893741,-0.00263386750341479,0.00667491346547595
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,23795,0.0142636369449128,0.00528251251092108,0.00390991242350751,0.0246173614663182,0.00693548583319373
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,23738,0.00858257933701534,0.00318018057352228,0.00234942541291167,0.014815733261119,0.00696453015930965
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",23337,0.0164073949598261,0.0060833756537218,0.00448397867853137,0.0283308112411208,0.00699991960354153
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,23647,-0.00889087859080818,0.00329685402787353,-0.0153527124854403,-0.00242904469617606,0.00700638607347758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,23663,-0.00814988172574306,0.00302380111574365,-0.0140765319126006,-0.0022232315388855,0.00703868271488932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,23056,-0.0140450147614741,0.00521491737201168,-0.024266252810617,-0.00382377671233123,0.00708128892997117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,23725,-0.00627448819960984,0.00233100522127081,-0.0108432584333006,-0.00170571796591906,0.00711276338893436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,28307,0.00590083802767483,0.00219360015897755,0.00160138171607882,0.0102002943392708,0.00714887068373104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,28176,-0.0206068348051405,0.00766994130229114,-0.0356399197576311,-0.00557374985264987,0.00722039815917093
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,28521,0.010813244837415,0.00402612331247655,0.00292204314496092,0.018704446529869,0.00724045869357755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,23642,0.0132321318281428,0.00493149935245925,0.00356639309732271,0.022897870558963,0.00729751099028051
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,28187,0.00443462329506129,0.00165328744700502,0.00119417989893144,0.00767506669119114,0.00731591262673223
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,23795,-0.0132204006459423,0.00493656170965925,-0.0228960615968744,-0.00354473969501017,0.0074101174481465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,28176,-0.00687844787821735,0.00256967496235532,-0.0119150108044338,-0.00184188495200093,0.00743770503522332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",27682,-0.0153401821585354,0.00574292950568531,-0.0265963239896786,-0.00408404032739222,0.00756378087416151
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,23738,-0.0123245308200077,0.00461398503261002,-0.0213679414839233,-0.00328112015609202,0.0075649066357266
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,23071,0.00703071148151612,0.00263338805639275,0.00186927089098634,0.0121921520720459,0.00759417235320624
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",23071,0.00723339961128848,0.00271716648112254,0.00190775330828829,0.0125590459142887,0.00777060552356295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,23846,-0.00974481217608409,0.00366193420726886,-0.0169222032223311,-0.00256742112983712,0.00779355468759489
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,27702,0.00660240873322952,0.00248458788136139,0.00173261648576119,0.0114722009806978,0.00788038508876469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,28307,-0.0173021593978732,0.00651168337119473,-0.0300650588054149,-0.00453925999033152,0.0078861548212096
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,28320,0.00608320015613873,0.00229029047502042,0.0015942308250987,0.0105721694871788,0.00790986039831809
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,23373,0.00696473800716702,0.00262319232166934,0.00182328105669512,0.0121061949576389,0.00793476297617805
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,28152,-0.00319434256233303,0.00120408801584362,-0.00555435507338653,-0.00083433005127953,0.00798448762188796
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,23795,0.0124919702608087,0.00471078561509143,0.00325883045522954,0.021725110066388,0.00801216347775738
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",23790,-0.0041151433646482,0.00155266022712771,-0.00715835740981852,-0.00107192931947788,0.00804539405102118
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,28125,0.00462248615690088,0.00174731501968621,0.0011977487183159,0.00804722359548586,0.00816205958625188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,28187,-0.00466916181073413,0.00176504456289887,-0.00812864915401592,-0.00120967446745234,0.00816515869099689
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,27682,-0.0103044141337142,0.00390878047766943,-0.0179656238699463,-0.00264320439748215,0.00838815907796127
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,23056,0.0139887077074532,0.00530749920119877,0.00358600927310366,0.0243914061418028,0.00840326602369013
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,28187,-0.00478983200331976,0.00181802523891366,-0.00835316147159054,-0.00122650253504898,0.00842739987654463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,28307,-0.00814228276570924,0.0030962638693922,-0.014210959949718,-0.00207360558170052,0.00855034240226348
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,23775,-0.0127321344395763,0.00484773998458892,-0.0222337048093705,-0.00323056406978198,0.00863471115238621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,28521,-0.00620814999824142,0.00237004174079126,-0.0108534318101923,-0.00156286818629055,0.00881244055329033
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,23071,0.00607311715624759,0.00232021547556273,0.00152549482414463,0.0106207394883505,0.00886395703206577
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,27863,0.00712946273676196,0.00272446158737421,0.00178951802550851,0.0124694074480154,0.00887975191209269
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,27965,0.0234041032031997,0.00894383569693915,0.00587418523719899,0.0409340211692005,0.00888097590565427
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,23056,0.00900160365347496,0.00344252928426957,0.00225424625630659,0.0157489610506433,0.00893319091134465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,23071,-0.015282279453637,0.00584532866399421,-0.0267391236350657,-0.00382543527220838,0.0089431150875711
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,23071,0.00837155099929689,0.00320595952934156,0.00208787032178744,0.0146552316768063,0.00902712176998088
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,23662,0.00614609010669652,0.00235544100717307,0.00152942573263731,0.0107627544807557,0.00907805185412071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,28389,0.00768026469350593,0.00294370425751207,0.00191060434878227,0.0134499250382296,0.00908422197432718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,28176,0.0215519847175436,0.00827190427157383,0.00533905234525891,0.0377649170898283,0.00918034799093824
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,23872,0.0129347530819139,0.00497113882770782,0.00319132097960656,0.0226781851842212,0.00927472814057789
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,23725,0.00691437248033707,0.00265758321757417,0.00170550937389168,0.0121232355867824,0.00928065336480656
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,23337,-0.010240071537112,0.00394662988646182,-0.0179754661145771,-0.00250467695964682,0.0094750141312755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,28091,-0.0130672293203742,0.0050370258042148,-0.0229397998966352,-0.00319465874411315,0.00948508709670224
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,28377,0.00722643041933077,0.0027863383470782,0.0017652072590575,0.012687653579604,0.00950472009894227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,28187,0.021511863629781,0.00829858310406123,0.005246640745821,0.037777086513741,0.0095404305024191
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,28182,-0.00684677045682727,0.0026423265007627,-0.0120257303983222,-0.00166781051533238,0.00956939369515988
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",27910,-0.0129191005231563,0.00498835638733789,-0.0226962790423385,-0.003141922003974,0.00960673379485958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,23795,-0.00566890020563925,0.00219283963255631,-0.00996686588544962,-0.00137093452582888,0.00973851871386903
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,28187,-0.0159011130559799,0.00615579771629314,-0.0279664765799145,-0.0038357495320454,0.00979635373649303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,27516,-0.0211234039976838,0.00818225072331925,-0.0371606154153896,-0.00508619257997808,0.00983910741256366
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,27562,-0.0115388530729573,0.00447147728124255,-0.0203029485441927,-0.00277475760172193,0.00986954475837474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,23775,-0.0190001989651936,0.0073667002123976,-0.0334389313814929,-0.00456146654889432,0.00990887500837536
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,27562,-0.0134321679311346,0.00521522913998094,-0.0236540170454973,-0.00321031881677198,0.0100127751331398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,27702,0.00851226873349436,0.00330665488388136,0.0020312251610869,0.0149933123059018,0.010049926439692
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,27544,-0.0118052319604129,0.00459969443935113,-0.0208206330615411,-0.00278983085928468,0.0102775524929585
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,28187,0.00618032670651254,0.0024092010481766,0.00145829265208641,0.0109023607609387,0.0103137509973982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,28204,0.0329193088150441,0.0128348642409925,0.00776297490269873,0.0580756427273894,0.0103276169010572
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,23872,-0.00470211666579627,0.00183381418785548,-0.008296392473993,-0.00110784085759953,0.0103498920925633
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,26395,0.00858886649358674,0.00335010182829495,0.00202266691012864,0.0151550660770448,0.0103599165824398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,23738,-0.00610118580704738,0.00238034452096252,-0.0107666610681339,-0.00143571054596084,0.0103787596371136
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,28224,0.00460950437530244,0.00179938633836595,0.00108270715210517,0.0081363015984997,0.010421000570759
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,27702,0.00742035394395604,0.00289798761678572,0.00174029821505603,0.013100409672856,0.0104568335821885
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,23056,0.00830552348313685,0.00324580731647668,0.00194374114284255,0.0146673058234312,0.0105083336102909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,28224,-0.00679741170336554,0.00265917703629253,-0.0120093986944989,-0.00158542471223219,0.0105871516544579
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,28367,0.00352864561637052,0.0013839281932637,0.000816146357573663,0.00624114487516738,0.0107857990061847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,23738,-0.0093535489661959,0.00367096455865648,-0.0165486395011626,-0.0021584584312292,0.0108410771788708
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,23738,-0.00868857935460159,0.00342337379012409,-0.0153983919832448,-0.00197876672595838,0.0111546117626159
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,28430,0.00559279451858233,0.00220602115913174,0.00126899304668412,0.00991659599048054,0.0112423252484821
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,27702,-0.00973272899500409,0.00385289892856213,-0.0172844108949859,-0.00218104709502232,0.0115398656278371
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,23795,-0.00992330969254394,0.0039490561189812,-0.0176634596857471,-0.00218315969934079,0.011983237336743
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,27702,0.0112846253435718,0.00449624446478905,0.00247198619258527,0.0200972644945584,0.0120859872698991
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,27562,0.02150315451569,0.00857488458421407,0.00469638073063045,0.0383099283007496,0.0121580184662172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,23862,-0.0104734300299542,0.00417800193728399,-0.0186623138270308,-0.00228454623287754,0.0121894383636424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,23319,-0.00557282788386334,0.00222343903853136,-0.00993076839938481,-0.00121488736834187,0.0122035063985696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,28237,0.00570920143916098,0.00228214801124729,0.0012361913371163,0.0101822115412057,0.0123662143934455
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,23725,-0.00764440276125991,0.00306221044482577,-0.0136463352331184,-0.00164247028940141,0.0125539864259944
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,28553,0.00446820303905827,0.00179264618992001,0.000954616506815042,0.0079817895713015,0.012689712653316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,23056,0.010030274744487,0.00403201224891036,0.00212753073662266,0.0179330187523513,0.012865682414963
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,23725,-0.00871937755307033,0.00350684092189508,-0.0155927857599847,-0.00184596934615597,0.0129114401396805
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,23795,-0.00597512980104376,0.00241251094495892,-0.0107036512531632,-0.00124660834892428,0.0132662469406598
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,23337,-0.0130799523496877,0.00528200703741888,-0.0234326861430287,-0.00272721855634672,0.0132814050538789
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,27969,-0.0057015288204764,0.00230307679607265,-0.0102155593407788,-0.00118749830017401,0.0133066139326653
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,23198,-0.00499332197791901,0.00202369685419491,-0.00895976781214104,-0.00102687614369698,0.0136160088379549
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,27520,0.0146527331851949,0.00594079141552038,0.00300878201077492,0.0262966843596148,0.0136515911504629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23071,0.0145410254319108,0.00591325329557868,0.00295104897257658,0.026131001891245,0.0139375509405971
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,23140,-0.00978080540550638,0.00397833416452759,-0.0175783403679805,-0.0019832704430323,0.0139584604842067
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,23725,0.00956662396457395,0.00390039123603402,0.00192185714194727,0.0172113907872006,0.0141846465783603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,23795,-0.00919180370725259,0.00375552557074244,-0.0165526338259078,-0.00183097358859741,0.0143906462412948
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,23707,-0.0157692385886692,0.00644420530922891,-0.0283998809947579,-0.00313859618258056,0.01441063192821
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,23337,-0.00617935065285661,0.00252967057874652,-0.0111375049871998,-0.00122119631851343,0.014583232557773
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,28325,0.00688285069452721,0.00281881605973523,0.00135797121744617,0.0124077301716083,0.0146222475509894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,23337,-0.0123412173007999,0.00505429641411343,-0.0222476382724622,-0.00243479632913753,0.0146245310735496
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,22978,-0.0111437418735026,0.00456430759417198,-0.0200897847580796,-0.00219769898892549,0.01463401799528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,27632,0.00873706809015449,0.00359558509408597,0.00168972130574598,0.015784414874563,0.0151075112003312
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,23795,-0.0173276216036504,0.00713969703173336,-0.0313214277858478,-0.00333381542145304,0.0152341211498126
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,23056,0.0127629405495497,0.00527456598309908,0.00242479122267547,0.0231010898764239,0.0155404103306557
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,23846,-0.00489081187578714,0.00202578570051426,-0.00886135184879509,-0.000920271902779186,0.0157738692894149
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,23872,0.0046626883164316,0.00193289329317592,0.000874217461806792,0.00845115917105642,0.0158604068278321
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,27682,-0.00859214332443537,0.00356498072554329,-0.0155795055465002,-0.00160478110237051,0.0159523828847199
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,27562,-0.00602279448045513,0.00249943980350794,-0.0109216964953307,-0.00112389246557957,0.0159740056234344
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,23056,0.00883960039805512,0.00367505037543917,0.00163650166219435,0.0160426991339159,0.0161670050113144
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,28224,-0.0200062860247675,0.00832363650359881,-0.0363206135718212,-0.00369195847771386,0.016243106768304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,28276,0.00828732062707731,0.00344889640614024,0.00152748367104243,0.0150471575831122,0.0162724591176342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,28072,0.00973531567882405,0.00405371498703729,0.00179003430423096,0.0176805970534171,0.0163309579922204
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,28195,-0.00589678909371088,0.00245626954045842,-0.0107110773930094,-0.00108250079441238,0.0163697715995318
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,23071,0.00611181986263098,0.00255382792929925,0.00110631712120446,0.0111173226040575,0.0167101020350243
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,28184,-0.00648867815788119,0.00271461343286656,-0.0118093204862996,-0.00116803582946273,0.0168421971287921
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,27500,-0.00996930826118379,0.00418918111590428,-0.0181801032483562,-0.0017585132740114,0.017329994679688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,28411,-0.00495946759465708,0.00208407204249366,-0.00904424879794466,-0.000874686391369508,0.0173332704655771
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,27900,0.00558655981689427,0.00234913912891042,0.000982247124229848,0.0101908725095587,0.0174073550421545
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,28428,-0.00987028254387891,0.0041504598568987,-0.0180051838634004,-0.00173538122435745,0.0174078372783853
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,27702,-0.0138391487458168,0.00581960935143959,-0.0252455830746384,-0.00243271441699522,0.0174126166707215
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,23738,-0.0082443242241959,0.00346702206023584,-0.0150396874622581,-0.00144896098613367,0.0174181614387529
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",28307,-0.00995740034828117,0.00419051859340146,-0.018170816791348,-0.0017439839052143,0.0174998390312615
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,23071,-0.0108187316949252,0.00455456909764805,-0.0197456871263154,-0.00189177626353506,0.0175400686858507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,28553,0.00688173946570623,0.00289976876630463,0.00119819268374916,0.0125652862476633,0.0176411602239739
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,23862,-0.00368102568110142,0.00155107510637197,-0.00672113288959047,-0.000640918472612364,0.0176421524675442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,23147,-0.00446855713742382,0.00188381016929288,-0.00816082506923787,-0.000776289205609771,0.0176961724421387
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,28187,-0.00845274806800737,0.0035652098723798,-0.0154405594178718,-0.00146493671814296,0.0177516274476319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,23893,0.0030269680268163,0.00127907298250653,0.000519984981103502,0.0055339510725291,0.0179635217763687
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,27702,-0.0128831847166373,0.00544511989383548,-0.0235556197085548,-0.00221074972471977,0.0179880137826271
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,23365,0.00358768367457387,0.0015168061654349,0.000614743590321477,0.00656062375882627,0.0180241716903791
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,23337,-0.0150122271456443,0.00638084467701477,-0.0275186827125933,-0.00250577157869539,0.0186458153356798
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,27544,0.00524478932092473,0.00223518789196929,0.00086382105266491,0.00962575758918454,0.0189595158268643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,23725,0.00844175619079395,0.00360167444687957,0.00138247427491,0.0155010381066779,0.0190944619739871
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,23775,-0.00613434696169199,0.00261989806553168,-0.0112693471701341,-0.000999346753249899,0.0192174795078651
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,27965,0.00653738172392184,0.00279371405607965,0.00106170217400573,0.0120130612738379,0.0192890592199357
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,28072,0.0111028875037588,0.00474932425515814,0.00179421196364885,0.0204115630438688,0.0194055198032545
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,28452,0.00615301873734909,0.00263901774005902,0.000980543966833417,0.0113254935078648,0.0197309865956823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,23775,-0.00820195230349313,0.00352166764862283,-0.0151044208947939,-0.00129948371219238,0.0198675811877162
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,28091,0.0149441291389722,0.00641665142962344,0.00236749233691025,0.0275207659410341,0.0198682050559915
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,27965,0.00970330000620316,0.00417102321315924,0.00152809450841105,0.0178785055039953,0.0200064854023571
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,23393,0.00447938970718856,0.00192978136847704,0.00069701822497357,0.00826176118940355,0.0202851321077311
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28520,-0.00436755938133448,0.00188200026581923,-0.00805627990234016,-0.000678838860328791,0.0203100211733137
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,23795,0.00518860825801001,0.002236250867182,0.000805556558333297,0.00957165995768673,0.0203370532037952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,23188,-0.0147965165627897,0.00637810746634066,-0.0272976071968174,-0.00229542592876199,0.020355396681158
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23393,0.0113596642703994,0.00490669048242184,0.00174255092485258,0.0209767776159462,0.0206140101551866
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,23188,0.0069340833457221,0.00299598622422371,0.00106195034624363,0.0128062163452006,0.020651327200985
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,28521,0.0014095871708727,0.00060926717232087,0.000215423513123797,0.00260375082862161,0.0206979550526622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,27682,0.00772274249485254,0.00333932534795083,0.00117766481286892,0.0142678201768362,0.0207483375300249
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,27682,0.00497100928982133,0.00215089992585915,0.000755245435137393,0.00918677314450526,0.0208329894899842
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23393,-0.0166789727197423,0.00722146031087509,-0.0308330349290574,-0.00252491051042708,0.0209167689752843
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,22978,0.0055438666703874,0.00240243469782602,0.000835094662648407,0.0102526386781264,0.0210300471907595
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,23163,0.00593740844991303,0.00257392631840536,0.000892512865838522,0.0109823040339875,0.0210774605430432
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,23071,0.00571757824253918,0.00247891613819452,0.000858902611677917,0.0105762538734005,0.0210924739905183
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,28521,-0.00658139433110134,0.00285521146245905,-0.0121776087975211,-0.000985179864681596,0.0211711331729245
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,23188,-0.00509764605781174,0.00221485224208638,-0.00943875645230105,-0.000756535663322427,0.0213680415641981
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,23188,-0.00638957057372495,0.00277770249480746,-0.0118338674635476,-0.000945273683902318,0.0214396303970457
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,23188,-0.0100249345010626,0.00435939439904506,-0.0185693475231909,-0.00148052147893428,0.021478813089464
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,23846,0.00828732688345189,0.00360616096845024,0.00121925138528942,0.0153554023816144,0.0215645831774102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,23188,-0.00682436284942512,0.00297841665774494,-0.0126620594986052,-0.00098666620024504,0.0219566138983124
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,28553,0.00643511084075544,0.00281061866970932,0.000926298248125177,0.0119439234333857,0.0220534659439242
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,23071,0.00843023211219078,0.00369740355588464,0.00118332114265688,0.0156771430817247,0.0226143385528845
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,23862,0.00737161510979319,0.00323465320707673,0.00103169482392281,0.0137115353956636,0.0226787949308241
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,28553,-0.00388584353931158,0.00170678481890465,-0.0072311417843647,-0.000540545294258467,0.022811286976666
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,28105,-0.00768423751570328,0.00337531573446976,-0.014299856355264,-0.00106861867614256,0.0228177220900371
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,23071,0.00755381093651243,0.00331872741716907,0.00104910519886105,0.0140585166741638,0.0228481527459053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,28091,0.00413167409809281,0.00181697713289767,0.000570398917613374,0.00769294927857225,0.0229778652688568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,23725,0.00690738561567569,0.00304216394981958,0.000944744274029317,0.0128700269573221,0.0231831582492408
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,23056,0.0110238118063112,0.00485839781318628,0.0015013520924661,0.0205462715201563,0.02327618932739
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,23188,0.00622545092400941,0.00274464871554876,0.000845939441533841,0.011604962406485,0.0233253207575081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,27702,-0.0102304358683393,0.0045184682105762,-0.0190866335610687,-0.00137423817560999,0.0235733254395968
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,27965,-0.0108180048239101,0.00477912412503947,-0.0201850881089875,-0.00145092153883277,0.023606625489741
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,23775,-0.00341372019543538,0.00151277936987348,-0.0063787677603874,-0.000448672630483361,0.0240428605131782
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,28307,-0.00389668379224804,0.00172695063342482,-0.00728150703376068,-0.000511860550735395,0.024053467055396
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,28362,-0.0126785011683268,0.00562042293099398,-0.023694530113075,-0.00166247222357858,0.0240912938519859
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,23198,-0.00788036526948256,0.00349492799961879,-0.0147304241487354,-0.00103030639022974,0.0241551463013813
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,23872,0.0221630187108315,0.00985561191817153,0.00284601935121532,0.0414800180704477,0.0245361264041433
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,23337,0.00329080048648046,0.00146687331891388,0.000415728781409256,0.00616587219155167,0.0248796374185468
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,28384,-0.00755249142837646,0.00336792277088513,-0.0141536200593113,-0.0009513627974416,0.0249382120573537
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,23071,-0.0102385533784272,0.00456727984963248,-0.0191904218837068,-0.0012866848731475,0.0249890765419125
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23198,-0.00957924284208095,0.00428074198826095,-0.0179694971390724,-0.00118898854508948,0.0252466318755235
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,28176,0.00924676318390398,0.0041370661495049,0.00113811353087438,0.0173554128369336,0.0254184877405933
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,28091,-0.00525179359110214,0.00234982049568702,-0.0098574417626487,-0.00064614541955559,0.0254267247211401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,23393,0.0113955405019864,0.00510853360193383,0.00138281464219607,0.0214082663617767,0.0257113057132675
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,23846,0.00994655866090418,0.00446434935788448,0.0011964339194506,0.0186966834023578,0.025889985508874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,23725,-0.00533466700716731,0.00239634535652378,-0.0100315039059539,-0.000637830108380701,0.0260123007800098
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,28224,-0.00431710516402062,0.00194832932291964,-0.0081358306369431,-0.000498379691098129,0.0267132577747618
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,27638,0.0057996224257177,0.0026220399604156,0.000660424103303132,0.0109388207481323,0.0269835139483255
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,23071,0.010742211933736,0.0048593249274012,0.0012179350760296,0.0202664887914423,0.0270706434533792
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,23163,-0.00637296403116488,0.00288679328972165,-0.0120310788790193,-0.000714849183310444,0.027280026157127
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],28091,0.00853083599465717,0.00388315426697429,0.000919853631387571,0.0161418183579268,0.0280369378726509
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,23071,0.00761459651773934,0.00346695839762196,0.000819358058400292,0.0144098349770784,0.0280780090111969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,23872,-0.0039212716177061,0.00178686783821829,-0.00742353258061395,-0.000419010654798252,0.0282094843442393
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",28521,0.0101343937421816,0.00462203734760142,0.00107520054088277,0.0191935869434803,0.0283424752006319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,23198,-0.0120748470149321,0.00551569997902137,-0.022885618973814,-0.00126407505605025,0.0285938670836726
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,22043,-0.00798583760344999,0.00365203575304161,-0.0151438276794115,-0.000827847527488436,0.0287762930536493
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,27544,-0.00576341306260438,0.0026393877111468,-0.0109366129764521,-0.000590213148756657,0.0289987823926767
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,22978,0.0045171293752882,0.002073155407607,0.000453744776378476,0.00858051397419792,0.0293517000046384
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,28046,-0.00455090814697328,0.00209291039231832,-0.00865301251591719,-0.000448803778029363,0.0296804389392533
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,23071,0.00514109648267904,0.00236502716676382,0.000505643235821947,0.00977654972953613,0.029730284368429
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,23846,-0.00595850456097279,0.00274342354861218,-0.0113356147162527,-0.000581394405692926,0.0298713024809045
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,23188,-0.0055307207336002,0.00254736355639148,-0.0105235533041275,-0.0005378881630729,0.0299295828596588
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28553,-0.00343359739169388,0.00158233671787232,-0.00653497735872363,-0.000332217424664128,0.030018576474855
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,23071,-0.0104236422830264,0.00480725333248851,-0.0198458588147039,-0.00100142575134893,0.0301448764523602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,23056,0.00492086909672942,0.00227335076788244,0.00046510159167984,0.009376636601779,0.030429441763834
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,23056,0.00914647949275214,0.00423227813287827,0.000851214352310734,0.0174417446331935,0.0306960003878458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,27500,0.00793843370914738,0.00367614815674346,0.000733183321930209,0.0151436840963646,0.030824409008164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,23845,0.00217471994509123,0.00100890862564621,0.000197259038824657,0.0041521808513578,0.0311313606570634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,23393,0.0064520416601252,0.00299719245790522,0.000577544442630971,0.0123265388776194,0.0313528450341772
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,23393,-0.0102275529597937,0.00476107058726111,-0.0195592513108255,-0.00089585460876193,0.0317110967472665
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,23071,0.00895675168240509,0.00417004654144971,0.00078346046116365,0.0171300429036465,0.0317338281165334
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23071,0.00746972910859564,0.00348494053974816,0.00063924565068926,0.014300212566502,0.0320889477001334
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,23071,0.0106423274847261,0.00496989115575855,0.00090134081943931,0.0203833141500128,0.0322554462395919
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,28176,-0.0218715763884945,0.0102398541453367,-0.0419416905133544,-0.0018014622636345,0.032693998700539
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,27489,-0.0061661017965771,0.00289483093393725,-0.0118399704270941,-0.000492233166060087,0.0331772815080832
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,28261,0.00391158599218349,0.00183771754169011,0.000309659610470874,0.0075135123738961,0.0333040896520837
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,28224,0.00497650396274718,0.00233990924528359,0.000390281841991343,0.00956272608350301,0.0334458915236207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,23056,0.00553616154228016,0.00260807213786814,0.0004243401520586,0.0106479829325017,0.0337894128518688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,27702,-0.00539941729963295,0.00254824587863519,-0.0103939792217579,-0.000404855377507974,0.0341098173765676
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,23056,0.00913696924910368,0.00431596546450732,0.000677676938669332,0.017596261559538,0.0342691502881491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,23337,-0.00415149414312868,0.00196410552260921,-0.00800114096744273,-0.000301847318814623,0.0345530399312674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",27702,0.0104077200018974,0.00492657633335385,0.000751630388523902,0.020063809615271,0.0346468179853744
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,28224,0.0110268527169393,0.00522163982967888,0.00079243865076873,0.0212612667831099,0.0347157654801408
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,23071,0.0120612524964831,0.00572080887472283,0.000848467102026327,0.0232740378909398,0.0350147328094892
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,23795,0.0142960045101679,0.00678750085565455,0.000992502833085007,0.0275995061872508,0.0351952568716621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,27702,0.0109858671867838,0.00522305246341249,0.000748684358495341,0.0212230500150723,0.0354448566065522
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,23738,-0.00876572071515441,0.00417023684892778,-0.0169393849390529,-0.000592056491255958,0.0355662506952706
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,27544,-0.00917639190967399,0.0043685044427394,-0.0177386606174432,-0.00061412320190476,0.0356869456941208
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,23393,-0.010119914988878,0.00482710752623754,-0.0195810457403036,-0.000658784237452381,0.036050707479924
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,23862,-0.0125613489823563,0.00600676523879538,-0.0243346088503952,-0.000788089114317343,0.0365206716003211
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,22978,-0.00523016297767477,0.00250386301422233,-0.0101377344855505,-0.000322591469799006,0.0367333355871169
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23071,0.00572603057075103,0.00274347839182782,0.000348812922768491,0.0111032482187336,0.0368862018739454
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,22978,0.00370882636727154,0.00178099659138652,0.00021807304815397,0.00719957968638912,0.0373129379733103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,22783,-0.00557910854047671,0.00267941743591627,-0.0108307667148726,-0.000327450366080808,0.0373344721313934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,27702,0.00693685556164688,0.0033373509996177,0.000395647602396192,0.0134780635208976,0.037667789141187
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,28087,-0.00495086033390214,0.00238230981695801,-0.00962018757513983,-0.00028153309266444,0.0377021666922792
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23188,0.00844875037537505,0.00406727084764932,0.000476899513982382,0.0164206012367677,0.0377892063616054
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,22978,-0.00868859065599996,0.00418987576602114,-0.0169007471574014,-0.000476434154598535,0.0381172967905511
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",28091,0.00982778795037135,0.00474363562001621,0.000530262135139585,0.0191253137656031,0.0382947068741529
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,28129,-0.0040940512102645,0.00198013539366708,-0.00797511658185198,-0.000212985838677023,0.0386904265713343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,23775,-0.00397455591051777,0.00192332910203868,-0.00774428095051359,-0.000204830870521954,0.038792282144477
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,28320,-0.00585459143315838,0.00283505401103804,-0.0114112972947929,-0.000297885571523814,0.0389252463500502
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",23725,0.00608630876372465,0.00295004037322672,0.000304229632200275,0.011868387895249,0.0391113983713956
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,26907,-0.00394931993068581,0.00192014179313192,-0.00771279784522436,-0.000185842016147257,0.0397164809039076
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,23393,-0.0180883915507455,0.00880310559315998,-0.0353424785133391,-0.000834304588151945,0.0399119370566723
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,28233,-0.014855832907082,0.00723888065498458,-0.0290440389908518,-0.000667626823312202,0.0401567229316088
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,28064,-0.00543680257600854,0.00265197164166261,-0.0106346669936672,-0.000238938158349836,0.0403641137689047
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,22936,-0.0122854347871455,0.00599350829486242,-0.0240327110450758,-0.000538158529215127,0.0403962578411138
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,22978,0.00366109199827455,0.00178794892441133,0.000156712106428339,0.00716547189012076,0.0406057461002815
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,27965,-0.0134346797685021,0.00658339229166733,-0.02633812866017,-0.000531230876834111,0.0412907694140001
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,22978,0.00586334633309513,0.00287753341434517,0.000223380840978593,0.0115033118252117,0.0415984599580497
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,23198,0.00346684653240012,0.00170144520218504,0.00013201393611743,0.0068016791286828,0.0416023533739574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,23056,0.00669619533706141,0.00329186838744051,0.000244133297678009,0.0131482573764448,0.0419466400725991
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,28143,0.00571518995880048,0.00281023126491213,0.000207136679572699,0.0112232432380283,0.0419904050792323
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,28143,-0.00359928332008669,0.00176984638314163,-0.00706818223104429,-0.000130384409129088,0.0419942545446597
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,23738,-0.0060624639617989,0.00298149615557702,-0.0119061964267299,-0.000218731496867941,0.0420269701385812
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,23725,0.00475025227966581,0.00234238545708135,0.000159176783786358,0.00934132777554527,0.042576000193695
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,23444,-0.00584516620115854,0.00288548849951548,-0.0115007236602089,-0.000189608742108197,0.0428057052717815
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,23071,-0.00934196324767274,0.00462199385390724,-0.0184010712013309,-0.000282855294014547,0.0432708380489766
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,27702,-0.0082228471435089,0.004071556288142,-0.0162030974682672,-0.000242596818750589,0.0434362419124926
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,28091,-0.00334474085664886,0.00165653541033058,-0.00659155026089679,-9.79314524009304e-05,0.0434844164139219
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,27562,0.00543144780680788,0.00269456093701535,0.000150108370257794,0.010712787243358,0.0438402182075359
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,23188,-0.00535614240324852,0.00266168006164118,-0.0105730353240652,-0.000139249482431804,0.0441981441572495
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23163,0.00654430155876765,0.00325270913992391,0.000168991644516787,0.0129196114730185,0.0442363369408613
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,27965,-0.00409168169438054,0.00203468677959769,-0.00807966778239201,-0.000103695606369065,0.0443388518672092
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,23071,0.00710629592838191,0.00353954792015983,0.000168782004868655,0.0140438098518952,0.0446884608591485
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,22978,0.00908682176372001,0.00453173203067366,0.000204626983599632,0.0179690165438404,0.0449582720253174
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,27702,0.00819800106483784,0.00409997110077873,0.000162057707311522,0.0162339444223642,0.0455611655780433
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23071,0.0066803953174299,0.00334537864998761,0.000123453163454175,0.0132373374714056,0.0458474986432364
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,28061,0.00336318823664546,0.00168920805151294,5.23404556800923e-05,0.00667403601761082,0.0464921995390714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,28320,0.00903150593727258,0.00453996645193199,0.000133171691485875,0.0179298401830593,0.046674046581463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,28176,0.0124514343820689,0.00626178615626338,0.000178333515792705,0.0247245352483451,0.0467683293930248
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,23738,0.0133007322616448,0.0067045946362457,0.000159726774603252,0.0264417377486864,0.0472870281968399
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,23653,0.00381168993444973,0.00192266810078621,4.32604569087515e-05,0.00758011941199071,0.0474348409071555
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,28224,0.0117452334902782,0.00592631309150138,0.00012965983093547,0.0233608071496209,0.0475025115137368
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,28176,-0.00526370565394716,0.00265602481165113,-0.0104695142847834,-5.78970231109466e-05,0.0475115179469767
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,23188,-0.0105086254402294,0.00530955863380655,-0.0209153603624903,-0.000101890517968582,0.0478064328989504
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,27682,0.0103787211759422,0.00524705080818388,9.4501591901771e-05,0.0206629407599826,0.0479374359627146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,23795,-0.00853248680896818,0.00431387954217171,-0.0169876907116247,-7.72829063116418e-05,0.0479498274715603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,23188,-0.0122691514380277,0.00620928212342587,-0.0244393443999424,-9.8958476112956e-05,0.0481737340451116
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,23198,-0.0116577892937878,0.00590921972634165,-0.0232398599574175,-7.57186301582075e-05,0.0485286596451892
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,23163,-0.0109261077577356,0.00554153295323478,-0.0217875123460758,-6.4703169395464e-05,0.0486584885757616
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,28553,0.00832967994276706,0.00423342388690988,3.21691244236869e-05,0.0166271907611104,0.0491238816503266
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",28320,-0.00371265931873917,0.00188823179319608,-0.00741359363340348,-1.17250040748604e-05,0.0492841708968731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,28070,0.00383227736646495,0.0019500217061824,1.02348223474493e-05,0.00765431991058244,0.0493953252992573
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",23846,-0.0118362196512009,0.00604157463072152,-0.0236777059274151,5.26662501326193e-06,0.0501094087040115
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,27682,-0.00652941511421502,0.00333487535629838,-0.0130657708125598,6.94058412980918e-06,0.0502495784470554
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,28320,-0.00545746251496064,0.00278835798417443,-0.0109226441639425,7.71913402124787e-06,0.0503300521404632
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,22978,0.00907861274147374,0.00463940380148447,-1.46187094358305e-05,0.0181718441923833,0.0503773222509176
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,28362,-0.0090870975562532,0.00464648035142857,-0.0181941990450532,2.00039325467926e-05,0.0505109238556486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,28176,-0.011177968765104,0.00572998542728994,-0.0224087402025922,5.28026723843021e-05,0.0510925486831629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",28187,0.0050374212349576,0.00258360981643809,-2.64540052610542e-05,0.0101012964751762,0.0512145379644788
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,22936,0.00697336339890768,0.00358185636960919,-4.70750855263331e-05,0.0139938018833417,0.0515640369892164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,27109,0.00635813637212733,0.00327523425872157,-6.13227749669569e-05,0.0127775955192216,0.0522350633759153
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,28195,-0.0392479148388,0.0202381824395137,-0.078914752420247,0.000418922742646904,0.0524747407146263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,23071,0.00533477100333738,0.00275246822893231,-6.006672536995e-05,0.0107296087320447,0.052613805786371
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,23071,0.00430408338890605,0.00222849059039134,-6.37581682609795e-05,0.00867192494607308,0.0534471403815316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,28307,-0.00382560692473536,0.00198127289153824,-0.0077089017921503,5.76879426795857e-05,0.0535074529959869
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,23862,-0.00570810989684757,0.00295728550436101,-0.0115043894853951,8.81696917000001e-05,0.0535956886919718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,27232,-0.00474639817669948,0.00245919932887944,-0.00956642886130319,7.3632507904227e-05,0.0536099873994058
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,27562,0.0218551927559862,0.0113253249323265,-0.000342444111373717,0.0440528296233462,0.0536464682243125
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,23872,-0.00622918210573207,0.00323339721720573,-0.0125666406514553,0.000108276439991156,0.0540522017962558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,23337,-0.00943229382784451,0.00489753549307414,-0.0190314633942698,0.000166875738580794,0.0541256816429612
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,27562,-0.0057786696688054,0.00300109753422162,-0.0116608208358798,0.000103481498268977,0.0541747697570354
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,28320,-0.0037145109448008,0.00193150584383828,-0.00750026239872382,7.12405091222302e-05,0.0544754284576568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,27500,0.0118817363883065,0.00618334050511972,-0.000237611001728198,0.0240010837783411,0.054669913812477
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",28195,-0.0123295736524731,0.00643406675922357,-0.0249403445005513,0.000281197195605119,0.0553375882333471
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,27791,0.0224621605499492,0.0117359633755397,-0.000540327666108724,0.0454646487660071,0.0556355744762189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",23795,0.00476660602158245,0.00249841147357844,-0.0001302804666313,0.00966349250979619,0.056422032549449
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,27702,-0.00705971002344406,0.00370496060242142,-0.01432143280419,0.000202012757301917,0.056728693822332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,23795,-0.00357780565701341,0.00187915461515576,-0.00726094870271869,0.00010533738869187,0.0569295006403599
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,27528,0.0141979997032669,0.00746604853125583,-0.000435455417994501,0.0288314548245284,0.0572240582961502
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,23846,-0.00345271192388647,0.00181825403320665,-0.00701648982897151,0.000111065981198561,0.0575875685643425
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,23872,0.00336619113067166,0.00177356333487934,-0.000109993005691844,0.00684237526703517,0.0577105229621341
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,22978,0.00403911937149756,0.00212938669831884,-0.000134478557207367,0.00821271730020249,0.0578607563229785
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,28320,-0.0136908869608827,0.00722032298796818,-0.0278427200173003,0.000460946095534948,0.0579490765201777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,27544,-0.00481050245561073,0.00253720484746477,-0.00978342395664167,0.000162419045420214,0.0579724828725422
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,23846,-0.00955878991999539,0.00504377110900387,-0.019444581293643,0.000327001453652196,0.0580823347927712
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,28521,-0.00817771570198346,0.00431708316028442,-0.0166391986961409,0.00028376729217401,0.0581994594465793
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,23846,0.00636619941195629,0.00336120409084183,-0.000221760606093706,0.0129541594300063,0.0582339929847955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,23846,-0.00422299744474307,0.00223186437207036,-0.00859745161400097,0.000151456724514831,0.0584845834457854
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,23893,0.00191403309366466,0.00101192437916179,-6.93386894924449e-05,0.00389740487682176,0.0585726033876391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,28176,0.0105846986767938,0.00559780260438947,-0.000386994427809564,0.0215563917813971,0.0586523920629777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,23071,-0.00467126445853718,0.00247142107924998,-0.00951524977386713,0.000172720856792773,0.0587554143966033
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,23056,0.00763493318111004,0.00404403058176141,-0.000291366759142327,0.0155612331213624,0.0590450286971408
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,23188,0.00622639372019408,0.00331587985341325,-0.000272730792495894,0.0127255182328841,0.0604279079356707
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,23775,-0.0034569628003128,0.00184725112673658,-0.0070775750087165,0.000163649408090897,0.0613006590367363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,27562,-0.00930333677379417,0.00497895448130732,-0.0190620875571565,0.000455414009568169,0.0616985314933842
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,27682,-0.00601371210205021,0.00321884258610947,-0.0123226435708248,0.000295219366724356,0.0617330563086465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,23725,0.00664294047072576,0.00355852561974154,-0.000331769743967667,0.0136176506854192,0.0619463758769452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,23071,0.0058689170240428,0.00314527137569132,-0.000295814872312182,0.0120336489203978,0.062061142065123
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,27702,0.00474345035232076,0.00254898773655409,-0.000252565611325261,0.00973946631596678,0.0627667263360548
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,28140,-0.00367344940499094,0.001975453358464,-0.00754533798758039,0.000198439177598506,0.0629600029866883
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,23188,0.0129359814997193,0.00695687709100427,-0.000699497598649053,0.0265714605980877,0.0629757103105073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,27652,-0.00542834156198219,0.00292134867036838,-0.0111541849559042,0.000297501831939827,0.0631565173351665
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,28428,-0.0066679629222171,0.00359516812547533,-0.0137144924481487,0.000378566603714534,0.063649248117275
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23163,0.00401398995066866,0.00216638522463191,-0.00023212508960988,0.00826010499094719,0.0639163749595898
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,22978,0.00599723390361433,0.00323883772807166,-0.00035088804340612,0.0123453558506348,0.064087150191614
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,23163,0.00547364104591116,0.00295642561539729,-0.000320953160267517,0.0112682352520898,0.064119180322758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,27871,-0.00850853544595844,0.00459823623971302,-0.017521078475796,0.00050400758387908,0.0642677806890916
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,23862,-0.00456427752950014,0.00246829762894873,-0.00940214088223966,0.000273585823239369,0.0644470627397979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,28091,-0.0238541971951399,0.0129200739962162,-0.0491775422277237,0.00146914783744389,0.0648606970866408
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,28553,0.00914696433745377,0.00495486451399619,-0.000564570109978754,0.0188584987848863,0.0648942194784666
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23198,0.00507113545144142,0.00274786087586963,-0.000314671865263066,0.0104569427681459,0.0649797919441823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,23188,0.00336562754825535,0.00182372228004435,-0.00020886812063157,0.00694012321714228,0.0649817245725661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,23862,-0.0110811316311839,0.00602490987384981,-0.0228899549839296,0.00072769172156169,0.0658953338955342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,27434,-0.00887812804261215,0.00482988177243758,-0.0183446963165898,0.000588440231365511,0.0660486494869972
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,23393,0.00523944117681434,0.00285287771593624,-0.0003521991464207,0.0108310815000494,0.0662896329341337
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,27562,0.00933586797189177,0.0050977270703596,-0.000655677086013036,0.0193274130297966,0.0670548550390945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,27682,-0.00946779667072899,0.00518585755437496,-0.0196320774773039,0.000696484135845946,0.0679069185226287
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,27544,0.00685374138056378,0.00375764720102071,-0.000511247133436801,0.0142187298945644,0.0681712410142401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,23071,-0.00629480894817783,0.00345144941988591,-0.0130596498111542,0.000470031914798556,0.068192820577298
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,28276,0.00391604928342215,0.00215225457939414,-0.000302369692190368,0.00813446825903467,0.0688441943986591
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,23056,0.00698580001776307,0.00384626588955717,-0.000552881125768986,0.0145244811612951,0.0693442387785932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,23337,0.00458097514426548,0.00252288391903301,-0.000363877337039221,0.00952582762557018,0.0694186046337677
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,28452,-0.00400131794872312,0.002208225159804,-0.00832943926193896,0.000326803364492728,0.0699957624947728
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,23071,-0.0085785434840097,0.00474730006638589,-0.017883251614126,0.00072616464610664,0.0707696513115089
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,27562,-0.00730846245210528,0.0040446003023514,-0.015235879044714,0.000618954140503476,0.0707782080558103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,23775,-0.00455777903159925,0.00252799823142053,-0.00951265556518349,0.000397097501984992,0.0714134156053562
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,23327,-0.0026317385504849,0.00145996773998951,-0.00549327532086435,0.000229798219894548,0.0714638911229186
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23198,0.00650738806988182,0.00361635298752783,-0.000580663785672724,0.0135954399254364,0.0719630729507063
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,23071,-0.00473698133494698,0.00263737083480774,-0.00990622817117014,0.000432265501276182,0.0724917264032317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,23733,0.00470726186766302,0.00262483082348795,-0.000437406546373355,0.0098519302816994,0.0729284024138391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,28452,0.00739477586800446,0.00412652065436887,-0.000693204614558522,0.0154827563505675,0.0731416189722647
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,23056,0.00766628118573811,0.00427799473529321,-0.000718588495436575,0.0160511508669128,0.0731417899389279
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,23393,-0.00909257757482855,0.00508972526655221,-0.0190684390972709,0.000883283947613778,0.0740381761358487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,27431,0.0070496291989706,0.00395017705864901,-0.000692717835981455,0.0147919762339226,0.0743313899930832
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,28115,0.0106860375002449,0.00598879584614534,-0.00105200235819994,0.0224240773586898,0.0743795040792679
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,27544,-0.00752873009835836,0.00423299700009031,-0.0158254042185354,0.000767944021818655,0.0753194341123647
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,28135,0.00280237046877608,0.00157681875908965,-0.000288194299039631,0.00589293523659179,0.0755411211566665
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,23725,-0.00623425110540066,0.00350994663965576,-0.0131137465191259,0.000645244308324622,0.0757182299136752
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,23795,0.00927645673172057,0.00522558951412534,-0.000965698715965085,0.0195186121794062,0.0758779658742696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,22978,0.00500661443213655,0.00282040857945366,-0.000521386383592622,0.0105346152478657,0.075888347285294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,27910,0.00385958155296809,0.00217902455144947,-0.000411306567872863,0.00813046967380905,0.0765312507453368
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,23738,-0.00571606461898167,0.00322777127300059,-0.0120424963140628,0.00061036707609948,0.0765899395540678
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,28174,0.00556184419399672,0.00314156329377578,-0.000595619861803818,0.0117193082497973,0.0766702586249677
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,23071,0.00535249186523775,0.00302818162608452,-0.000582744121887912,0.0112877278523634,0.0771477613258436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,28224,-0.00542848854722108,0.00307494467684852,-0.0114553801138442,0.000598403019402016,0.0775084061216947
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,23337,0.00621694983763027,0.00352703851547207,-0.000696045652694994,0.0131299453279555,0.077971897131681
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,23337,-0.00372160915363288,0.00211444724071655,-0.00786592574543732,0.000422707438171565,0.078406319337454
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,23795,0.00910228667747591,0.00517852712441795,-0.00104762648638328,0.0192521998413351,0.0788117757327016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,23893,0.00309992422452302,0.00176853643839777,-0.000366407194736607,0.00656625564378264,0.0796459171897317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23071,0.00792657969960121,0.00452265761275059,-0.000937829221389944,0.0167909886205924,0.0796775262885777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,23165,0.00834311857201573,0.00476422276801722,-0.000994758053298028,0.0176809951973295,0.0799242863085074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,28187,0.00505501676392426,0.00288813073106485,-0.000605719468962856,0.0107157529968114,0.0800821309191721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23056,0.00738440105247157,0.00421950319832992,-0.000885825216255074,0.0156546273211982,0.0801205639369478
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,28176,-0.00436622366633048,0.00250982895517922,-0.00928548841848174,0.000553041085820785,0.08193143825389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,23841,-0.0129897072409068,0.00748032999006688,-0.0276511540214379,0.00167173953962428,0.0824856918013768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,23393,0.00487276396035435,0.00280691160790924,-0.000628782791147763,0.0103743107118565,0.0825791880946256
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,23348,0.00600428377515959,0.00346754114732379,-0.000792096873595041,0.0128006644239142,0.0833636998166871
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22614,0.0127524072288737,0.00736749649796836,-0.00168788590714433,0.0271927003648917,0.0834830678578471
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,23163,-0.00659251237635071,0.003813630938285,-0.0140672290153893,0.000882204262687892,0.0838813670535735
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,23393,-0.00631221097796082,0.00365793953896912,-0.0134817724743403,0.000857350518418658,0.084429142955283
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,23056,0.00546428301528937,0.00316833577476547,-0.000745655103250949,0.0116742211338297,0.0846032534043178
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,22978,0.00985998969600832,0.00571792854087992,-0.00134715024411633,0.021067129636133,0.0846493127759311
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,23188,-0.00496703690101828,0.00288241040477054,-0.0106165612943685,0.000682487492331988,0.0848614829708513
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,27544,-0.00382946910550977,0.00222516268061049,-0.00819078795950634,0.000531849748486789,0.0852649845847599
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,23725,-0.00468600429897756,0.0027246267878947,-0.0100262728032512,0.000654264205296045,0.0854690956891932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,28276,-0.00612362456410727,0.00356056914582624,-0.0131023400899267,0.000855090961712165,0.085471694870706
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,23779,-0.00233587532067596,0.00135980852205142,-0.00500110002389674,0.00032934938254482,0.0858466326688578
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,27544,-0.00413923960378652,0.00241090852158624,-0.00886462030609555,0.000586141098522505,0.0860124250915751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,28224,-0.0037266421224329,0.0021772016644194,-0.00799395738469492,0.000540673139829128,0.0869692246135075
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,23071,-0.00706052444984285,0.00412708734112033,-0.0151496156384387,0.001028566738753,0.0871358122100522
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,23775,-0.00531925512911879,0.00311211987177967,-0.0114190100778069,0.000780499819569361,0.087425786190175
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,28187,-0.00533637214502725,0.00312488907586256,-0.0114611547337179,0.000788410443663359,0.087703094670443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,27544,-0.0086122486514512,0.00504569759599039,-0.0185018159395924,0.00127731863668997,0.0878612239178852
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,27702,-0.00573936768950082,0.0033648359782531,-0.0123344462068769,0.000855710827875261,0.0880769945972801
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,23163,0.00736283137529077,0.00432158030101435,-0.00110746601469735,0.0158331287652789,0.0884438650209199
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,28452,-0.00246691765600675,0.00145126741046792,-0.00531140178052387,0.000377566468510381,0.0891725752454369
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,23393,0.00333925685656137,0.00196659016392295,-0.000515259864727613,0.00719377357785035,0.0895223403620688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,27761,-0.00347585031504906,0.00204910942723265,-0.00749210479242505,0.000540404162326928,0.0898452866188961
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,27702,-0.00503096152686834,0.00296615578998694,-0.0108446268752427,0.000782703821506058,0.0898740556294659
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,23056,0.00815966944556253,0.00481295175814217,-0.00127371600039613,0.0175930548915212,0.0900213075467108
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,23337,-0.00991406850245775,0.00584905172045329,-0.0213782098745462,0.0015500728696307,0.0900911750852425
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,23188,0.00633683546306928,0.00373925974613375,-0.000992113639352869,0.0136657845654914,0.0901502496694226
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,23071,-0.00517492058820331,0.00305506899906702,-0.0111628558263747,0.000813014649968035,0.0903015750865925
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,23664,-0.00537153646943412,0.00317553894309462,-0.0115955927978996,0.000852519859031345,0.0907477713463253
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,23188,-0.00447741146007803,0.00264745939586135,-0.00966643187596629,0.000711608955810224,0.0908100286827536
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,22978,0.00394277207593738,0.00233551917045877,-0.000634845498161816,0.00852038965003658,0.091390643875621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,23056,0.00395873767282958,0.00234744256331983,-0.000642249751277293,0.00855972509693645,0.0917314553007436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,23056,0.00665720828307012,0.0039491473608574,-0.00108312054421038,0.0143975371103506,0.0918607648366451
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,23725,0.0100113761651091,0.0059487722453761,-0.00164821743582808,0.0216709697660462,0.0924015192463495
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,23393,-0.00609252873642325,0.00363904324670529,-0.0132250534999656,0.00103999602711912,0.0941023792861989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,23198,-0.00733132937359944,0.00438167774194747,-0.0159194177478165,0.0012567590006176,0.0943056356602702
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,28238,0.010655112490968,0.00637672564559898,-0.00184326977440605,0.023153494756342,0.0947450335059779
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,23056,-0.00733903192375512,0.00440343791549777,-0.0159697702381307,0.00129170639062051,0.0955957085146646
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,27702,0.00508858824164591,0.00306485718139171,-0.000918531833881854,0.0110957083171737,0.0968650545733577
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,27544,0.00825078146125521,0.00497261585268028,-0.00149554560999813,0.0179971085325086,0.0970780882139968
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,28521,-0.00525734299033264,0.00317250552993547,-0.0114754538290062,0.000960767848340875,0.0974985350111831
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23163,0.00611536268691296,0.00369162146841638,-0.00112021539118314,0.0133509407650091,0.0976236492564683
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,23188,-0.00461242855067696,0.00278523861237147,-0.010071496230925,0.000846639129571127,0.097730020531624
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,27562,0.00653255090903502,0.00394549451421724,-0.00120061833883077,0.0142657201569008,0.0977942011005732
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,22978,0.0105752676604539,0.00638915560355252,-0.001947477322509,0.0230980126434169,0.0978995898242778
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,28224,-0.00403358499817988,0.00243872766460857,-0.00881349122081267,0.000746321224452911,0.098144517349722
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,23738,0.0133190077528832,0.00806081648004196,-0.00248019254799902,0.0291182080537655,0.0984835920597163
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,27562,-0.00536096756123296,0.00324777766083917,-0.0117266117764777,0.00100467665401181,0.0988199924015443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,23725,0.00472130429171675,0.00286104613065476,-0.000886346124366574,0.0103289547078001,0.0989148553677241
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,22940,0.00550048259077777,0.00333570397240582,-0.00103749719513763,0.0120384623766932,0.0991670636314844
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,23846,-0.00363890165506521,0.0022134555274022,-0.00797727448877351,0.0006994711786431,0.10019118732751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,23862,0.00296782339564548,0.00180873519063063,-0.000577297577990563,0.00651294436928152,0.100846305859996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,23071,-0.00676778901936978,0.00412644740763731,-0.0148556259383389,0.00132004789959933,0.100997885350657
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,23163,-0.00427652323562002,0.00260767396559615,-0.00938756420818847,0.000834517736948434,0.101023703260524
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,27965,0.00468532465140558,0.00286025824470573,-0.000920781508217652,0.0102914308110288,0.101416785578464
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,23071,0.00480250027030507,0.00293212918235317,-0.000944472927107135,0.0105494734677173,0.101458629101665
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,23481,0.00381775141559048,0.00233634063144753,-0.000761476222046679,0.00839697905322764,0.102256912947872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,28176,-0.0112567086867495,0.00690137021338201,-0.0247833943049782,0.00226997693147924,0.102883956959751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,27702,-0.00540205349858062,0.00331406243835672,-0.0118976158777598,0.00109350888059854,0.103104471616062
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,23393,0.00932313972043742,0.0057233345509415,-0.00189459599940792,0.0205408754402827,0.103332863933679
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,28388,0.00252208048808752,0.00155113592254213,-0.000518145920095043,0.00556230689627009,0.103969884219257
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,23071,0.00615215811649284,0.00378877177319092,-0.00127383455896136,0.013578150791947,0.104434958499555
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,28091,-0.00992054943695993,0.00613077638429623,-0.0219368711501805,0.00209577227626069,0.105640326048982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,23071,0.00445537976648263,0.00275793635099812,-0.000950175481473691,0.00986093501443895,0.106221352766917
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,23056,0.00380197374671855,0.00235596208268668,-0.000815711935347348,0.00841965942878445,0.106591678929723
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,23775,-0.0149900587926917,0.0093089083515589,-0.0332355191617471,0.00325540157636376,0.10734745173761
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,27682,-0.00492364914736862,0.00306282588848408,-0.0109267878887974,0.00107948959406017,0.10794493823576
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,28496,-0.00563121387766298,0.00350920941870226,-0.0125092643383194,0.00124683658299346,0.108571837337243
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,23862,0.00342637765794426,0.00213913389663099,-0.000766324779452484,0.007619080095341,0.10922208629912
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,28176,-0.00404073022123912,0.00252748547178909,-0.00899460174594573,0.000913141303467497,0.10989504843975
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,23795,0.00286130948422099,0.00179023777180884,-0.000647556548524325,0.00637017551696631,0.10999293568787
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,28176,-0.003716311900428,0.0023255175132573,-0.00827432622641231,0.000841702425556306,0.110041285288109
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,23460,0.00148398033575756,0.000929156196128869,-0.000337165808655023,0.00330512648017014,0.110250904105682
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,27702,-0.00425914286446588,0.0026697940844906,-0.00949193927006746,0.000973653541135695,0.110654874155104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23056,0.00710908098115857,0.00446367234102358,-0.00163971680724764,0.0158578787695648,0.111251781802009
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,27082,0.00251588813670091,0.00158212848933134,-0.000585083702388509,0.00561685997579033,0.111803201697138
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,23393,-0.00479505344390771,0.00301801733916567,-0.0107103674286724,0.00112026054085701,0.112117018089299
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23071,0.00634288890042529,0.00400046583532555,-0.00149802413681279,0.0141838019376634,0.112857960258099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,27682,0.00362625660598757,0.00228720039263515,-0.000856656163577314,0.00810916937555246,0.112874093297062
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,23188,-0.0095621624650924,0.00603176333209212,-0.021384418595993,0.00226009366580815,0.112911530323614
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,23393,0.00426548496696684,0.0026915374427618,-0.00100992842084628,0.00954089835477996,0.113030675889694
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,23071,-0.00727876091588241,0.00459671892614382,-0.0162883300111243,0.00173080817935947,0.113328371787178
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,23337,0.0116864243291947,0.00738334816863402,-0.00278493808132797,0.0261577867397174,0.113478736809291
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,23795,-0.00237964045883997,0.00150405385602389,-0.00532758601664679,0.00056830509896686,0.113628379425413
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,28120,-0.00218944553624668,0.00138400761662146,-0.00490210046482475,0.000523209392331392,0.113669814581838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,27682,-0.00252551397660023,0.00160171528471975,-0.00566487593465094,0.000613847981450482,0.114863142184219
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,28521,-0.00812422539418148,0.0051540003323636,-0.0182260660456141,0.00197761525725117,0.114968910150267
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,23828,-0.00515178104335747,0.00326856911900159,-0.0115581765166006,0.00125461442988565,0.115002701054071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,28187,0.00259695273231077,0.00164877943741946,-0.000634654965031364,0.00582856042965291,0.115250157951936
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23198,0.00375419577381782,0.00238498065896863,-0.000920366317760701,0.00842875786539634,0.115478198876184
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,28091,0.00706972637829633,0.00449931943340542,-0.0017489397111783,0.015888392467771,0.116127048704081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,27682,-0.00653824103879016,0.0041666928781338,-0.0147049590799324,0.00162847700235209,0.116620238979113
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,23163,0.00509440692998011,0.0032543596665167,-0.00128413801639263,0.0114729518763529,0.117500491067764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,23725,-0.00558453236475553,0.00356833760278655,-0.0125784740662172,0.00140940933670611,0.117590733751439
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,24857,0.00334293971527752,0.00213721077503863,-0.00084599340379819,0.00753187283435322,0.11779272344796
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,28348,-0.00442399378339529,0.00283063720610079,-0.00997204270735283,0.00112405514056225,0.118088042536547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,23725,0.00593351265759543,0.00379949133503037,-0.0015134903590641,0.013380515674255,0.118381513243714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,27346,0.00713841961875662,0.00457815272063093,-0.00183475971368,0.0161115989511932,0.118952158542204
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,28320,-0.0028712482241334,0.00184450332158963,-0.00648647473444908,0.000743978286182284,0.119564511461531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,23071,0.00663151424368198,0.00426385236707877,-0.0017256363957924,0.0149886648831564,0.1198914521819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,28224,-0.0072760031453813,0.00467862673654311,-0.0164461115490058,0.00189410525824319,0.119919695495481
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,23862,0.0026960307868129,0.00173646947994621,-0.00070744939388168,0.00609951096750748,0.120533609949149
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,28091,-0.00229771647182031,0.00148111750375947,-0.00520070677918888,0.000605273835548258,0.120831554422552
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,22978,0.00843300037056062,0.00543713057215653,-0.00222377555086618,0.0190897762919874,0.120914986109718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,28428,-0.00628021895994968,0.00404976270271786,-0.0142177538572767,0.00165731593737731,0.120969817176841
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,23795,-0.0125016466129489,0.00806548914442634,-0.0283100053360245,0.00330671211012674,0.121150703310216
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,23056,0.0032107589411114,0.00207399129245915,-0.000854263992108529,0.00727578187433133,0.121610444331355
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,23795,0.00396505623790596,0.00256546480302619,-0.00106325477602536,0.00899336725183729,0.122226392090617
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,28134,-0.00716288993468875,0.0046357882313503,-0.0162490348681354,0.00192325499875784,0.122326363718774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,23163,-0.0062808155444814,0.00407154797109617,-0.0142610495678299,0.00169941847886709,0.122938805422761
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,28082,-0.00274731314852335,0.00178506213061296,-0.00624603492452475,0.000751408627478055,0.123801547275369
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,23337,-0.0040802411158759,0.00265240591227634,-0.00927895670393753,0.00111847447218573,0.123984689967445
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,28082,0.00823892997500677,0.00535605266367863,-0.00225893324580333,0.0187367931958169,0.123999595328864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,23163,-0.0137968061258932,0.00897332810402978,-0.0313845292097915,0.0037909169580052,0.124176015731034
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,23056,0.00779715997781667,0.00507554400521528,-0.00215090627240527,0.0177452262280386,0.124497787708476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,27985,0.00518963910197272,0.00338976317104164,-0.0014542967132689,0.0118335749172143,0.125787140561571
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,23135,-0.00885660673160846,0.00579250744541025,-0.0202099213246126,0.00249670786139563,0.126283993826363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,27448,0.0049508577944163,0.00324041418089067,-0.00140035400012941,0.011302069588962,0.126562004238826
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,23198,-0.00957192026229252,0.00626661142025928,-0.0218544786460007,0.00271063812141567,0.126663402077315
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,23071,0.00416520338213197,0.002729978659392,-0.00118555479027634,0.00951596155454029,0.127091471019558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,23725,-0.0111962477357851,0.00735493692915044,-0.02561192411692,0.00321942864534976,0.127953146196762
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,23163,0.00384594196065872,0.00252663567975644,-0.0011062639716639,0.00879814789298134,0.127982833163265
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",27544,0.00314436205179603,0.00206776170615709,-0.000908450892271873,0.00719717499586393,0.128356722430227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,23795,0.0131196031056432,0.0086298302252938,-0.00379486413593264,0.0300340703472191,0.128458430923731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,23766,-0.00325441624182274,0.00214157666754227,-0.00745190651020558,0.000943074026560105,0.128615884426339
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,28187,-0.00476691997345806,0.00313692912326522,-0.0109153010550579,0.00138146110814177,0.128619354358969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,23725,-0.00361409154296891,0.00237895403792665,-0.00827684145730515,0.00104865837136732,0.12872712679324
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,27965,0.0108540906975469,0.00716300611626254,-0.00318540129032765,0.0248935826854215,0.12970819697143
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,28276,-0.00857960900926985,0.00566217576779111,-0.0196774735141404,0.00251825549560072,0.129720414924752
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,23163,0.00525445270757542,0.003490178344763,-0.00158629684816006,0.0120952022633109,0.132210015085356
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,27682,-0.00634668158772662,0.00421835218171891,-0.0146146518638957,0.00192128868844245,0.132453674945783
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,23029,-0.00353670572195541,0.00235202535180011,-0.00814667541148363,0.00107326396757281,0.132676161981471
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,23725,-0.00388361526190272,0.00259401165334112,-0.00896787810245132,0.00120064757864589,0.134368474088272
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,23188,0.00445474651635388,0.00297567914877025,-0.00137758461523581,0.0102870776479436,0.134393338894565
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,23795,-0.0063251209719982,0.00422632582638088,-0.0146087195917047,0.00195847764770833,0.13451053391457
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,27702,-0.00683329237202262,0.00456798490404883,-0.0157865427839583,0.00211995803991309,0.13468861750289
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,27544,0.0039026963667786,0.00260992177141294,-0.00121275030519076,0.00901814303874796,0.134839597362435
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,28091,0.00331674741484505,0.00222138037185226,-0.00103715811398539,0.00767065294367548,0.135421732871467
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,23071,-0.0060323438927716,0.00405754743850925,-0.0139851368722497,0.00192044908670653,0.137108510235392
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,27702,-0.00713167069434507,0.00480340325999791,-0.016546341083941,0.00228299969525084,0.137631502734338
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,28307,-0.00632867446703814,0.00428219983059413,-0.0147217861350026,0.00206443720092636,0.139444969024121
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,23056,-0.00857456747534834,0.00581018649673721,-0.0199625330089533,0.0028133980582566,0.140016143034382
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,28224,-0.00430652442367371,0.0029203488996657,-0.0100304082670185,0.00141735941967106,0.140314884543832
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,23795,-0.00760741931097776,0.00516256615667333,-0.0177260489780575,0.00251121035610197,0.140609768119109
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,23056,0.00415140714968348,0.00283145257971249,-0.001398239906553,0.00970105420591996,0.142614055606489
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,28275,0.00272825339229706,0.00186224611992284,-0.00092174900275171,0.00637825578734583,0.142922837772474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,28224,0.0040402802490924,0.00275837143309771,-0.00136612775977912,0.00944668825796391,0.143004665931367
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,28411,0.00346213326022356,0.00236561971758819,-0.0011744813862493,0.00809874790669642,0.143336041237652
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,27562,-0.00671423924681307,0.00459705882158083,-0.0157244745371115,0.00229599604348537,0.144150083029672
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,27562,0.00552656601456612,0.00378701874667975,-0.00189599072892618,0.0129491227580584,0.144481640263592
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",22978,-0.0092639903159597,0.00634872159895899,-0.0217074846499193,0.00317950401799992,0.144526531010655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,28091,0.00818972211073275,0.0056188743684139,-0.0028232716513585,0.019202715872824,0.144979153200122
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,23846,0.00274433956776134,0.0018847026973252,-0.000949677718996047,0.00643835685451874,0.145374635491987
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23056,0.00490804743936611,0.00337472285935582,-0.00170640936497129,0.0115225042437035,0.145861335072231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,28091,0.00742713606251609,0.00511808234402932,-0.00260430533178138,0.0174585774568136,0.146747589365533
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23149,-0.00356792875222105,0.00245885082560451,-0.00838727637040589,0.0012514188659638,0.146777994696515
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,23846,0.00281737753465641,0.00194181592611504,-0.000988581680529067,0.00662333674984189,0.146821327471848
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,27562,-0.00297141763205669,0.00205445645311558,-0.00699815228016323,0.00105531701604985,0.148096638552273
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,28176,-0.00342905499280265,0.00237619414768207,-0.0080863955222595,0.0012282855366542,0.149007074477909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,28363,-0.00605708617619921,0.00421245058779106,-0.0143134893282697,0.00219931697587128,0.150473233695424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,23775,-0.00456837161710401,0.00317856510808991,-0.0107983592289602,0.00166161599475221,0.150662022357925
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,23393,-0.00362733280767182,0.00252630864602109,-0.00857889775387316,0.00132423213852952,0.151066008201173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,28220,-0.0055927703964835,0.00390156478230108,-0.0132398373697936,0.00205429657682661,0.15173506584252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23188,-0.00784759961966983,0.00548106476962046,-0.0185904865681259,0.00289528732878628,0.15222442097684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,22978,0.00312962946621293,0.00218774816732082,-0.00115835694173588,0.00741761587416174,0.152579868557296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",28187,-0.00373985591164828,0.00261764663437793,-0.00887044331502903,0.00139073149173248,0.153098909753655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,22878,-0.00428367303733872,0.00300045164681371,-0.0101645582650936,0.00159721219041616,0.153398772564533
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",23775,0.010314471372722,0.00723634425879477,-0.00386876337451572,0.0244977061199598,0.154063276807602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,23071,0.00468453349086655,0.00328770432761176,-0.0017593669912525,0.0111284339729856,0.154209881239887
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,23299,-0.00357782367312192,0.00251287376626529,-0.00850305625500188,0.00134740890875804,0.154518466040777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23188,0.0034494831334011,0.00242302298582055,-0.00129964191880718,0.00819860818560939,0.154567677161221
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,28091,0.00254544647264529,0.00178875017213835,-0.000960503864745881,0.00605139681003646,0.15473835631061
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,23893,0.00202569624102222,0.00142697756391875,-0.000771179784258541,0.00482257226630297,0.155745611128067
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",27544,0.0048650569286014,0.00343576040171738,-0.00186903345876467,0.0115991473159675,0.156785096538518
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,23738,-0.00247677625603185,0.00175600405719157,-0.00591854420812732,0.000964991696063634,0.158416544587688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,27562,0.00533657671363751,0.0037867369317936,-0.00208542767267794,0.012758581099953,0.158763358929179
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,23163,0.0036531481267556,0.0025952939033105,-0.00143362792373297,0.00873992417724418,0.15926155605035
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,27702,0.00626088604014882,0.00445582856339386,-0.00247253794410315,0.0149943100244008,0.160002674882452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,23163,-0.00467586880280203,0.00333711921785199,-0.0112166224697919,0.00186488486418786,0.161176875470338
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,23738,-0.00250524751745313,0.00178806798788492,-0.00600986077370758,0.000999365738801318,0.161199683442599
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,23163,0.00363705412193322,0.00259649918745595,-0.00145208428548044,0.00872619252934689,0.161301340877473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,22978,0.00388030044817152,0.00277438422901016,-0.00155749264068838,0.00931809353703143,0.16194142428028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,27702,-0.00377487069314784,0.00269992517185616,-0.0090667240299859,0.00151698264369023,0.162082528029401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,23163,-0.00284905789618692,0.00203822126252194,-0.00684397157072992,0.00114585577835609,0.162181780621824
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23056,0.00305869174470564,0.00218909716026002,-0.00123193868940399,0.00734932217881528,0.162355191539581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,23725,0.00463524251290913,0.00332271365126005,-0.00187727624356056,0.0111477612693788,0.163023735990928
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,23188,0.00208293063829345,0.0014946805005024,-0.000846643142691257,0.00501250441927815,0.163463134868816
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,28320,-0.00879555071969212,0.00631316331989567,-0.0211693508266876,0.00357824938730339,0.16356778989042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,27544,-0.00648214253188323,0.00465773820381175,-0.0156113094113543,0.0026470243475878,0.16402656973488
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,23872,-0.00218887267819114,0.00157486342457491,-0.00527560499035797,0.00089785963397568,0.164577998124444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,23071,-0.0112353689808344,0.00809162876450717,-0.0270949613592684,0.00462422339759967,0.164992901489889
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,23163,0.00296981595641183,0.0021392807703627,-0.00122317435349907,0.00716280626632273,0.165080063942148
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,28307,-0.00663981668101889,0.00479360839663536,-0.0160352891384242,0.00275565577638641,0.166020714483368
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,28091,0.00368333131792549,0.00266839497794139,-0.00154672283883964,0.00891338547469062,0.167488476652018
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,23862,0.00248842890564671,0.00180338425083398,-0.00104620422598789,0.00602306203728132,0.167640792955911
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,26744,-0.00375828181258159,0.00274139159974629,-0.00913140934808432,0.00161484572292113,0.170405351493833
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,22978,0.00384824317432884,0.00281105085798548,-0.0016614165073227,0.00935790285598039,0.17102216677781
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,22978,-0.00718506315320574,0.0052525028444632,-0.0174799687283536,0.00310984242194213,0.17134696004777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,28123,0.00588763282547797,0.00431731083961776,-0.00257429642017283,0.0143495620711288,0.172664462565181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,23071,-0.0114596955862772,0.00841009082343993,-0.0279434736002195,0.00502408242766507,0.173017949411864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",23846,-0.00682298961185483,0.00502537911328291,-0.0166727326738893,0.00302675345017967,0.174569705829288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,28176,0.00432665259795314,0.00320090285414204,-0.00194711699616526,0.0106004221920715,0.176482940303881
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,28224,-0.00532450446353106,0.00394022328306727,-0.0130473420983429,0.00239833317128079,0.176603627156717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,27562,0.0128040906928126,0.0094772087823333,-0.00577123852056066,0.0313794199061859,0.176693629676602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,28428,-0.0042466521768687,0.00314358656226894,-0.0104080818389158,0.00191477748517841,0.176740152554624
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,23163,-0.00849722988187355,0.00629464841683587,-0.0208347407788719,0.00384028101512476,0.177056980634875
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,23163,-0.00370086884511343,0.00274250523199018,-0.00907617909981417,0.00167444140958732,0.177206233616643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",23738,-0.0134616414095772,0.0100018963965089,-0.0330653583467346,0.00614207552758031,0.178344758343881
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,28072,-0.00773620176814362,0.00575394880421366,-0.0190139414244024,0.00354153788811516,0.178796637079827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,23862,0.00761523775146416,0.00566586016698115,-0.00348984817581888,0.0187203236787472,0.178942813719335
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23056,-0.00296017735298776,0.00220536148945603,-0.00728268587232158,0.00136233116634606,0.179523633476002
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,23846,-0.00589336317112912,0.00440075694147368,-0.0145188467764175,0.00273212043415929,0.180527997466515
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,23687,-0.00473126875063119,0.00353452929295795,-0.0116589461648288,0.0021964086635664,0.180718587870029
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,22978,0.004002390032174,0.00299043493544054,-0.00185886244128945,0.00986364250563745,0.180780210643726
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,27682,0.0101162587554616,0.00758374093110655,-0.00474787346950721,0.0249803909804305,0.182234354845201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,27682,-0.00444029462889354,0.00333029431979702,-0.0109676714956957,0.00208708223790862,0.182443049451933
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,22978,0.00405731546081672,0.00304519801328749,-0.00191127264522677,0.0100259035668602,0.18275347579131
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,23757,0.00216928351588932,0.00163218996201501,-0.00102980880966011,0.00536837584143875,0.183839910941529
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,27840,0.0105659259959601,0.00795681926395594,-0.00502943976139355,0.0261612917533137,0.184219309205099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,23056,0.00391063909197787,0.00294900731972628,-0.00186941525468564,0.00969069343864138,0.184824158478622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,23862,0.00302000811589283,0.00227817090602422,-0.00144520685991463,0.0074852230917003,0.184975503277346
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,28033,0.00202466367967031,0.00152945194979598,-0.000973062141929819,0.00502238950127044,0.185585665309952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,23725,0.00447235506237498,0.00337865894853254,-0.00214981647674879,0.0110945266014988,0.185613079337521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,28224,0.00256470849460927,0.0019398204159444,-0.00123733952064174,0.00636675650986029,0.186133229239543
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,27562,-0.00933446065943839,0.0070717381238833,-0.0231950673822497,0.00452614606337288,0.186857018083991
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,23056,0.00446910060866566,0.00338674699394117,-0.00216892349945903,0.0111071247167903,0.186986716953342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,23862,0.00546675958954508,0.00415554353053986,-0.00267810573031304,0.0136116249094032,0.188343081771628
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,23775,0.021451702564786,0.0163456119856983,-0.0105856969271826,0.0534891020567547,0.189403631793705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,27544,-0.003448077306903,0.002629073442416,-0.00860106125403836,0.00170490664023236,0.189693732863703
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,27702,-0.00566154299805479,0.00432379593831472,-0.0141361830371516,0.00281309704104206,0.190412529017509
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,23188,-0.00575189972914901,0.0043951496152489,-0.0143663929750369,0.00286259351673883,0.190651481070794
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,28471,0.00320705266232303,0.0024535807774829,-0.00160196566154346,0.00801607098618952,0.19119246450135
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,23056,0.00310462401546686,0.00237841602106807,-0.00155707138582656,0.00776631941676028,0.191792645023671
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,27562,-0.00469692189312995,0.00359879227851299,-0.0117505547590154,0.00235671097275551,0.191856635858019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23198,-0.0029252833737302,0.00224739286168955,-0.00733017338264172,0.00147960663518131,0.193054401682903
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,28336,-0.00275198057858407,0.00211580850504347,-0.00689896524846927,0.00139500409130113,0.193380087065531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,23738,-0.00677658401593791,0.00521388308302417,-0.0169957948586653,0.00344262682678947,0.193709851451101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,23725,-0.00703816326301029,0.00542534479884473,-0.017671839068746,0.00359551254272539,0.194549262683566
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,28553,-0.00152233692714212,0.0011768324661157,-0.00382892856072889,0.000784254706444646,0.195818071428273
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,23337,0.00837778443876886,0.00648387799762843,-0.00433061643658286,0.0210861853141206,0.196337151122061
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,23738,-0.00249712941183294,0.00193499762008861,-0.00628972474720662,0.00129546592354073,0.196887001977026
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,27702,0.0125134099753402,0.00969906811551905,-0.0064967635310771,0.0315235834817576,0.19700372919611
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,27702,-0.003639859323984,0.00282252465707329,-0.00917200765184765,0.00189228900387965,0.19720877505657
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,23056,0.00970283376665649,0.00758352770134313,-0.00516088052797606,0.024566548061289,0.200747377382346
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,23862,0.00260028192424842,0.00203799508159334,-0.00139418843567452,0.00659475228417136,0.202002603893759
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,23775,0.00658837438337702,0.00516776298065399,-0.0035404410587048,0.0167171898254588,0.202357560133137
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,23393,-0.00504995233504246,0.00397051985304599,-0.0128321712470126,0.00273226657692767,0.203434894956725
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,23188,-0.00785144780547495,0.00618034011601937,-0.0199649144328729,0.00426201882192302,0.203958179262699
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23163,-0.00426787248782673,0.00337388520055242,-0.0108806874809095,0.00234494250525602,0.205893867542
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,27702,0.00513239596265924,0.00405977603462239,-0.00282476506520064,0.0130895569905191,0.206166497720778
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,23337,-0.00520923411820921,0.00412127025458002,-0.013286923817186,0.00286845558076762,0.206247143212568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,27562,-0.00454518628749854,0.00359699952200092,-0.0115953053506203,0.00250493277562326,0.206382560384594
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,27702,-0.00434583286265385,0.00344599379180705,-0.0110999806945957,0.00240831496928796,0.207274028313674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,28521,-0.00477778034623015,0.00378940502315956,-0.0122050141916229,0.0026494534991626,0.207381865959053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,23071,-0.00479617719911942,0.00381224746488694,-0.0122681822302978,0.00267582783205899,0.208369408845232
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,23393,0.00518067320973348,0.00413716694474203,-0.00292817400196089,0.0132895204214279,0.210499593793624
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,28320,0.00745784352114095,0.00598964241549177,-0.00428185561322291,0.0191975426555048,0.213096726478573
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,23337,0.0101080163075716,0.00812138786388312,-0.00580990390563926,0.0260259365207826,0.213285124219829
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,23188,0.00418824373048329,0.00337310119850667,-0.00242303461858979,0.0107995220795564,0.214374721699899
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",23795,-0.00398775150018191,0.0032185830972886,-0.0102961743708676,0.00232067137050375,0.215366120925241
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,28091,-0.00759621006548401,0.00613792801331679,-0.0196265489715849,0.0044341288406169,0.215880181887476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23198,0.00418383546833778,0.00338271023660329,-0.00244627659540466,0.0108139475320802,0.216162953564719
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,23188,0.00874099410650464,0.00706844854044891,-0.00511316503277523,0.0225951532457845,0.216240236379773
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,23738,-0.00377610231304222,0.00305487647427664,-0.00976366020262443,0.00221145557654,0.216437343429095
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,23188,0.00247328914436325,0.00200235073775092,-0.00145131830162856,0.00639789659035506,0.216771293700349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,27702,-0.00244771021717782,0.00198228258438835,-0.00633298408257899,0.00143756364822334,0.216917739255336
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,28091,-0.00710232745453585,0.005757183167905,-0.0183864064636297,0.00418175155455796,0.21734507585718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,27682,0.0112923097041598,0.00915764156807793,-0.00665666776927298,0.0292412871775925,0.217548042258338
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,23188,-0.00342553454399079,0.00278028582874363,-0.0088748947683283,0.00202382568034672,0.217931705074663
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,23188,-0.00531642842182411,0.00431954220334371,-0.0137827311403778,0.00314987429672957,0.218415720785349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,28224,0.00268380907721152,0.00218058214244998,-0.00159013192199043,0.00695775007641348,0.218416759704173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23163,0.00350763352995746,0.00285065824728083,-0.00207965663471297,0.00909492369462789,0.218535747995946
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,22978,0.00533363572219977,0.00434269658550472,-0.00317804958538949,0.013845321029789,0.219390036635587
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,23188,0.00628371604849694,0.00511753271027922,-0.00374664806365034,0.0163140801606442,0.219504490886253
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,23393,0.00526342396636089,0.00429075811366181,-0.00314646193641625,0.013673309869138,0.219952016198607
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,23188,0.00478239178620935,0.0039048235021046,-0.00287106227791566,0.0124358458503344,0.220685815897969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,27682,0.00444573530485352,0.00364255052708991,-0.00269366372824271,0.0115851343379497,0.222285542974156
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,22978,-0.00606099911024915,0.00497817242822854,-0.0158182170695771,0.0036962188490788,0.223420881111608
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,27544,0.00710359898136482,0.00583524779077766,-0.00433348668855939,0.018540684651289,0.223477596897695
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,22978,0.00460338441424711,0.00378901789070546,-0.00282309065153559,0.0120298594800298,0.224405996076432
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,22978,-0.00243846065714312,0.00200746380678856,-0.00637308971844869,0.00149616840416245,0.224494092270414
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,23775,-0.00305666000959961,0.00251670472633185,-0.00798940127321005,0.00187608125401082,0.22455040207899
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,27431,0.00252612319028434,0.00208065959397982,-0.00155196961391611,0.0066042159944848,0.224721029461697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,23795,-0.00224182547456672,0.00184859968246803,-0.00586508085220406,0.00138142990307062,0.225250661136719
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,27562,0.00719019024945478,0.00593648284502108,-0.00444531612678654,0.0188256966256961,0.225834172450876
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,28322,0.0126117720177257,0.0104151190311902,-0.00780186128340705,0.0330254053188584,0.225940000409717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,27965,-0.00667729901143145,0.00551578637265949,-0.0174882403018441,0.00413364227898114,0.226066764698835
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,23393,0.00253084254550804,0.0020934569862539,-0.0015723331475496,0.00663401823856568,0.226702040615585
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,27702,0.00237206116844365,0.00196524371491531,-0.00147981651279036,0.00622393884967767,0.227440103018083
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,23393,-0.00495662733361279,0.00411006994553111,-0.0130123644268538,0.00309910975962819,0.227840673037121
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,28260,0.00252612728914013,0.00209689804362057,-0.0015837928763562,0.00663604745463645,0.22833029491438
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,28125,0.00850098657013625,0.00705765944830503,-0.00533202594854162,0.0223339990888141,0.228404565538948
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,28187,0.00239079248889667,0.00199200606757913,-0.00151353940355843,0.00629512438135177,0.230074338909834
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,28521,-0.00221444364209984,0.00184716816007966,-0.00583489323585598,0.00140600595165631,0.230603380751285
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,28103,-0.00728562038169141,0.00608846377928326,-0.0192190093890866,0.00464776862570378,0.231462056496592
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,23188,0.00404333785112746,0.0033812458642866,-0.00258390404287427,0.0106705797451292,0.23178176680559
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,23795,-0.00407759502997326,0.00341366048792616,-0.0107683695863085,0.00261317952636202,0.232296922047266
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",23071,-0.00511975618143518,0.00429841830654535,-0.0135446560622641,0.00330514369939371,0.233634797307378
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23393,0.0057283264052449,0.00481396316198881,-0.00370704139225317,0.015163694202743,0.234082133930339
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",23071,0.00418439524747197,0.00351666309537274,-0.0027082644194586,0.0110770549144025,0.234107135171025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,23795,0.00246559108012948,0.00207222207213068,-0.00159596418124666,0.00652714634150562,0.234125266414304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,27965,-0.0076394625398787,0.00642439907538747,-0.0202312847276381,0.00495235964788074,0.234397583532862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,23862,0.0026735807968373,0.00225044204955539,-0.00173728562029127,0.00708444721396587,0.234835500204376
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,23795,0.00920831384122324,0.0077801279332001,-0.00604073690784895,0.0244573645902954,0.236595772387317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23393,-0.00400035295581686,0.00339148933202446,-0.0106476720465848,0.00264696613495108,0.238200427538702
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,28237,0.00274033504080525,0.00232553764401254,-0.00181771874145932,0.00729838882306982,0.238660567082175
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,23725,-0.00227768300079731,0.00193426496172437,-0.00606884232577707,0.00151347632418245,0.238990079769288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,23071,0.00270208148188395,0.00229690204265891,-0.00179984652172751,0.0072040094854954,0.239446187713013
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",23163,-0.00315160537638564,0.00268230407112249,-0.00840892135578573,0.00210571060301445,0.240022001361061
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,23188,-0.00431117135916077,0.00366996686995889,-0.0115043064242802,0.00288196370595866,0.240120147507255
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,27544,-0.00540550255513152,0.00460176953616263,-0.0144249708460103,0.00361396573574723,0.240141976438879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,27562,-0.00286281049878465,0.00243769035870702,-0.00764068360185041,0.00191506260428112,0.240247141712408
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,27544,-0.00239775164069751,0.00204569517859395,-0.00640731419074166,0.00161181090934664,0.241168559507752
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,27562,0.00286358267243814,0.00244697150570284,-0.00193248147873943,0.00765964682361571,0.241908154713465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,22978,0.0048312956716356,0.00414352262898574,-0.00329000868117645,0.0129526000244477,0.243631601147683
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,22978,0.00509260767446205,0.00437237821485085,-0.00347725362664562,0.0136624689755697,0.244143401419922
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,28037,0.00564432646261594,0.00484671345641336,-0.00385523191195424,0.0151438848371861,0.244203895042484
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,23071,0.00544282441883154,0.00467638460601189,-0.00372288940895176,0.0146085382466148,0.244478283968821
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,28176,-0.00828087711752839,0.0071189855702602,-0.0222340888352384,0.0056723346001816,0.244754057055961
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,23071,0.00281050075223128,0.00241660569959867,-0.00192604641898211,0.00754704792344467,0.244843498904211
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,27544,0.00623145986509154,0.00536076299089324,-0.0042756355970592,0.0167385553272423,0.245074847280299
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,22395,-0.0088047212722297,0.00757864912836681,-0.0236588735638286,0.00604943101936924,0.245337321116828
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,22978,-0.00287053720510986,0.00247457134713168,-0.00772069704548796,0.00197962263526825,0.246055199394455
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,27702,-0.00652234531818987,0.00562495456021337,-0.0175472562562081,0.00450256561982835,0.246247190475047
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,23163,-0.0041527555950032,0.0035814656318208,-0.011172428233372,0.00286691704336556,0.246259141620613
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,23188,-0.00213057582519977,0.00184383000741051,-0.00574448263972437,0.00148333098932483,0.24789093129161
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,23738,0.0023404241613129,0.00203372028711331,-0.00164566760142919,0.00632651592405498,0.249822308601264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,28428,0.00212183730302695,0.00184522732382845,-0.00149480825167682,0.00573848285773072,0.25019241662377
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,28176,-0.00531634888903454,0.00462759222522348,-0.0143864296504726,0.00375373187240348,0.250632981668296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,28320,0.0101866546632821,0.00888933157837784,-0.00723643523033846,0.0276097445569027,0.251829013302911
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23056,-0.00467489702223051,0.00408246163889241,-0.0126765218344596,0.00332672778999861,0.252172507002957
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",27682,0.00725473015474714,0.00634600867258295,-0.00518344684351545,0.0196929071530097,0.252967217146309
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,23056,-0.00386365229865173,0.00339216127059398,-0.0105122883890159,0.00278498379171247,0.254717379178112
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,28187,0.00571096714613328,0.00501638057145463,-0.00412113877391778,0.0155430730661844,0.254936592249807
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,28176,-0.00478387888978339,0.00420393007597846,-0.0130235818387012,0.0034558240591344,0.255149387249191
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",22978,0.00379254386908258,0.0033370717976053,-0.0027481168542238,0.010333204592389,0.255764016747251
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,23738,0.0069070098139708,0.00607958290820356,-0.00500897268610819,0.0188229923140498,0.255926489183057
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,23795,-0.00232880044282642,0.00205417026113463,-0.0063549741546503,0.00169737326899746,0.256934367412465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,28305,0.00298749497528334,0.00263537331881269,-0.00217783672958954,0.00815282668015622,0.256966281294889
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,23056,0.00568998406916588,0.00502761988087072,-0.00416415089734072,0.0155441190356725,0.257753400576245
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",23198,0.00672196749976108,0.00594126905788609,-0.00492291985369566,0.0183668548532178,0.257897363418684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,27682,0.00549044276588961,0.0048850199471846,-0.00408419633059221,0.0150650818623714,0.261050538026788
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,23337,0.00670242655627805,0.00596740946247957,-0.00499369599018191,0.018398549102738,0.26137606036697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,23775,0.00307679930358123,0.00274028629387255,-0.00229416183240897,0.00844776043957142,0.261532882942236
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,23872,0.00243641217078531,0.00217660214666112,-0.00182972803667049,0.00670255237824111,0.262995743079612
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,23725,-0.00635242666068422,0.00567944902851035,-0.0174841467565645,0.00477929343519607,0.263367624575997
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,23163,-0.00240196792825265,0.00214839138471257,-0.00661281504228929,0.00180887918578398,0.263565403750418
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,23725,-0.00439699503268444,0.0039384989253184,-0.0121164529263085,0.00332246286093962,0.264256310075311
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,23188,0.0016380532107175,0.00146811880786946,-0.00123945965270665,0.00451556607414164,0.26454083284269
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,28521,0.003409857019156,0.00305728808807994,-0.00258242763348069,0.00940214167179269,0.264722373895072
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,27702,0.00268227097366132,0.0024063068281485,-0.00203409040950975,0.00739863235683239,0.264995668091968
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,23738,-0.00442773713067319,0.00399340050698854,-0.0122548021243707,0.00339932786302434,0.267543415852502
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,28187,0.00182118631247638,0.00164564544615711,-0.00140427876199157,0.00504665138694432,0.268446114655772
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,22978,0.00374071890042848,0.00338114200404384,-0.00288631942749745,0.0103677572283544,0.26858761444671
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,23393,0.00430231958774924,0.0038892029821773,-0.00332051825731827,0.0119251574328168,0.268642082905706
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,27702,0.00366469044489415,0.00332122865692763,-0.00284491772268401,0.0101742986124723,0.269856977113062
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,28428,-0.00351504211451651,0.0031975533273758,-0.00978224663617307,0.00275216240714005,0.271650399795732
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,22978,0.00400378403133385,0.00364682169929456,-0.00314398649928349,0.0111515545619512,0.272267035474846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,27544,0.00788986815663061,0.00720123634379374,-0.00622455507720512,0.0220042913904663,0.273251674984038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,28553,-0.00238801428849775,0.00218005213749615,-0.0066609164779902,0.0018848879009947,0.273353655534394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,22978,0.00189934022155393,0.00173424764588117,-0.00149978516437315,0.00529846560748102,0.273442481941542
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,23725,0.00724994775050672,0.00663821176523208,-0.00576094730934815,0.0202608428103616,0.274776632178831
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,23056,0.00463434184198381,0.00424655947344865,-0.00368891472597553,0.0129575984099432,0.275144903794971
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,23056,0.00420426430848425,0.00385482100642262,-0.00335118486410408,0.0117597134810726,0.275437892923581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,23198,-0.00543126113728711,0.004986598163701,-0.0152049935381411,0.00434247126356686,0.276089538206838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,28452,-0.00192391938402785,0.0017715794555084,-0.00539621511682433,0.00154837634876862,0.277492169473474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,23738,-0.010921492417421,0.0100904421243285,-0.0306987589811048,0.00885577414626288,0.279103530630564
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,23163,-0.00265644160419105,0.0024551584703273,-0.00746855220603255,0.00215566899765045,0.279271012834547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,23693,-0.00434776191742142,0.00402054257816255,-0.01222802537062,0.00353250153577718,0.279536076695969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,28320,-0.00195818052140745,0.00181170514523688,-0.00550912260607173,0.00159276156325683,0.279773293325703
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,27562,0.00274967586504779,0.00258371514025318,-0.00231440580984845,0.00781375753994403,0.287232322616223
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,27562,-0.00548664370882676,0.00515914959349108,-0.0155985769120693,0.00462528949441575,0.287574416645046
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",28176,-0.00696876569322654,0.00656016520808821,-0.0198266895010794,0.00588915811462636,0.288115389890608
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,28091,-0.00227216971034286,0.00214249987426104,-0.00647146946389451,0.00192713004320878,0.288915999735914
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",27910,0.00695976356295424,0.00656660564886145,-0.00591078350881421,0.0198303106347227,0.289211866449231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,23775,-0.00670472465481183,0.00632694115020861,-0.0191055293092207,0.00569607999959705,0.289287190915932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,23846,0.0051833680867239,0.00489839383904997,-0.00441748383781405,0.0147842200112618,0.289985444000556
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,23056,0.00694433938394192,0.00656319826613682,-0.00591952921768624,0.0198082079855701,0.290033497406473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,27615,-0.00644959207405557,0.00609763420001898,-0.0184009551060928,0.00550177095798163,0.290192189751391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,23393,0.0025704164268679,0.00243093122951138,-0.00219420878297441,0.0073350416367102,0.290349427968318
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,23846,-0.00219455704468747,0.00208189453940018,-0.00627507034191182,0.00188595625253687,0.291840784023196
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,27562,-0.00283856289966227,0.00270779991303268,-0.00814585072920631,0.00246872492988178,0.294513646087629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",28142,0.00784088401388106,0.00748429641358143,-0.00682833695673854,0.0225101049845007,0.294811303135079
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,23071,0.00343103293437451,0.00328467098227403,-0.00300692219088259,0.0098689880596316,0.29623774626099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,27881,0.00484045117673707,0.00463443225094418,-0.00424303603511353,0.0139239383885877,0.296284463444635
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,23188,-0.00284136770982037,0.00273961232190046,-0.00821100786074527,0.00252827244110452,0.299680385178934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,28195,-0.0018712332936019,0.00180738621736442,-0.00541371027963617,0.00167124369243237,0.300525743151536
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,23071,-0.00701843895399997,0.00678082018201756,-0.0203088465107544,0.00627196860275446,0.30065978951742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,22978,-0.00187768683246558,0.00181432846049158,-0.00543377061502907,0.00167839695009792,0.300716651107175
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,23198,-0.00285152956587485,0.00276831480095678,-0.00827742657575014,0.00257436744400044,0.302992718394946
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,23775,-0.006650534022809,0.00645902228998804,-0.0193102177111856,0.00600914966556757,0.303184690339677
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,28224,-0.00270249236215509,0.00262848612600098,-0.007854325169117,0.00244934044480683,0.303885521334591
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,22978,0.00215144082688166,0.00209690122304286,-0.00195848557028236,0.00626136722404567,0.304897856835646
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,28307,0.00265105434549873,0.00259020477989598,-0.00242574702309739,0.00772785571409484,0.306083944556693
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,27966,-0.0031883120147422,0.0031181999168063,-0.00929998385168255,0.00292335982219815,0.306560352635611
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,27544,-0.00429712320238853,0.00420541816491619,-0.0125397428056243,0.0039454964008472,0.306881517678862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,22978,-0.00401026137064649,0.00392823405360134,-0.0117096001157051,0.00368907737441214,0.307321351910318
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,22978,-0.00445617233920436,0.00436533036724145,-0.0130122198589976,0.00409987518058888,0.30735527947168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,28187,-0.00208662987710138,0.00204444439660574,-0.00609374089444863,0.00192048114024587,0.307436542496857
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23071,0.00425524397283805,0.00417589691907797,-0.00392951398855476,0.0124400019342309,0.308213088497422
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,23198,-0.0020794061331195,0.00204273938995068,-0.00608317533742283,0.00192436307118383,0.308712440509797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,23188,0.00209222882195462,0.00205706322334923,-0.00193961509580986,0.00612407273971911,0.30911883317176
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,28120,-0.00283631425192585,0.00278892939379644,-0.00830261586376686,0.00262998735991517,0.309166779073845
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,28320,0.00249077786463283,0.0024498664588342,-0.0023109603946822,0.00729251612394787,0.309305120555312
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,23198,0.00424273784739531,0.00418721851131473,-0.00396421043478157,0.0124496861295722,0.310946925260717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,22978,-0.00556409410919626,0.0054919456802265,-0.0163283076424402,0.00520011942404768,0.311005337458086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,23163,-0.00426475310652282,0.00424719590368762,-0.0125892570777506,0.00405975086470491,0.315324604928712
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,23163,0.00199948227600326,0.00199307845865355,-0.0019069515029577,0.00590591605496422,0.315768574486726
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,23163,0.00248972625926027,0.00248592560499913,-0.00238268792653803,0.00736214044505857,0.316581659046363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,28187,-0.00300686194784248,0.00300899502583165,-0.00890449219847252,0.00289076830278756,0.317662278362267
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,23198,-0.00285304512051255,0.00285873652001872,-0.00845616869974923,0.00275007845872413,0.318285352034287
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,23725,0.006426095736007,0.00644437917272754,-0.00620488744253898,0.019057078914553,0.318695628368718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23188,-0.00191940493578923,0.00192572122241962,-0.00569381853173169,0.00185500866015323,0.318910826174765
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,23738,-0.0117357607408497,0.0117945941813873,-0.0348531653363689,0.0113816438546694,0.319740659017102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",23337,-0.00705964398409622,0.00710374809856714,-0.0209829902572878,0.00686370228909537,0.320334729102823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,28415,-0.00184415943006784,0.00186071035656249,-0.00549115172893031,0.00180283286879464,0.321642731202902
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,23725,0.00377029638664521,0.00380964854484726,-0.00369661476125542,0.0112372075345458,0.322345347983754
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,23188,-0.00285188590660899,0.00288595529397924,-0.00850835828280831,0.00280458646959032,0.323067590073433
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",23795,0.00461821997246588,0.00467446228841989,-0.0045437261128371,0.0137801660577689,0.323178286785552
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,23071,-0.00766421448577208,0.00776768975899828,-0.0228888864134087,0.00756045744186456,0.323810500296592
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,23862,0.00267148884282018,0.00271210051422041,-0.00264422816505182,0.00798720585069219,0.32462141599447
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,28278,0.00189311584598913,0.00192395214426644,-0.00187783035677309,0.00566406204875134,0.325137496805423
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,23056,-0.0057157229816846,0.00581821173365331,-0.0171194179796451,0.00568797201627589,0.325920608467557
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23056,0.00220743945242678,0.00225155452477472,-0.00220560741613168,0.00662048632098523,0.326895629148653
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,28363,0.00486177610224639,0.00496294041410985,-0.00486558710940892,0.0145891393139017,0.327284037229411
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,23725,0.00747438744047525,0.00763134480009171,-0.0074830483677045,0.022431823248655,0.327376297223039
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,28553,0.00211623783106319,0.00216109193829148,-0.00211950236798812,0.0063519780301145,0.32746738685134
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,22978,0.00388057975467626,0.00396844303913014,-0.00389756860201882,0.0116587281113713,0.328154115729527
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,23393,0.0023411267622644,0.00240057634201092,-0.002364002868077,0.0070462563926058,0.329453651706054
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,28187,0.00225684734132373,0.00232022684994579,-0.00229079728457002,0.00680449196721748,0.330718771831674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,23337,-0.00565910276465463,0.0058320117545706,-0.017089845803613,0.00577164027430375,0.331881257126144
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,23872,0.0060336994995023,0.00623950075350872,-0.00619572197737479,0.0182631209763794,0.333545642061955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",27881,-0.00269301529680064,0.00279296776547118,-0.00816723211712416,0.00278120152352287,0.334947610350923
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,27544,0.00313389357454379,0.00325060821384086,-0.0032372985245843,0.00950508567367187,0.335007006804253
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",23775,0.00168903582475126,0.00175285791549373,-0.00174656568961646,0.00512463733911898,0.335261481375483
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,23845,0.00148390358440918,0.00154468609517707,-0.00154368116213787,0.00451148833095624,0.336737637039458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,28336,-0.00197773756623223,0.00206519404771531,-0.00602551789975424,0.00207004276728978,0.338246356019017
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,23163,-0.00179646300987316,0.00187599068161226,-0.00547340474583319,0.00188047872608687,0.338270645712178
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23071,-0.00266108053323226,0.0027823268438845,-0.00811444114724589,0.00279228008078137,0.33886875184049
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,23071,-0.00246364515196236,0.00257908093736936,-0.0075186437892063,0.00259135348528158,0.33946559658353
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,23684,-0.00261287404621663,0.00273625545527186,-0.00797593473854948,0.00275018664611622,0.339633638872884
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,23163,-0.00437838202176665,0.00458636417121104,-0.0133676557973403,0.00461089175380698,0.339763647403928
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,23725,0.00460981052117624,0.00483395959980118,-0.00486475029443407,0.0140843713367865,0.340280515449958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,23188,-0.00500685906475319,0.00528465993775683,-0.0153647925427566,0.0053510744132502,0.343428268781892
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,27489,0.00311190282062394,0.00329005161996199,-0.00333659835450155,0.00956040399574944,0.344232254726232
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,23725,-0.00331017593505593,0.00350087196674328,-0.0101718849898728,0.00355153311976089,0.344398512676207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,23355,0.00342169696337658,0.00362574931401937,-0.0036847716921014,0.0105281656188545,0.34532183939894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23071,-0.00427027164678032,0.00452834324196366,-0.0131458244010291,0.00460528110746845,0.345685816922895
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,27562,0.00301250082731108,0.0032045611001052,-0.00326843892889511,0.00929344058351727,0.347191647254893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,23738,0.00219664346408138,0.00234095734005827,-0.00239163292243284,0.00678491985059559,0.348072776671261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,23738,-0.00274074734899011,0.0029270152610437,-0.00847769726063577,0.00299620256265554,0.349096106280262
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,27682,-0.00309774233134999,0.00332417249542583,-0.00961312042238461,0.00341763575968463,0.351404737634106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,23163,0.00270800485010621,0.00291141900359897,-0.00299837639694778,0.00841438609716019,0.35231228884025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23198,0.00132659876178181,0.00142805796516214,-0.00147239484993598,0.0041255923734996,0.352923104587846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,23775,-0.0029423669541788,0.0031685407816621,-0.00915270688623651,0.00326797297787892,0.353096040417067
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,28390,-0.00258604973715023,0.00278880994643341,-0.00805211723215972,0.00288001775785926,0.353781236024568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,23198,-0.00484152338444677,0.00523400693311208,-0.0151001769733464,0.0054171302044529,0.354968879563947
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,27562,-0.00427984397857396,0.00462703487024593,-0.013348832324256,0.00478914436710807,0.354992365375028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23393,0.00407479711555788,0.00440952845014726,-0.00456787864673075,0.0127174728778465,0.355449472503791
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,28187,-0.00200777576952729,0.00217511543189889,-0.00627100201604912,0.00225545047699454,0.355980556726035
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,23056,0.00461952467390181,0.00500668204913302,-0.0051935721423989,0.0144326214902025,0.356187892049851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,23393,-0.004237620270004,0.0046196962450517,-0.0132922249103053,0.00481698437029733,0.358997992371533
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,28176,-0.00367875989314619,0.00401327636532701,-0.0115447815691871,0.00418726178289475,0.359335215378897
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,22936,0.00499430549667486,0.00545291729331426,-0.00569341239822109,0.0156820233915708,0.359731045640409
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,23738,-0.0037607661250399,0.00410625826785211,-0.01180903233003,0.00428750007995024,0.359748561421409
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,27544,0.00300621340480164,0.00329686259023817,-0.00345563727206517,0.00946806408166845,0.361860579978123
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",27544,-0.00335903157851736,0.00369088131060294,-0.0105931589472991,0.0038750957902644,0.362783386206519
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,23071,0.00445439424185084,0.00492223522137398,-0.00519318679204216,0.0141019752757438,0.365499450822537
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,23795,0.00977301354290915,0.010827766320467,-0.0114494084452061,0.0309954355310244,0.366753661216839
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,23284,-0.00689319363136342,0.00764408897962752,-0.0218756080314334,0.00808922076870652,0.367189538590105
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,27544,-0.00368649718389855,0.00410700205344215,-0.0117362212086452,0.00436322684084806,0.369399917921153
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,28176,-0.00342168435180287,0.00382005024459149,-0.0109089828312022,0.00406561412759646,0.370411527548243
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,23795,-0.00272297482560452,0.00304391516103189,-0.00868904854122702,0.00324309889001798,0.371029625191332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,28224,0.00278252564598923,0.00311172759205185,-0.0033164604344324,0.00888151172641085,0.371219283390666
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23393,0.00530250683551951,0.0059562841748191,-0.00637181014712592,0.0169768238181649,0.373347596307218
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,23198,-0.00465680740497353,0.00525882092003466,-0.0149640964082415,0.0056504815982944,0.375883750505516
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23393,0.00415591472408018,0.00471774645382255,-0.00509086832541201,0.0134026977735724,0.378375051423286
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,23071,-0.00275714663659329,0.00313290839490659,-0.0088976470906102,0.00338335381742361,0.378836104519112
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,23337,0.00265107680298254,0.00302385557679364,-0.003275680127533,0.00857783373349807,0.380647385988672
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,23700,0.0042006218809878,0.00479607522779449,-0.0051996855654894,0.013600929327465,0.38112280211939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,23872,-0.00145647518140235,0.00166533325425378,-0.00472052835973975,0.00180757799693505,0.381808655064806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,23846,0.00583215558151606,0.00668978627834356,-0.00727982552403732,0.0189441366870694,0.383326284850333
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,28176,-0.0028781629368281,0.00330230990984955,-0.00935069036013321,0.00359436448647701,0.383455607143635
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,27562,0.00300593322220259,0.00346712661669353,-0.00378963494651673,0.00980150139092191,0.385959920794451
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,22978,0.00370577540793783,0.00427842142197859,-0.0046799305791402,0.0120914813950159,0.386414305831935
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,27682,-0.0013546256263559,0.00156426327943002,-0.00442058165403874,0.00171133040132693,0.386506916782427
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23198,0.00153452963790091,0.00177271419293121,-0.00193999018024426,0.00500904945604608,0.386697398284058
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,23163,0.00406865306800946,0.00471173631315225,-0.00516635010576895,0.0133036562417879,0.387863545671088
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,23725,-0.00159588069147198,0.00184901258083671,-0.00521994534991193,0.00202818396696797,0.388091832373177
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,23725,0.0031994262984391,0.00370767799661228,-0.00406762257492097,0.0104664751717992,0.388190655692503
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,23795,-0.00494963562292133,0.00574513849363896,-0.0162101070704537,0.00631083582461104,0.388952357138322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23393,0.00372138827592854,0.00432638879639005,-0.00475833376499596,0.012201110316853,0.389709455932112
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,28452,-0.00173405181586872,0.00201782242930353,-0.00568898377730365,0.00222088014556621,0.390144819753152
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,28187,-0.00466652664777405,0.00543389117376006,-0.0153169533483438,0.00598390005279567,0.390468236792339
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,28176,-0.0052376908521063,0.00610846896053799,-0.0172102900147608,0.00673490831054817,0.391204967318843
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,23056,0.00440273313800779,0.00513526509077467,-0.00566238643991057,0.0144678527159261,0.391258935676574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,28224,-0.0046700441546882,0.00546773204562908,-0.0153867989641212,0.00604671065474479,0.393051343224323
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,22978,0.00196026379896001,0.00230382931556297,-0.0025552416595434,0.00647576925746343,0.394849346239695
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,23056,-0.00255433462415427,0.00301199297023689,-0.00845784084581857,0.00334917159751003,0.3964163488969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,23056,-0.00426426020956811,0.00504873099345697,-0.0141597729567438,0.00563125253760754,0.398331693206344
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,27448,0.00259087953941024,0.00306884670239669,-0.00342405999728728,0.00860581907610776,0.398536041838765
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,23163,-0.00348123372661046,0.00413848479939213,-0.011592663933419,0.00463019648019812,0.400252667815327
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",22940,0.00148713456671333,0.00177388579605229,-0.00198968159354917,0.00496395072697583,0.401843722289561
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,23775,-0.00551421825346333,0.0066024459630123,-0.0184550123409675,0.00742657583404078,0.403625837477749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,23163,-0.00295049924581217,0.00353543253985881,-0.00987994702393544,0.00397894853231109,0.40397909582339
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,28252,0.00129080622823082,0.00154770133396403,-0.00174268838633867,0.00432430084280031,0.404279549680613
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,23393,0.00480447692086346,0.00576951182001669,-0.00650376624636925,0.0161127200880962,0.405002463040721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,27682,0.00608783608642183,0.0073213738027012,-0.00826205656687253,0.0204377287397162,0.405689629426577
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,23056,-0.003008352107811,0.00362162383964909,-0.0101067348335232,0.00409003061790122,0.406172143772031
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,22936,0.00231821568965057,0.00280160012061784,-0.0031729205467604,0.00780935192606153,0.407984260145291
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23071,0.00297441644626978,0.00360100248107232,-0.00408354841663197,0.0100323813091715,0.40881446625843
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,23056,0.00548417575504663,0.00663975038108138,-0.00752973499187288,0.0184980865019661,0.408834691163412
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,22978,0.00452904878885742,0.00548361390584399,-0.0062188344665968,0.0152769320443116,0.408855738341332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,23188,-0.00146499618283405,0.00177697073361855,-0.00494785882072641,0.00201786645505831,0.409701138579245
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,28187,-0.00161392486447908,0.00196415292152091,-0.00546366459066006,0.00223581486170189,0.411260290815161
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,23198,-0.00571587378700439,0.00696433342094212,-0.0193659672920509,0.00793421971804216,0.411805538014462
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",27489,0.00262978258436439,0.00320532668351814,-0.00365265771533116,0.00891222288405993,0.411971663081492
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,27682,-0.00303420840917273,0.00370174052638848,-0.0102896198408941,0.00422120302254868,0.412410893375568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,23795,0.00189309521798444,0.00231030344540143,-0.00263509953500236,0.00642128997097124,0.412558404927418
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,23393,0.0023240279549729,0.00284040443723467,-0.00324316474200706,0.00789122065195286,0.413249516295972
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,23738,-0.00309532754073496,0.00378595937058919,-0.0105158079070898,0.00432515282561986,0.413604827911233
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,28061,-0.00233466509041234,0.00286914961976757,-0.00795819834515678,0.0032888681643321,0.415816143984861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,23188,0.00364992321741912,0.00450428904232749,-0.00517848330554275,0.012478329740381,0.417763619542546
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,27702,-0.00196854172733119,0.00243041048677168,-0.00673214628140368,0.0027950628267413,0.417968601297401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,23480,0.00180702176804179,0.00223621020719823,-0.00257595023806675,0.00618999377415032,0.419056576727688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,27544,0.00617367467493459,0.00764211509818671,-0.00880487091751136,0.0211522202673806,0.419184520942238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,23846,0.00195642649839132,0.00242320161603356,-0.00279304866903446,0.0067059016658171,0.419459927364764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23071,0.00260455345326641,0.00325336433690202,-0.00377204064706155,0.00898114755359436,0.423387526023473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,23056,0.00422214115049408,0.00528032539450253,-0.00612729662273088,0.014571578923719,0.423951602296019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,23893,-0.00125710567373869,0.00157733787112837,-0.0043486879011503,0.00183447655367293,0.425470962200261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,27562,0.00415308672832369,0.00522138193435094,-0.00608082186300416,0.0143869953196515,0.426387764538531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,27562,-0.00460163282276024,0.00579754510499718,-0.0159648212285547,0.00676155558303424,0.427364756418333
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,28091,-0.0046502018106676,0.00586667067901598,-0.0161488763415389,0.00684847272020373,0.427989926926019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,23393,0.00397852579603674,0.00502198409707601,-0.00586456303423225,0.0138216146263057,0.428239337976792
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,27544,0.00212048465565673,0.00268583349915163,-0.00314374900268047,0.00738471831399393,0.429822472809749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,23163,0.00352570962991592,0.00446660212295356,-0.00522883053107307,0.0122802497909049,0.429915915694941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,23862,-0.00451783419792484,0.00572638385082138,-0.0157415465455348,0.00670587814968507,0.430148700087297
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,22978,0.00251599928743195,0.00319208796291138,-0.00374049311987436,0.00877249169473826,0.430588679528484
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,28291,0.00139255744510348,0.00176770889883529,-0.00207215199661369,0.00485726688682065,0.43083474228726
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,23393,0.0023583364639417,0.00299947763143991,-0.00352063969368051,0.00823731262156392,0.431729559098953
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,27702,0.00154763276211421,0.00197422519453533,-0.00232184861917505,0.00541711414340347,0.433094310044342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,23188,0.00248936614368241,0.00317644924074566,-0.00373647436817908,0.00871520665554391,0.433227336470597
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,22978,-0.00394285636099637,0.00504054854946295,-0.0138223315179438,0.00593661879595101,0.434088872943406
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,27682,0.00146862913009159,0.00188086875450037,-0.00221787362872913,0.00515513188891231,0.434912175818723
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,23846,-0.00563757726729949,0.00722638526760378,-0.0198012923918029,0.00852613785720391,0.435317438493272
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,23071,0.00260477424610507,0.00335546832880205,-0.00397194367834694,0.00918149217055709,0.437593174070189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,28391,-0.00149240504098422,0.00192437779479964,-0.00526418551879151,0.00227937543682307,0.438035362465278
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,28320,0.00452857534968736,0.00584807095871963,-0.00693364372940311,0.0159907944287778,0.438718017826067
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,27562,0.00258163106320895,0.00334239805037159,-0.00396946911551936,0.00913273124193726,0.439890768375159
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,28159,0.00676981093740433,0.00876485127705401,-0.0104092975656215,0.0239489194404302,0.439894860839306
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,22978,0.00161573019412902,0.00209367561767365,-0.00248787401651133,0.00571933440476938,0.440288549984182
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,23188,0.00479456311131317,0.00621939066959329,-0.00739544260108968,0.016984568823716,0.440770745622435
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23393,-0.00340999743885067,0.00442692619369771,-0.0120867727784982,0.00526677790079685,0.441138287867756
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,23370,0.00528201122424716,0.00687510652520576,-0.00819319756515612,0.0187572200136504,0.442328243092419
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,27956,0.00669476989834862,0.00873872507184178,-0.0104331312424613,0.0238226710391585,0.443621053676872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,28428,-0.00152382945044558,0.00199106737241604,-0.00542632150038101,0.00237866259948985,0.444079669387029
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,27682,0.00318319926924625,0.00416286688238529,-0.00497601982022892,0.0113424183587214,0.444477479193429
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23071,0.00362170004768059,0.00473632689357132,-0.00566150066371919,0.0129049007590804,0.444479300555042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,23738,0.00285197480580078,0.00374261622137627,-0.00448355298809671,0.0101875025996983,0.446051434226807
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,27544,-0.00371810013194151,0.00488753805125199,-0.0132976747123954,0.00586147444851238,0.446824462975105
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,23163,-0.00119567515478409,0.0015742189277054,-0.00428114425308668,0.00188979394351851,0.447540022811682
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,27477,0.00392155143865854,0.00517442579451227,-0.0062203231185855,0.0140634259959026,0.448534231152074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,23687,-0.00456194228924397,0.00601967586123168,-0.0163605069772581,0.00723662239877013,0.448555198406404
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,28488,-0.00270948157232252,0.00358163729983178,-0.00972949067999281,0.00431052753534778,0.449360256837169
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,28022,-0.00142334894112491,0.00188155720528223,-0.00511120106347808,0.00226450318122827,0.449371470320138
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,23725,0.00209842189743392,0.00277877894198552,-0.0033479848288577,0.00754482862372555,0.450160661249646
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,28142,-0.00207346057224806,0.00275235291608264,-0.00746807228777003,0.00332115114327392,0.451251272599776
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,23163,0.00404301706591151,0.00537194429388064,-0.00648599375009454,0.0145720278819176,0.451687699709701
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23071,-0.00265269778663989,0.00352719886460291,-0.0095660075612616,0.00426061198798181,0.452017095061343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,28320,-0.00243276585638867,0.00324206699365482,-0.00878721716395211,0.00392168545117477,0.453035151038491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,28195,-0.00198499811543656,0.00264913966273334,-0.00717731185439391,0.00320731562352079,0.453683170351138
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",23862,0.00319737658381764,0.00427568979999107,-0.00518297542416486,0.0115777285918001,0.454585953421199
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",23331,-0.00325945868715654,0.00438080445702325,-0.0118458354229221,0.00532691804860903,0.456864615557469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,22978,0.00368900145456985,0.00495954193820624,-0.00603170074431438,0.0134097036534541,0.456993602798976
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,28176,0.00285321810373464,0.00383603925802133,-0.00466541884198717,0.0103718550494564,0.457008085749379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,23469,0.00283778312695347,0.00381582804532839,-0.00464123984189017,0.0103168060957971,0.457073080994172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,27544,0.00250871245633092,0.00337993278473479,-0.00411595580174927,0.00913338071441111,0.457949856631181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,27702,-0.00167419467061638,0.0022614778880629,-0.00610669133121966,0.0027583019899869,0.459118198534143
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,22978,0.00591355377546353,0.00799186480236425,-0.0097505012371704,0.0215776087880975,0.459339916729259
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,23738,-0.00457214267777758,0.00618803175322283,-0.0167006849140943,0.00755639955853917,0.459994069239952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,23071,-0.00333717895975285,0.00453871338747571,-0.0122330571992052,0.00555869927969954,0.462182665318324
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,23071,-0.00495591572574633,0.00674043260013759,-0.018167163622016,0.00825533217052334,0.46219358813101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,23188,-0.00151436441564052,0.00206725420535103,-0.00556618265812854,0.0025374538268475,0.463841128089655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,23163,0.00296408550306474,0.00404823678424456,-0.0049704585940546,0.0108986296001841,0.4640589627194
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,23163,-0.00419166239250037,0.00573031165563617,-0.0154230732375473,0.00703974845254653,0.464487664382806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,22978,0.00279096117581263,0.00382325558696778,-0.00470261977464422,0.0102845421262695,0.465400093531627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,28390,-0.00317911484338772,0.00435634756220705,-0.0117175560653135,0.0053593263785381,0.465539183084652
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,23188,0.0013176466706723,0.00180843066418837,-0.00222687743113692,0.00486217077248151,0.466245590820676
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,23163,0.00328975090047382,0.00452060137947257,-0.00557062780329243,0.0121501296042401,0.46678980995507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,27682,0.00300754127765413,0.00413329261829205,-0.00509371225419828,0.0111087948095065,0.466841295183994
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",27544,0.00137811670836549,0.0018963229157218,-0.00233867620644923,0.00509490962318022,0.467396919002296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23071,-0.00227945511687875,0.00313681349998599,-0.00842760957685128,0.00386869934309379,0.467430267604558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,23795,-0.00146470925813528,0.0020272786212348,-0.00543817535575548,0.00250875683948493,0.469994092380297
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,23337,-0.0014759749656771,0.00204569349810104,-0.00548553422195513,0.00253358429060094,0.470607036640544
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],27702,0.00274467767519432,0.00380864910179055,-0.00472027456431516,0.0102096299147038,0.471135054616566
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,23188,0.00340380116031715,0.00473581724734659,-0.00587840064448217,0.0126860029651165,0.472310998382404
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,23071,-0.00233741381077474,0.00325654072053663,-0.00872023362302653,0.00404540600147706,0.472912714951669
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,28224,0.00240973684121456,0.00335816464140659,-0.00417226585594235,0.00899173953837148,0.473024979182822
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,23056,0.00318621973710051,0.00444261845667436,-0.00552131243798125,0.0118937519121823,0.473261610387291
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,27702,-0.00284138827293679,0.00397379712795667,-0.0106300306437319,0.00494725409785828,0.474595895353002
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",28187,-0.00376559476339882,0.00527178843473599,-0.0140983000954814,0.00656711056868373,0.475052736665538
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,27562,0.00149392905942521,0.00209384973328413,-0.00261001641781169,0.00559787453666211,0.475552125251149
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,23188,0.00147765896181774,0.00207196844359661,-0.00258339918763162,0.0055387171112671,0.475749771605328
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,22978,0.00310682952393599,0.00435901783601016,-0.00543684543464392,0.0116505044825159,0.476016293664317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,23056,0.0023349912114678,0.00327998218675972,-0.00409377387458125,0.00876375629751684,0.476539216366191
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,27928,0.00341507536481909,0.00480517223586455,-0.00600306221747544,0.0128332129471136,0.47727100808394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,23393,0.0020192815932696,0.00284264637410095,-0.00355230529996827,0.00759086848650746,0.47749251813177
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,22594,0.00338083905830018,0.00477621218887481,-0.00598053683189444,0.0127422149484948,0.479046074865274
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23198,0.00218479549028989,0.00308673476386193,-0.00386520464687948,0.00823479562745927,0.479075651106389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",28307,0.00168540123753394,0.00238341496503742,-0.00298609209393939,0.00635689456900728,0.479487082761979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,27320,0.00591620541852368,0.00836717624516425,-0.0104834600219982,0.0223158708590456,0.479527072765683
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,28195,-0.00251943077193839,0.00356348963634298,-0.00950387045917063,0.00446500891529385,0.479564720501583
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,23071,0.00161686666144477,0.00229302495556497,-0.00287746225146257,0.00611119557435212,0.480740267473811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",27965,0.00279604276299251,0.00397350046261511,-0.00499201814373311,0.0105841036697181,0.481642649349487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,27702,0.00144026170573638,0.00205452843882611,-0.00258661403436281,0.00546713744583556,0.483297585559439
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,23198,-0.000860515852277724,0.00122916505600734,-0.0032696793620521,0.00154864765749665,0.483883364078122
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,22978,0.0017729530395041,0.00253446278392432,-0.00319459401698757,0.00674050009599578,0.484222956227133
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,27863,0.00158449666576781,0.00227793206505534,-0.00288025018174065,0.00604924351327628,0.486694212001678
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,27544,-0.00401108172441956,0.00577008103476037,-0.0153204405525499,0.00729827710371077,0.486966095786643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,28428,-0.00136005028391462,0.00195877828330811,-0.00519925571919851,0.00247915515136928,0.487477194450873
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",27682,-0.00205593428779172,0.00297959808844044,-0.00789594654113497,0.00378407796555154,0.490197525066287
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,27702,0.00295198267930602,0.0042833270467501,-0.00544333833232417,0.0113473036909362,0.49071587244784
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,27544,-0.00261585290951072,0.00380555175056594,-0.01007473434062,0.00484302852159852,0.491850288747111
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,27544,-0.00242630072138783,0.00353023661188912,-0.00934556448069051,0.00449296303791485,0.491905003542064
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,27682,-0.00367668297004405,0.00535444338543208,-0.0141713920054909,0.00681802606540282,0.49230266067894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,28381,-0.00174936242756925,0.00255230757125721,-0.00675188526723338,0.00325316041209487,0.493094470927218
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,28553,-0.00246480081490888,0.00359860458025486,-0.00951806579220841,0.00458846416239064,0.493392152061811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,22978,0.00225376324651173,0.00329093788181921,-0.00419647500185391,0.00870400149487737,0.493452311670661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,23862,0.00203572615371856,0.00299856467855155,-0.00384146061624248,0.00791291292367959,0.497207688537983
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,23071,0.00236555093270303,0.00348700298844575,-0.00446897492465063,0.0092000767900567,0.497530715255294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,27917,-0.00269909547889825,0.00398914993868774,-0.0105178293587262,0.00511963840092972,0.498659560049788
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,23071,0.00185071040438929,0.0027367440859211,-0.00351330800401607,0.00721472881279464,0.498891680437909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,28319,0.00517767820432517,0.00765917024715231,-0.00983429548009335,0.0201896518887437,0.499039609860165
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,28268,0.00549655712040156,0.00816833772917832,-0.010513384828788,0.0215064990695911,0.501009977090804
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,23056,0.00496341308925947,0.00742225303958616,-0.0095842028683294,0.0195110290468483,0.503680459198389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,23071,0.0023064693089333,0.00345818396248654,-0.00447157125754032,0.00908450987540693,0.504804555119828
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,23778,-0.00296446914861786,0.00444655473408421,-0.0116797164274229,0.00575077813018718,0.504977276247592
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,23198,-0.00256843938054511,0.00385370202271885,-0.0101216953450741,0.00498481658398384,0.505106986443566
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23188,-0.00281975942894162,0.00423704714682821,-0.0111243718367249,0.00548485297884166,0.50573667998637
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,23393,-0.00199180281754804,0.00299821075768936,-0.00786829590261918,0.00388469026752311,0.506485363368886
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,27562,0.00144561069528263,0.00220238043358448,-0.00287105495454295,0.00576227634510821,0.511581567093272
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,23198,0.00524125620474616,0.00799297829935039,-0.0104249812619806,0.0209074936714729,0.512002715547116
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,28380,0.00114010820768446,0.00173881108634225,-0.00226796152154636,0.00454817793691527,0.512033671917146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,28091,-0.00253058475836531,0.0038632956132452,-0.0101026441603259,0.00504147464359529,0.512452099958777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27682,0.0014206872668223,0.00218721685942746,-0.00286625777765552,0.00570763231130013,0.515994075483427
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,28224,-0.00142572036298538,0.00219751805055844,-0.00573285574207993,0.00288141501610916,0.516481572275196
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,27702,0.00214845605879297,0.00331349599548275,-0.00434599609235322,0.00864290820993916,0.51673452481798
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,23188,-0.00227152384400707,0.00350337239927962,-0.00913813374659514,0.00459508605858099,0.51674428934634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,23071,-0.00326258984574409,0.0050483781897984,-0.0131574110977489,0.00663223140626077,0.518114219301906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,22978,0.00182857937753339,0.00284165183873583,-0.00374105822638884,0.00739821698145563,0.519911523397344
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,23795,0.00336166343813173,0.00522768892306141,-0.00688460685106863,0.0136079337273321,0.520198095548411
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,23795,-0.00157231785784728,0.00244935152276845,-0.00637304684247345,0.00322841112677888,0.520923328112071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,23188,-0.00242341188022139,0.00377707429980002,-0.00982647750782942,0.00497965374738665,0.521132227345801
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,23872,0.00106967460978157,0.00167794492901869,-0.00221909745109505,0.0043584466706582,0.523811258205484
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,23071,0.00265215548548743,0.0042097370483239,-0.00559892912922741,0.0109032401002023,0.528697541000119
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,27544,-0.00172293598992715,0.00273783393855425,-0.00708909050949348,0.00364321852963917,0.52915380689016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",23071,0.00169397762341277,0.002693650346299,-0.00358557705533326,0.00697353230215881,0.529435115998796
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,22744,0.00199816861659969,0.00317748816909353,-0.00422970819482362,0.00822604542802301,0.529452514171755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,23188,-0.00146275808494431,0.00232775953821211,-0.00602516677984005,0.00309965060995143,0.529749820697748
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,28411,0.00259407541229842,0.00413161770355753,-0.00550389528667434,0.0106920461112712,0.530101035093762
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,23188,-0.000726839808252801,0.00115987795254468,-0.00300020059524037,0.00154652097873477,0.530893564364219
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,23725,0.00266348872662911,0.00425624471963875,-0.00567875092386283,0.0110057283771211,0.531462823521599
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,28091,-0.000901880696786056,0.00144326242570843,-0.00373067505117459,0.00192691365760248,0.532048134213123
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,23023,0.00364805778911177,0.00584226044135375,-0.00780277267594157,0.0150988882541651,0.532354217560167
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,23775,-0.0011922822243761,0.00191761709199298,-0.00495081172468234,0.00256624727593014,0.534110931390738
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,22978,0.0023960183370449,0.00386126000264589,-0.00517205126814104,0.00996408794223083,0.534916658043749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,28155,-0.00383877763943426,0.00621382427571606,-0.0160178732198377,0.00834031794096922,0.536725232353932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,23725,-0.00321653308489606,0.00524425509113286,-0.0134952730635165,0.00706220689372435,0.539654701948464
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,27562,0.00337634472167757,0.00551242052894157,-0.0074279995150479,0.014180688958403,0.540213595787336
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,23393,-0.00361773625816742,0.00591810989917222,-0.015217231660545,0.00798175914421013,0.541007418092906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",23775,0.00228944628459185,0.00375384680290802,-0.00506809344910787,0.00964698601829158,0.541938275663161
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,27702,-0.00196446787610039,0.00322309874819254,-0.00828174142255777,0.00435280567035699,0.542200296631101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,28336,0.00418065505945221,0.00686823350866234,-0.00928108261752598,0.0176423927364304,0.542731922146816
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,28165,0.00395564585615455,0.00650680303549181,-0.00879768809340941,0.0167089798057185,0.543242364486538
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,23163,-0.00262840539297549,0.00432964201613024,-0.0111145037445908,0.00585769295863979,0.543808938836386
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23188,-0.00182827905434926,0.00303370177697458,-0.00777433453721943,0.00411777642852091,0.546743350765172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,23757,-0.00398297587567377,0.00662691914192909,-0.0169717373938548,0.00900578564250724,0.547825876890531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,23725,0.00451243942209929,0.00751055987536004,-0.0102082579336064,0.019233136777805,0.547970516950209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,28091,0.000778629852261059,0.00130451141583781,-0.00177821252278106,0.00333547222730317,0.550595856574375
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,23893,0.00126015903398183,0.00211362084215623,-0.00288253781664438,0.00540285588460805,0.551041497581308
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,28195,0.000950243322322122,0.00159443313427327,-0.00217484562085349,0.00407533226549774,0.551196280797209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,23163,-0.00248461397318189,0.00418603551670142,-0.0106892435859167,0.0057200156395529,0.552820114694426
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,23393,0.00273209526982681,0.0046051629740015,-0.00629402415921613,0.0117582146988697,0.553007630817929
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,23188,-0.00191030192259832,0.00325657555560697,-0.00829319001158799,0.00447258616639135,0.557479189460186
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",27562,0.00318663556458689,0.00544728539285781,-0.00749004380541441,0.0138633149345882,0.558555765585482
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,28082,0.00170910253263591,0.00293036254493103,-0.00403440805542891,0.00745261312070073,0.559736919794705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,23862,0.00354707605278953,0.00608711755389117,-0.00838367435283716,0.0154778264584162,0.560088322002615
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,27562,0.00307878516904465,0.00529960035174342,-0.00730843152037247,0.0134660018584618,0.561281150405218
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23056,0.00227453713090424,0.00391777520255243,-0.00540430226609851,0.009953376527907,0.561536940648582
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,23846,-0.00355005305027836,0.00612290100346404,-0.0155509390170679,0.00845083291651116,0.562055523974866
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,28176,0.00395739416689302,0.00682754756148185,-0.00942459905361142,0.0173393873873974,0.56217444780221
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,28194,-0.00195858232225559,0.00342087608783224,-0.00866349945440677,0.00474633480989559,0.566961964927729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,23337,0.00437048112252703,0.00765233938544135,-0.010628104072938,0.0193690663179921,0.567916980227856
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,23188,0.00168308280438265,0.00295186810263838,-0.00410257867678857,0.00746874428555386,0.56856421442499
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,23337,-0.00321754338459672,0.0056483864705841,-0.0142883808669416,0.00785329409774812,0.568927797439645
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,28358,0.00230478218989535,0.00404672244251741,-0.00562679379743878,0.0102363581772295,0.568992253559742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,23795,-0.00144768259910933,0.00254885949703179,-0.00644344721329163,0.00354808201507298,0.570058870665237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,27910,-0.0029304797713921,0.00516448506822501,-0.0130528705051131,0.00719191096232891,0.570427163580256
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,28176,-0.00179676939350439,0.00316659878747379,-0.00800330301695301,0.00440976422994423,0.570438126323035
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,27806,-0.00265245894194724,0.0046833732703824,-0.0118318705518967,0.00652695266800227,0.57115602552657
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,23337,0.00325610980227911,0.00576483978897523,-0.00804297618411234,0.0145551957886706,0.572200101222121
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,23393,-0.00266289551975011,0.00475867048298186,-0.0119898896663945,0.00666409862689433,0.575765763576104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,27702,0.00128949609851322,0.00231087483106467,-0.00323981857037354,0.00581881076739998,0.576840638938482
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,27918,-0.00128104560773382,0.00230146200018324,-0.00579191112809296,0.00322981991262533,0.577789819061374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,23725,-0.00167676008781976,0.00301436641125419,-0.00758491825387797,0.00423139807823845,0.578040955379916
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,28307,-0.00211154785889415,0.00379749455354442,-0.0095546371838412,0.00533154146605291,0.578189889951975
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,27682,0.00320280298483128,0.00576890360667441,-0.00810424808425057,0.0145098540539131,0.578773299489719
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,28288,0.00112767485485397,0.00203500066385655,-0.00286092644630487,0.00511627615601282,0.579487558419403
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,28176,-0.00258153323944527,0.0046620981503865,-0.0117192456142028,0.00655617913531227,0.579769559390872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,23071,-0.00166828927708401,0.00302295348451087,-0.00759327810672532,0.0042566995525573,0.581040066548434
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,23056,0.00345024670525456,0.00625857474411454,-0.00881655979320995,0.0157170532037191,0.581444943276626
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,23188,0.00108948749218259,0.00197975013279685,-0.00279082276809924,0.00496979775246443,0.582108192289722
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",23846,-0.00200671230442818,0.00364889049625198,-0.00915853767708207,0.0051451130682257,0.582357886833167
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,27562,-0.00172487006699189,0.00315311117591018,-0.00790496797177585,0.00445522783779207,0.584357397748034
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,23188,0.00105982419040917,0.00193786446287277,-0.00273839015682146,0.0048580385376398,0.584450533466536
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,23738,-0.00966405913204488,0.0177255452231308,-0.0444061277693813,0.0250780095052915,0.58561753240715
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,23071,0.0024338529935166,0.00447281338954786,-0.00633286124999721,0.0112005672370304,0.586347888310587
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,27544,0.00190379437288668,0.00349948892433869,-0.00495520391881714,0.00876279266459051,0.586431642176937
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,23795,-0.00131007991607439,0.0024109703480636,-0.00603558179827904,0.00341542196613025,0.586871331058827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23163,0.00183438393662197,0.00338081197617972,-0.00479200753669027,0.00846077540993421,0.587419555858054
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,23188,-0.00321199744243268,0.0059315535350766,-0.0148378423711828,0.00841384748631745,0.58816109338445
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,23071,-0.00188962647985224,0.0034963165168573,-0.00874240685289255,0.00496315389318807,0.588883629018067
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",22978,0.00212238230351142,0.00392822687300061,-0.00557694236756977,0.00982170697459262,0.589002186871497
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,23056,0.00186457447168531,0.00345419764412978,-0.00490565291080906,0.00863480185417967,0.589340466347457
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,23188,0.00108403697601976,0.00201254135955999,-0.00286054408871781,0.00502861804075734,0.59013987305823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,28268,0.00210544652185515,0.00391640314147678,-0.00557070363543934,0.00978159667914964,0.590859546032001
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,23056,0.00200286516911728,0.00372791196791428,-0.00530384228799471,0.00930957262622927,0.59109188813383
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",23056,-0.00309609719246015,0.00577319390805542,-0.0144115572522488,0.00821936286732849,0.591764391292616
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,23188,-0.00128246750151729,0.00240294028645035,-0.00599223046295997,0.00342729545992539,0.593548966703778
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,23188,0.00169678566390619,0.00319066398288069,-0.00455691574253995,0.00795048707035234,0.594871670298313
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,28202,0.00192640304298808,0.00362976574026893,-0.00518793780793901,0.00904074389391518,0.595614376560512
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,23393,0.00609578618498048,0.0115371011518091,-0.0165169320725653,0.0287085044425262,0.597251898291608
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,28307,0.00152899194545855,0.00289815450471488,-0.00415139088378262,0.00720937477469971,0.597798944825285
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,28091,-0.00316029048240524,0.00599584584622859,-0.0149121483410133,0.0085915673762028,0.598142192894852
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,23198,0.00173212276423565,0.00328711644145931,-0.00471062546102461,0.0081748709894959,0.598238263183358
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,23846,-0.00107330810810078,0.00204065636926475,-0.00507299459185969,0.00292637837565813,0.598919366577562
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",28320,0.00390553413328117,0.00751605597697308,-0.0108259355815861,0.0186370038481484,0.603328704208953
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,23337,0.000879692574060741,0.0017050186633951,-0.00246214400619366,0.00422152915431515,0.605899058110884
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,23893,-0.000598634288087809,0.00116545493852418,-0.0028829259675952,0.00168565739141958,0.607502452528492
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,23725,-0.00156609088626488,0.00305902296331648,-0.00756177589436519,0.00442959412183542,0.608685262082018
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,23071,-0.00168393135098662,0.00330850437965954,-0.00816859993511932,0.00480073723314608,0.610777725185461
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,28553,0.00249524222406259,0.00490339801774212,-0.00711541789071197,0.0121059023388371,0.610840124783803
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,27562,-0.00430164109417344,0.00845783530880578,-0.0208789982994328,0.0122757161110859,0.611037857714466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,22978,-0.00207370045685661,0.00407941015083479,-0.0100693443524928,0.00592194343877958,0.611224429210855
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,23071,0.00312134644395103,0.006156382892229,-0.00894516402481781,0.0151878569127199,0.612152792805519
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,23071,0.00133036059706415,0.00263752497059903,-0.00383918834530995,0.00649990953943824,0.613987002144319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,22978,0.00297137104322847,0.00593839706378474,-0.00866788720178961,0.0146106292882466,0.616822295885954
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,23188,0.00196785271347792,0.00393428184650352,-0.00574333970566899,0.00967904513262483,0.616952441428459
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,23337,0.00427763516231611,0.00857313938140808,-0.0125257180252437,0.021080988349876,0.617813786774874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,23862,-0.00310404682274082,0.0062430181629292,-0.0153403624220821,0.00913226877660041,0.619050550459808
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23393,-0.00129609312893891,0.00261540346627496,-0.00642228392283784,0.00383009766496002,0.620208516147568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,28224,0.000969603463156492,0.0019628456380586,-0.00287757398743836,0.00481678091375135,0.621325238785236
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,27750,0.00114815392808565,0.00232904424560468,-0.00341677279329952,0.00571308064947081,0.622036174878102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,23795,0.0026524287417567,0.00540899127531384,-0.00794919415785843,0.0132540516413718,0.623873788570838
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,27702,0.00174958783493386,0.00357144016846062,-0.00525043489524894,0.00874961056511667,0.624220572495565
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,27965,-0.00262567417541098,0.005411457901057,-0.0132321316614827,0.00798078331066073,0.627533723354275
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23393,-0.00164129495692022,0.00338442703427361,-0.0082747719440965,0.00499218203025605,0.62771278014909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,23140,-0.00143666671447211,0.0029789634139091,-0.00727543500573394,0.00440210157678972,0.629618236395609
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,23163,0.00138171082607374,0.00286892384465276,-0.00424137990944567,0.00700480156159316,0.630085490111661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,28307,0.00324244295949164,0.00675063651849624,-0.00998880461676099,0.0164736905357443,0.631005981581048
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,27411,0.00220224526210175,0.00458531089608691,-0.00678496409422859,0.0111894546184321,0.631030259717485
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,28428,0.00214687196015345,0.00448157081420332,-0.00663700683568505,0.010930750755992,0.631910640402767
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,27702,0.00162554932228737,0.00341965503306712,-0.00507697454252418,0.00832807318709893,0.634537878858252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,27544,0.00153534352611036,0.00323833749710383,-0.00481179796821314,0.00788248502043386,0.635421851303671
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,27562,0.00132171884284205,0.00279136379623128,-0.00414935419777126,0.00679279188345536,0.635858187096985
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23163,-0.00252179625828055,0.00532892487407214,-0.0129664890114619,0.00792289649490086,0.636055012690569
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,28091,-0.0028261525809532,0.00602804837570423,-0.0146411273973335,0.00898882223542709,0.63919210727591
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,28553,-0.00111516748646671,0.00237909833395856,-0.00577820022102549,0.00354786524809206,0.639262397310324
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,23198,-0.00223240900176719,0.00482162455521335,-0.0116827931299854,0.00721797512645098,0.643369183762129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,27702,-0.00292583197237501,0.00632109221209739,-0.0153151727080859,0.00946350876333587,0.643462548536308
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,23846,-0.0028586110183746,0.00619252544441262,-0.0149959608894233,0.00927873885267414,0.644356044981123
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,27544,-0.000961453666168519,0.00209283095049564,-0.00506340232913997,0.00314049499680293,0.645948130489244
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,23163,-0.00130142325413812,0.00283375437356484,-0.0068555818263252,0.00425273531804896,0.646053498665286
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,23872,0.00187645708125762,0.00410169438828979,-0.00616286391979037,0.00991577808230561,0.647327799328475
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,28224,-0.00206596153211201,0.00451692259798339,-0.0109191298241595,0.00678720675993542,0.647399633902751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,23893,0.000603530014316062,0.00132758292970568,-0.00199853252790708,0.0032055925565392,0.649395305757006
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,23163,0.00113427540822413,0.00250337787257128,-0.00377234522201558,0.00604089603846385,0.650482450650128
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,23775,0.00115189585430265,0.00255437136518695,-0.00385467202146377,0.00615846373006907,0.652029112004726
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,28299,-0.000720439995971512,0.00159838071085774,-0.00385326618925268,0.00241238619730966,0.652186774722142
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,22978,-0.00182686354588088,0.0040556822524438,-0.00977600076067073,0.00612227366890898,0.652393544474555
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,23007,-0.00169157671751093,0.00377135979670709,-0.00908344191905682,0.00570028848403497,0.653773300806434
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,23188,-0.00369047429237461,0.00823985409344234,-0.0198405883155216,0.0124596397307724,0.654243250533516
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,23163,-0.00102610140735844,0.00229944714013877,-0.00553301780203043,0.00348081498731354,0.655429285862327
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,28307,-0.00255381350489623,0.00572311204888986,-0.0137711131207204,0.00866348611092789,0.655435890563396
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,28198,0.0019420124148757,0.00435904738185419,-0.00660172045355852,0.0104857452833099,0.655952466130926
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,28307,-0.00216748704236449,0.00487001423009645,-0.0117127149333535,0.00737774084862455,0.656274085151925
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",23163,-0.00256632486775849,0.0057838854322057,-0.0139027403148817,0.00877009057936469,0.657261779530024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",27544,0.00129105155629437,0.00291177076829507,-0.00441601914956398,0.00699812226215271,0.657486775686277
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,23188,-0.000709657733058498,0.0016061470372151,-0.0038577059260001,0.0024383904598831,0.658610138396004
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,23071,-0.00179463665017388,0.0040720258438181,-0.00977580730405735,0.00618653400370959,0.659417461421694
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,23163,-0.00162400616278975,0.00368811925946709,-0.00885271991134524,0.00560470758576573,0.659698965820462
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,23163,0.00205479103456152,0.0046971081856994,-0.00715154100940931,0.0112611230785323,0.661782772656021
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,22479,0.0014992952177678,0.00342981338688109,-0.00522313902051914,0.00822172945605474,0.662016856239467
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,28276,-0.000892155715744946,0.00205330654618318,-0.00491663654626398,0.00313232511477409,0.663930825932343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,23725,-0.0024061107683752,0.00554179764342747,-0.013268034149493,0.00845581261274263,0.664165214734096
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,23738,-0.00190252570505956,0.00438940513884925,-0.0105057597772041,0.00670070836708497,0.664702075450619
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,23163,-0.00102596782990393,0.00237138287655915,-0.00567387826795986,0.00362194260815201,0.665276451379939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,23287,0.000902996871993058,0.00209176188119176,-0.00319685641514279,0.0050028501591289,0.665969280866405
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,27489,0.00101725799948828,0.00237430070324644,-0.00363637137887474,0.00567088737785129,0.668330301715275
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,23198,-0.00771145349479611,0.0180121116492487,-0.0430151923273236,0.0275922853377314,0.668563357929532
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23056,0.00215133974640892,0.00505400789330143,-0.00775451572446189,0.0120571952172797,0.670352271060467
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,23056,-0.00223099687577017,0.00524838575130523,-0.0125178329483284,0.00805583919678809,0.670780512472932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,23370,0.00287353865425647,0.00676299499381015,-0.0103819315336114,0.0161290088421244,0.670919732098958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,22978,0.00417914683933953,0.00985300382895393,-0.0151327406654102,0.0234910343440892,0.671460746308943
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23056,0.0016346535021965,0.00388612078396994,-0.00598214323438459,0.00925145023877759,0.674022719608656
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,23775,-0.0019657706510367,0.00471034031847761,-0.0111980376752528,0.00726649637317942,0.676440146982658
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,27682,-0.000777925805493343,0.00186712827176009,-0.00443749721814312,0.00288164560715643,0.676942831081307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,23738,0.00219630712537908,0.00530153307432435,-0.00819469770029664,0.0125873119510548,0.67867446166891
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,23071,0.00104144471119747,0.00251822630415398,-0.00389427884494434,0.00597716826733927,0.679198170872881
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,27544,-0.00148839712068223,0.00362705491555853,-0.00859742475517694,0.00562063051381249,0.68154530709629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,23751,-0.00237041521576384,0.00577925318804075,-0.0136977514643237,0.00895692103279603,0.681692698239788
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",28091,0.000969049204946373,0.00236821270062192,-0.00367264768827258,0.00561074609816533,0.682403276230774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,28068,0.00100548620566231,0.00247447023965956,-0.00384447546407043,0.00585544787539506,0.684492938658932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,27965,-0.00276902200402589,0.00684452886970055,-0.016184298588639,0.0106462545805872,0.685804125545746
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,23393,-0.00110768564888302,0.00273854613032553,-0.00647523606432107,0.00425986476655502,0.685863882320995
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,28276,0.00239246260629012,0.00592684244280674,-0.00922414858161109,0.0140090737941913,0.686461668889651
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,23188,0.000918715776031146,0.00228229364808158,-0.00355457977420876,0.00539201132627105,0.6872899533044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,23163,0.00159624769608513,0.00396619506956488,-0.00617749464026204,0.00936999003243229,0.687346856908208
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,22978,0.00121439182272426,0.00303317505954052,-0.00473063129397515,0.00715941493942368,0.688887856947601
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,28078,0.00120405148577166,0.00302575597370453,-0.00472643022268923,0.00713453319423255,0.690681788657301
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,22882,0.000943539103412576,0.00237374457144481,-0.00370900025661924,0.0055960784634444,0.691010063832881
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,27562,0.00247890066324865,0.00624634862552542,-0.00976394264278117,0.0147217439692785,0.691476758080519
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,28091,-0.00124571591587863,0.00313926376254531,-0.00739867289046744,0.00490724105871019,0.691504798298515
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,27702,0.00102380870643178,0.00258397837206441,-0.00404078890281446,0.00608840631567802,0.691950131799571
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23056,-0.00157488310388206,0.00397858522224292,-0.00937291013947818,0.00622314393171406,0.692226744195918
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,28146,0.000808812196634319,0.00206028040625599,-0.00322933739962741,0.00484696179289605,0.694637236240086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,23337,-0.0011467205473716,0.00292263913315261,-0.00687509324835072,0.00458165215360752,0.694797374866281
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,23725,-0.00105858669383693,0.00270674223151586,-0.00636380146760801,0.00424662807993416,0.69573234880948
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,23056,0.000933457391312688,0.00238858497000515,-0.00374816914989741,0.00561508393252279,0.695949187814194
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,23071,0.00133377138006613,0.00342152377573789,-0.00537241522038014,0.0080399579805124,0.696674771043266
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,28428,-0.000733986546473165,0.00188898079718625,-0.00443638890895822,0.00296841581601189,0.697602940184145
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,28307,0.000888830116473348,0.00228995754025129,-0.00359948666241917,0.00537714689536587,0.697913414508243
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,23056,0.00130699751647065,0.00336890411431008,-0.00529605454757711,0.00791004958051842,0.698049773311937
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,27702,-0.00103112060398529,0.00266714542486596,-0.00625872563672258,0.00419648442875199,0.699054722895959
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,23056,0.00158432543392074,0.00410338458928,-0.00645830836106805,0.00962695922890954,0.69942461459541
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,23188,-0.000773381908407606,0.00200816493660541,-0.0047093851841542,0.00316262136733899,0.700152994193307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,28224,-0.00336403781373068,0.00874138163292158,-0.020497145814257,0.0137690701867956,0.700358480737023
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,23846,0.00186033179500152,0.00484114349588247,-0.00762830945692812,0.0113489730469312,0.700777852887388
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,28224,0.00176259696555806,0.00462779869581678,-0.00730788847824282,0.0108330824093589,0.703301415504105
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,23163,0.00157650237605411,0.00414809737867947,-0.00655376848615765,0.00970677323826587,0.703908571647751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,23056,0.00245292388349286,0.00645617894038164,-0.0102011868396552,0.0151070346066409,0.703997680518491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,23188,0.00107967502297489,0.00284918518766024,-0.00450472794483918,0.00666407799078897,0.704734643478409
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,23163,0.00268044508226645,0.0070897096248975,-0.0112153857825326,0.0165762759470656,0.705378019630851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",22978,-0.0014086543081028,0.00374812814574593,-0.00875498547376482,0.00593767685755923,0.707047685797844
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,28414,0.00111302100036597,0.00296473215936218,-0.00469785403198391,0.00692389603271585,0.707350622415106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,23198,-0.00230960983282317,0.00615282457657794,-0.0143691460029159,0.00974992633726959,0.70738583783336
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,23261,0.00212880532028238,0.00574609176201344,-0.00913353453326396,0.0133911451738287,0.711029127056474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,23577,0.00251004907854417,0.00678195472386269,-0.0107825821802267,0.015802680337315,0.711306075346376
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,23795,0.000970837398879651,0.00262325885600223,-0.00417074995888472,0.00611242475664402,0.711319998515655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,28210,-0.00101257782592569,0.00273653491654591,-0.00637618626235568,0.0043510306105043,0.711368958366937
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,28224,0.00100149292854732,0.00270841818960439,-0.00430700672307728,0.00630999258017192,0.711556333471315
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,28553,0.000799430898395788,0.00217675499310547,-0.00346700888809093,0.00506587068488251,0.713429229670292
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,28307,-0.000601796777771651,0.00164007271133367,-0.00381633929198564,0.00261274573644234,0.713671749652474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,23725,-0.0016730297502138,0.0045629462851991,-0.010616404469204,0.00727034496877644,0.713879210501385
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,28428,0.00189925125414328,0.00519558900373225,-0.00828410319317192,0.0120826057014585,0.714703081132954
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,27544,-0.00122985594372924,0.00337190042763336,-0.00783878078189061,0.00537906889443214,0.715310737913499
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",23775,-0.00242252533050108,0.00666218260748111,-0.0154804032411641,0.0106353525801619,0.716142503699781
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23056,-0.00135666644107927,0.00373607042515119,-0.0086793644743756,0.00596603159221706,0.716513667905222
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,27920,-0.00126130549212394,0.00352511681446042,-0.00817053444846636,0.00564792346421849,0.720491727388902
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,23056,0.0028657013129505,0.00810032461445887,-0.0130109349313889,0.0187423375572899,0.723509917183326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,23056,0.00105983506874691,0.00302233667869785,-0.00486394482150087,0.00698361495899469,0.725841060319056
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,27281,-0.000631191829160712,0.00180345440955734,-0.0041659624718931,0.00290357881357167,0.726348564307203
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,23846,-0.00237056107365699,0.00681547306302619,-0.0157288882771883,0.0109877661298743,0.727978084165376
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23393,0.00171911090238216,0.00494964839123807,-0.00798219994444446,0.0114204217492088,0.728354201774114
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,28195,-0.000588851395812196,0.00171888426666132,-0.00395786455846839,0.00278016176684399,0.731918745777226
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,23775,0.00111786504445973,0.00326596977171518,-0.00528343570810203,0.00751916579702149,0.732145767592022
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,23188,0.00216080684106632,0.0063147012047498,-0.0102160075202433,0.0145376212023759,0.732213487914094
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,27544,0.00159411176302148,0.00465865293322571,-0.00753684798610091,0.0107250715121439,0.732215801932552
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,23725,-0.000983016821947446,0.00287661732733791,-0.00662118678352975,0.00465515313963486,0.732559637747235
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,27562,0.00201909556500482,0.00594110877471104,-0.00962547763342882,0.0136636687634385,0.733970847273894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,23725,-0.00109414827285809,0.00326536200192786,-0.0074942577966367,0.00530596125092053,0.737569834968253
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,27544,-0.00167142349595534,0.00500556263214296,-0.0114823262549556,0.00813947926304487,0.73844759310983
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,23393,0.000883574341119245,0.00265103196461713,-0.00431244830953032,0.00607959699176881,0.7389149886225
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,27965,-0.000743814862004478,0.00225697096678685,-0.0051674779569067,0.00367984823289774,0.741732405704223
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,28187,-0.000755410222974649,0.00230751710190946,-0.0052781437427172,0.0037673232967679,0.743391027326013
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,23725,-0.00100997409697669,0.00310319484650761,-0.00709223599613162,0.00507228780217823,0.744833798746292
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23163,-0.00121707871320749,0.00373958120741322,-0.0085466578797374,0.00611250045332241,0.744836982959183
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,28091,-0.000973530091376636,0.00299620657611836,-0.00684609498056863,0.00489903479781535,0.745243370928445
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,22978,-0.000930080498365617,0.00286256924819628,-0.00654071622483032,0.00468055522809909,0.745251322049666
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,28091,-0.000658031516115146,0.00202880274036334,-0.00463448488722729,0.003318421854997,0.745679460408176
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,23393,0.00158953075866025,0.00490182819838364,-0.00801805251017169,0.0111971140274922,0.745734225627406
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,28194,0.000701902429144476,0.00217995489558272,-0.00357080916619766,0.00497461402448661,0.747470042598028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,28091,-0.000735687720806479,0.00229351306996841,-0.00523097333794456,0.0037595978963316,0.74838789790892
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,23163,-0.00159532673660471,0.00517416252522045,-0.0117366852860368,0.00854603181282738,0.757837366773988
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,23071,0.000992057201367919,0.00323259024083183,-0.00534381967066247,0.00732793407339831,0.75892808685753
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,27281,-0.00178597060697954,0.00585432847694065,-0.0132604544217832,0.00968851320782413,0.760316388251654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,27965,-0.00117020310134617,0.0038408001195808,-0.00869817133572454,0.0063577651330322,0.760614507710552
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,23198,-0.000579216386419381,0.00190695211395545,-0.00431684252977206,0.0031584097569333,0.761329205845248
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,22978,-0.00112166631672497,0.00369358091948881,-0.00836108491892303,0.0061177522854731,0.761374517287714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,27544,-0.000933044357312363,0.00309219364292791,-0.00699374389745107,0.00512765518282634,0.762851110537692
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,23071,0.00228337067432462,0.00757948446429945,-0.0125724188757023,0.0171391602243515,0.763221453241705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,23393,-0.000932367343519636,0.00310358514681634,-0.00701539423127967,0.0051506595442404,0.763862357952686
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,23795,0.00138463462743942,0.00462998961782543,-0.00769014502349842,0.0104594142783773,0.76489853806577
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,27702,-0.000640228753914884,0.00215561521215441,-0.00486523456973753,0.00358477706190776,0.766464828495733
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,22978,0.000833891919468131,0.00280805837423976,-0.0046699024940418,0.00633768633297806,0.766496768757741
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,28553,0.00141777540824704,0.00479287496331507,-0.0079762595198505,0.0108118103363446,0.767378124209135
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,27702,0.000912101413346571,0.00309599983542215,-0.00515605826408084,0.00698026109077398,0.768296769520047
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,27562,0.000627235118999411,0.00213054387058244,-0.00354863086734218,0.004803101105341,0.768453408031958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,27918,0.000497466491470043,0.00170580848494722,-0.00284591813902651,0.0038408511219666,0.770571002518655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,22978,0.000811177482051051,0.00278198558935461,-0.00464151427308399,0.00626386923718609,0.770608719383815
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,23872,-0.000855086161542887,0.0029367383800111,-0.00661109338636464,0.00490092106327886,0.770924866012459
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,28187,-0.000842745769705857,0.00289807509974825,-0.00652297296521242,0.00483748142580071,0.771210244583864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,23337,-0.00135311468188324,0.00468663087758351,-0.0105389112019469,0.00783268183818045,0.772799754852387
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,28320,-0.00056306317637935,0.00195676058878929,-0.00439831393040635,0.00327218757764765,0.77353813994018
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,22978,-0.00136757576384333,0.0047552168961683,-0.0106878008803332,0.00795264935264654,0.773659502972955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,28176,-0.00066625435243713,0.00233098906753559,-0.00523499292480689,0.00390248421993263,0.775014457983314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,28176,-0.00129863406873253,0.00455257648347713,-0.0102216839763477,0.00762441583888264,0.775452757583995
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",23795,-0.00080118523731415,0.00286285397680891,-0.00641237903185962,0.00481000855723132,0.779590855292402
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,23188,-0.000584357124640439,0.00210585600602228,-0.0047118348964441,0.00354312064716323,0.78140521323549
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,23393,-0.000432631032762567,0.00157754644985061,-0.00352462207446977,0.00265936000894463,0.783900326731581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,23738,-0.00192591521446511,0.00702423694366607,-0.0156934196240506,0.0118415891951204,0.783947598003073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,28428,-0.0012703735300288,0.00464197164630922,-0.0103686379567949,0.00782789089673728,0.784339371000931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,23163,-0.00145774092001217,0.00534833260000429,-0.0119404728160206,0.00902499097599625,0.785193982666257
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,28115,0.00123107602137297,0.00454936479777617,-0.00768567898226832,0.0101478310250142,0.786697655498591
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,27544,0.00120947210989964,0.00447578135547111,-0.00756305934682372,0.00998200356662301,0.786988482744634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,28378,-0.000535501955159153,0.00198605647775304,-0.00442817265155512,0.00335716874123682,0.787446280276236
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,23071,0.000931670572853522,0.0034563142164331,-0.00584270529135535,0.0077060464370624,0.787504191455677
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,23071,0.000736251471522821,0.00273575056441803,-0.00462581963473652,0.00609832257778216,0.787837981958015
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,27544,0.000879408391007993,0.00326858215797894,-0.00552701263863073,0.00728582942064672,0.7878940791368
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,28553,0.000359674388364878,0.00133700284946237,-0.00226085119658136,0.00298019997331111,0.787919758131439
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,23393,0.00107790902839579,0.00405207419972164,-0.00686415640305864,0.00901997445985021,0.790230665838504
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,23775,0.00180486382241776,0.0068015207369515,-0.0115261168220072,0.0151358444668427,0.790733058610291
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23163,0.000931378424334623,0.00352124081469309,-0.00597025357246384,0.00783301042113308,0.791394781500503
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,27965,-0.000215314034438789,0.000833343692223717,-0.00184866767119727,0.0014180396023197,0.796120468761786
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,23056,0.000699130241276783,0.0027584027545978,-0.0047073391577349,0.00610559964028847,0.799919096260905
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,23056,-0.000653916711643948,0.00258098221589167,-0.00571264185479162,0.00440480843150372,0.799992577334758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,22978,0.00088816281858927,0.00350804434541691,-0.00598760409842788,0.00776392973560642,0.800132234920464
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,28091,0.000923924791877366,0.00366183343770245,-0.00625326874601943,0.00810111832977416,0.800801702643867
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,27702,0.00140155595954354,0.00556915215631756,-0.00951398226683886,0.012317094185926,0.80130253497574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,23862,-0.000429662908176672,0.0017274389304722,-0.00381544321190219,0.00295611739554885,0.803573116314413
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,23845,-0.000629263087726379,0.00254012839027824,-0.00560791473267174,0.00434938855721898,0.804346341872448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,28091,-0.000551085827609247,0.00223084719399013,-0.00492354632782991,0.00382137467261142,0.804886935965173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,27562,-0.000537905079611079,0.00219183986654024,-0.00483391121802996,0.0037581010588078,0.806138816423078
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,28307,0.0011485223526309,0.00468946106755796,-0.0080428213397827,0.0103398660450445,0.806523528639802
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,23188,-0.000607007101898349,0.00249421998971504,-0.00549567828173984,0.00428166407794314,0.807724419414368
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,23393,-0.00124234330080261,0.0051217361274126,-0.0112809461105313,0.00879625950892608,0.808346132174768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,22978,0.00100158117939553,0.00414830974588237,-0.00712910592253392,0.00913226828132498,0.809213789902655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,23337,0.000565084227491519,0.00234819348105878,-0.00403737499538369,0.00516754345036673,0.809831326405466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,23393,-0.00108638302472086,0.00452029731207248,-0.00994616575638292,0.0077733997069412,0.810073122121396
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,23775,-0.0013775955618314,0.00573624958112854,-0.0126206447408433,0.00986545361718055,0.81021128510679
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,28091,0.000243220527663201,0.00103467551834118,-0.00178474348828552,0.00227118454361192,0.814156602055648
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,28176,-0.000764825308005407,0.00326373675647787,-0.00716174935070203,0.00563209873469122,0.814722444244578
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,23163,-0.000565483079721173,0.00241843191019905,-0.0053056096237113,0.00417464346426896,0.815125078607103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,23393,0.000562927399203772,0.00241572128045388,-0.00417188631048583,0.00529774110889337,0.815742763889847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,23071,-0.000929866525245548,0.00403733952778082,-0.00884305199969595,0.00698331894920485,0.817847764829306
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",23071,-0.000612749626857068,0.00267959014353869,-0.00586474630819291,0.00463924705447877,0.819125193799917
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,23056,-0.00115506824603892,0.00510297656717792,-0.0111569023177076,0.0088467658256298,0.820929772889596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,27965,0.000661606561141348,0.00292562947986971,-0.00507262721940328,0.00639584034168598,0.821092936091768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,23337,-0.000439626818769147,0.00194848083044591,-0.00425864924644313,0.00337939560890483,0.821494740029968
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,23775,0.000599603956256663,0.0026764585530068,-0.00464625480763666,0.00584546272014998,0.822736773646231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,23731,-0.000568085358367635,0.00255068224612443,-0.00556742256077152,0.00443125184403625,0.823756143257766
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,28132,-0.000720061119383329,0.00323959286079156,-0.00706966312653478,0.00562954088776812,0.824106084324405
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,28091,0.00176552604990398,0.00794644849228862,-0.0138095129949817,0.0173405650947897,0.824176933924314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,28320,0.000643173288863069,0.00290420494351966,-0.00504906840043546,0.0063354149781616,0.824733714965568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,27544,0.00102044023878334,0.00464901758506756,-0.00809163422794909,0.0101325147055158,0.826265410722558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23188,-0.000726675071317206,0.00332385467153957,-0.00724143022753477,0.00578808008490035,0.826944724443319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,28452,-0.00164877321887926,0.00754909069204748,-0.0164449909752923,0.0131474445375338,0.827113685671782
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,23163,0.000542248062748722,0.00249502060758075,-0.00434799232810954,0.00543248845360699,0.827951459781843
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,27600,0.000723830413903477,0.00334504216598127,-0.0058324522314198,0.00728011305922676,0.828686120208773
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,23337,-0.000371982792439175,0.00174631327039107,-0.00379475680240567,0.00305079121752732,0.831320755316133
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,22978,0.00114188387058018,0.00538669107701293,-0.00941603064036516,0.0116997983815255,0.832122622049878
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,28307,-0.00113626751790705,0.00543248285709112,-0.0117839339178056,0.00951139888199154,0.834323491735846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,23163,0.000588365365817178,0.00283722787480608,-0.00497260126880274,0.0061493320004371,0.835720140853329
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,23163,-0.000689745032872075,0.00332775888507484,-0.00721215244761877,0.00583266238187462,0.835800719760608
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,23071,-0.000649406882315177,0.00313402987938034,-0.00679210544590064,0.00549329168127029,0.835846553783809
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,23287,0.00145406436393795,0.00702723500007485,-0.0123193162362088,0.0152274449640847,0.836075380890363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,28176,0.000582430683822998,0.00282476597804484,-0.00495411063314489,0.00611897200079089,0.836646149847175
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,27682,-0.000429617979023181,0.00210826405485571,-0.00456181552654037,0.00370257956849401,0.838528429961086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,27562,-0.000644257623026346,0.00316583867897854,-0.00684930143382428,0.00556078618777158,0.838743415458071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,27562,-0.000657581031136773,0.00325117318284098,-0.00702988046950509,0.00571471840723154,0.839715264818296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,23393,-0.000618756396630685,0.00307093623647238,-0.00663779142011655,0.00540027862685518,0.840318867386748
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,23393,0.00073434971404642,0.00368377001451137,-0.00648583951439587,0.00795453894248871,0.841992792275228
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,23188,0.00101749221064516,0.00514611785014938,-0.00906889877564762,0.0111038831969379,0.843265603003859
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,28307,0.000326732196622281,0.00165896059323515,-0.00292483056611861,0.00357829495936317,0.843868123721428
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,28091,-0.000307829465850762,0.00156688363503006,-0.00337892139050967,0.00276326245880815,0.844251806100381
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,23188,-0.00120826811329025,0.00618673767479698,-0.0133342739558923,0.0109177377293118,0.845160031273667
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,22978,-0.00116494857156753,0.00599731986816659,-0.0129196955131741,0.010589798370039,0.845985874983056
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,23163,0.000669078127739829,0.00345023513748758,-0.00609338274173583,0.00743153899721549,0.846238288914669
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,23071,-0.000524726565704997,0.00271908905038101,-0.00585414110445177,0.00480468797304178,0.846977264057391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,27870,-0.000743209384831328,0.00391142013428901,-0.00840959284803779,0.00692317407837513,0.849302589765222
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",23738,0.00133979311891249,0.00705387773602347,-0.0124858072436935,0.0151653934815185,0.849360040812407
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,22978,-0.000824657573331695,0.00434401827944797,-0.00933893340104972,0.00768961825438633,0.849438146743172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,23393,-0.00101570572706409,0.00535475439589347,-0.0115110243430153,0.00947961288888711,0.849559211808212
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,23056,0.000808041590782939,0.00434475407938117,-0.00770767640480415,0.00932375958637002,0.852461319547336
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,27544,-0.00181856679584467,0.00994448559673452,-0.0213097585654443,0.017672624973755,0.854899892414551
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,23775,-0.000280800663994148,0.00153976432247141,-0.00329873873603811,0.00273713740804981,0.855297060371963
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",23071,0.000495582851999299,0.00273433348471156,-0.00486371077803537,0.00585487648203397,0.856177275403818
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,22978,-0.000449439944846775,0.00252702948965184,-0.00540241774456438,0.00450353785487083,0.858839939025374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",26796,0.000351019083597088,0.00199186120142181,-0.00355302887118965,0.00425506703838383,0.860117194771997
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,28224,0.000983774285105622,0.00568716109248014,-0.0101630614561554,0.0121306100263667,0.862667123416367
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,23725,0.000726636544562357,0.00421243798901154,-0.00752974191390026,0.00898301500302497,0.863047614743294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,23725,-0.00071555650082344,0.00415891171289013,-0.0088670234580881,0.00743591045644122,0.863396713614277
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,23163,0.000963665713914603,0.00567561007581352,-0.0101605300346799,0.0120878614625091,0.865176237739473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,28428,-0.000419922355682717,0.00247868184262095,-0.00527813876721978,0.00443829405585434,0.865472551453033
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,28320,-0.000494018197010452,0.00292350411100558,-0.00622408625458139,0.00523604986056049,0.86581237700392
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,23163,0.000752871232669,0.0044878606005815,-0.00804333554447074,0.00954907800980874,0.866775706771482
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,23188,0.000461892329446885,0.00280453625155526,-0.00503499872360142,0.00595878338249519,0.869185704800621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,23163,0.000459179206818528,0.00285053430438434,-0.00512786802977477,0.00604622644341183,0.872027614459208
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,23738,-0.000958146280674216,0.00598603317944848,-0.0126907713123932,0.0107744787510448,0.872832302886032
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,23188,0.000320887372225759,0.00201786968145371,-0.00363413720342351,0.00427591194787503,0.873652263009231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,23738,0.000739129748415148,0.00470569843383814,-0.00848403918190761,0.0099622986787379,0.875190063387574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,28152,-0.000492778524816326,0.00316363099720301,-0.00669349527933423,0.00570793822970157,0.876220487777962
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,28276,-0.000791391421446916,0.00520453660325507,-0.0109922831638269,0.00940950032093302,0.879142276284911
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,28428,-0.00126899110514113,0.008384460772812,-0.0177025342198526,0.0151645520095704,0.879700424537524
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,22978,-0.000341249523354488,0.00231558888547287,-0.00487980373888131,0.00419730469217233,0.882840871880366
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,28320,-0.000208927732444756,0.00143967139189597,-0.00303068366056086,0.00261282819567135,0.884615724131712
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,28553,0.000271846308066423,0.00187556625261939,-0.00340426354706758,0.00394795616320043,0.884758537416008
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,27562,-0.000805715371104608,0.00558065848117776,-0.011743805994213,0.0101323752520038,0.885204309170687
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,23795,0.000648932708814615,0.00453784777984157,-0.00824524893967486,0.00954311435730409,0.886287829064329
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,23163,0.000679095778470079,0.00476883403419725,-0.00866781892855654,0.0100260104854967,0.886763014089932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,28237,-0.000296654925683137,0.00209250516706361,-0.00439796505312782,0.00380465520176155,0.88726251639107
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,23188,0.00026507753780024,0.00190910076702185,-0.00347675996556259,0.00400691504116307,0.88957034569265
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,23795,0.000800194724168475,0.00581327029538613,-0.0105938150547883,0.0121942045031253,0.890518465358657
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",23188,0.000272727781117636,0.00198685339112495,-0.00362150486548726,0.00416696042772253,0.89082159194966
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23056,-0.000428918330369043,0.00313256331592569,-0.0065687424295834,0.00571090576884531,0.891093267898135
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,23188,-0.000565767755578264,0.0041582986922142,-0.00871603319231809,0.00758449768116156,0.891777000968147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,23600,0.000275270110881533,0.00204608173252108,-0.00373505008485978,0.00428559030662284,0.892980489437744
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,22833,-0.000739936592568967,0.00553432569739399,-0.0115872149594612,0.0101073417743232,0.89364137758484
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,23071,0.000871681384208117,0.00672433069752155,-0.0123080067829341,0.0140513695513504,0.896859545136774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,23337,0.000287553426686125,0.00221847088038205,-0.00406064949886269,0.00463575635223494,0.896869897568676
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23071,0.000592541295628041,0.0045777144991093,-0.00837977912262619,0.00956486171388227,0.897010293804442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",23198,-0.000559753726407029,0.00435791339202635,-0.00910126397477867,0.00798175652196461,0.897797655551648
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,23071,-0.000496851989830708,0.00388956089019861,-0.00812039133461999,0.00712668735495857,0.898355953420186
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,23692,0.000245125793922327,0.00194076686184742,-0.00355877725529862,0.00404902884314327,0.899492698465688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,23872,0.000222597902916103,0.00179171510072735,-0.00328916369450951,0.00373435950034172,0.901128411572958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,23725,-0.000403401188450793,0.00325653103774863,-0.00678620202243811,0.00597939964553653,0.901415685103581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,23188,-0.000522082770257035,0.00425922925925612,-0.00887017211839903,0.00782600657788496,0.902443275361595
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,28195,-0.000641199609223444,0.00528314492420449,-0.0109961636606642,0.00971376444221735,0.903401195257689
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,28134,0.000935124847147739,0.00777662842291415,-0.014307066861764,0.0161773165560595,0.904287469379188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,23188,0.000502589435571229,0.00418475224026643,-0.00769952495535098,0.00870470382649344,0.904404842628385
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,28553,0.000204109074940722,0.00170752257072132,-0.00314263516367306,0.0035508533135545,0.904852185117249
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,23393,-0.000454278241935268,0.00382749749655725,-0.00795617333518748,0.00704761685131695,0.90552351831588
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,27682,-0.00026317881981217,0.00228081652149041,-0.00473357920193338,0.00420722156230904,0.908138440253168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,22978,0.000358535352992725,0.00319029506759517,-0.00589444297949382,0.00661151368547927,0.910520611276942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,23393,0.000562610274847475,0.00503703956221518,-0.00930998726709428,0.0104352078167892,0.911066495463839
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,28378,-0.000528710172464265,0.00475641191514757,-0.0098512775261535,0.00879385718122497,0.911492353497481
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,23355,0.000412861810812859,0.00373287771313281,-0.00690357850692746,0.00772930212855318,0.911933322382772
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,23071,-0.000372192917188745,0.00347641178207916,-0.0071859600100639,0.00644157417568641,0.914740423936117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,23188,-0.000292830538934961,0.00277286672093386,-0.00572764931196533,0.0051419882340954,0.915896113875641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,28428,0.000247632460769687,0.00236660188069284,-0.00439090722538828,0.00488617214692765,0.916665149321402
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,23188,0.000409249793128097,0.00392689666282591,-0.00728746766601069,0.00810596725226688,0.916997963700192
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,28176,-0.000482040537765788,0.00465050163468544,-0.00959702374174926,0.00863294266621768,0.917445107342061
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,23188,0.0002655735913347,0.00258013580144479,-0.00479149257949708,0.00532263976216648,0.918019352607666
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,28336,-0.000192359922741463,0.00189468152995007,-0.0039059357214436,0.00352121587596068,0.919133434375459
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,23071,0.000323682795824137,0.00319387599404341,-0.00593631415250095,0.00658367974414922,0.919277617309955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,23795,0.000164165334275453,0.00162666129564746,-0.00302409080519356,0.00335242147374447,0.919613511168523
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,28176,0.000198154659831924,0.00198762015183137,-0.00369758083775756,0.00409389015742141,0.920587631648524
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,28187,0.000188291250956125,0.00189726562969048,-0.00353034938323722,0.00390693188514947,0.920945656199036
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,28320,-0.000453963644965209,0.00457758649795038,-0.00942603318094795,0.00851810589101753,0.921003234432637
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,27702,0.000609449734141712,0.00629706270418025,-0.0117327931660516,0.012951692634335,0.922899284524717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,23846,-0.000226306742336612,0.00237042999187287,-0.00487234952640744,0.00441973604173421,0.923941720507091
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,28091,-0.000475068419863537,0.00497969169831759,-0.010235264148566,0.00928512730883895,0.923996866730473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,23795,-0.000445396362712601,0.00467675776866178,-0.00961184158928969,0.00872104886386449,0.924128066413972
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,28553,0.000552200015252015,0.00600999434563416,-0.0112273889021909,0.012331788932695,0.926793797467652
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,23623,-0.000578114985000805,0.00641348482058835,-0.013148545233354,0.0119923152633524,0.928176298732024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,27544,0.000350960297602546,0.00393306054331456,-0.007357838367294,0.00805975896249909,0.928897084542645
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',23071,-0.000260999690309679,0.00295034206385685,-0.0060436701354691,0.00552167075484974,0.929508494556809
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,28404,0.000404571489410658,0.00457819753712276,-0.00856869568334996,0.00937783866217127,0.929583892177715
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,23846,-0.000361951260081713,0.00421084774938859,-0.00861521284888335,0.00789131032871992,0.931501431253045
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,27682,0.000327999333840695,0.00393531926455697,-0.00738522642469097,0.00804122509237236,0.933575772155509
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,23056,-0.000563344768425614,0.00679442379857243,-0.0138804154136276,0.0127537258767763,0.933921588544139
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,23188,-0.000257528539897141,0.00321174980764912,-0.00655255816288942,0.00603750108309514,0.936092203683737
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,23163,-0.00038285375252977,0.00489065278726485,-0.00996853321556888,0.00920282571050934,0.937603814963358
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23278,0.000254335850378792,0.00332467167967108,-0.00626202064177652,0.0067706923425341,0.939022338665551
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,23056,-0.000276703962897977,0.00366039095746729,-0.00745107023953386,0.0068976623137379,0.93974268620458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23163,0.000535853155308201,0.00710365167820877,-0.013387304133981,0.0144590104445974,0.939870475018644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,23188,0.0001645886438676,0.00218974128439998,-0.00412730427355637,0.00445648156129157,0.940085264718073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,27910,-0.000410595522976011,0.00548478730474707,-0.0111607786402803,0.0103395875943283,0.940326009018767
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,23725,-0.000190899711014945,0.00255027906953966,-0.00518944668731269,0.0048076472652828,0.940331158072162
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,27702,0.000158754141539629,0.00218409709999977,-0.00412207617445992,0.00443958445753918,0.942056201242248
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,22397,-0.000118956006737164,0.00167397050995401,-0.00339993820624702,0.00316202619277269,0.943348896704654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,28091,-0.000135685847880555,0.0019415683167525,-0.00394115974871546,0.00366978805295435,0.944285957977886
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",27702,-0.000553213417713093,0.00807325761457146,-0.0163767983422732,0.015270371506847,0.94536886138207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,23393,-0.000397007204441634,0.00588246555816862,-0.0119266396984521,0.0111326252895689,0.946192253452654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23393,-0.000238676342859798,0.00357744686967642,-0.00725047220742558,0.00677311952170599,0.946807610959764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,23725,-0.000167752852844985,0.00252062189948979,-0.00510817177584497,0.00477266607015501,0.946938786556157
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,23163,-0.000299366004819671,0.00476265483258927,-0.00963416947669464,0.0090354374670553,0.949880950583941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,27544,0.00026717808200163,0.00433351775612945,-0.0082265167200121,0.00876087288401536,0.950838934737037
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",23775,-0.000240688980267637,0.00410207998657324,-0.00828076575395119,0.00779938779341591,0.953211574853147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,23738,-8.58454391191321e-05,0.00146610765791727,-0.00295941644863699,0.00278772557039872,0.953308402485121
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,27965,-0.000135525358962528,0.00234194707940517,-0.00472574163459665,0.0044546909166716,0.953853653938512
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23071,-0.000128136082446182,0.00230502655008401,-0.00464598812061084,0.00438971595571848,0.955669031399351
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,23188,0.000248480663050801,0.00448686190481075,-0.00854576867037827,0.00904272999647987,0.955836517063379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,28176,-0.000316536480466059,0.00581430119674008,-0.0117125668260766,0.0110794938651445,0.956584185231178
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23136,-0.000135588806135916,0.0026412193132572,-0.00531237866012003,0.0050412010478482,0.959058475467932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,23188,0.000158661294717107,0.00309295142150995,-0.0059035234914424,0.00622084608087662,0.959088742802129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,28521,-0.000126966365058127,0.00250708330544213,-0.0050408496437247,0.00478691691360844,0.959610306379295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23188,0.00015061606777226,0.00303916753121146,-0.0058061522934022,0.00610738442894672,0.960474780653189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,23393,0.000180390249204734,0.00366055082304747,-0.00699428936396831,0.00735506986237778,0.960696947886778
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,23393,0.000243684416173531,0.00546162984078356,-0.0104611100717622,0.0109484789041093,0.964412553205693
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",27562,-0.000149327821613514,0.00343834140517083,-0.00688847697574834,0.00658982133252131,0.965358926769702
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,23188,-0.000308062881268044,0.00723631829529995,-0.0144912467400559,0.0138751209775199,0.966043265777988
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,23893,-5.4350303433616e-05,0.00132054903526917,-0.00264262641256119,0.00253392580569395,0.967170795929318
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,22981,-0.000171754849561767,0.00428287204253081,-0.00856618405292215,0.00822267435379862,0.96801157606016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,23775,-6.45395820916385e-05,0.00181024520206564,-0.00361262017814029,0.00348354101395701,0.971559826923065
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,28553,-7.31427661957225e-05,0.00217629794532574,-0.00433868673903418,0.00419240120664274,0.973189338490031
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,23862,0.000294153820783301,0.00946451622229834,-0.0182562979749214,0.018844605616488,0.97520628145639
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,23163,0.000104666955781282,0.00344598022633793,-0.00664945428784106,0.00685878819940362,0.975769330863997
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,28036,-0.000113775526322611,0.00384196476840031,-0.00764402647238722,0.007416475419742,0.976375197558751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,27702,0.000104292995949343,0.00380966730819122,-0.00736265492810544,0.00757124092000413,0.97816013312013
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,27773,9.92362399746655e-05,0.00376993672609115,-0.007289839743164,0.00748831222311333,0.978999857766744
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23198,4.5237597064577e-05,0.00178622801398968,-0.0034557693103552,0.00354624450448435,0.979795338244286
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,23795,-0.000196797963937079,0.00790107180478635,-0.0156828987013183,0.0152893027734442,0.980128750223112
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,23188,3.26670388398931e-05,0.00139168106043638,-0.00269502783961541,0.00276036191729519,0.981273114876322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,27702,0.000100929551879672,0.00446474963455464,-0.00864997973184743,0.00885183883560677,0.981964823973796
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,23795,-7.14810263144043e-05,0.00351891054590311,-0.0069685456962845,0.00682558364365569,0.983793539290455
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,22978,-6.8231139602914e-05,0.00337519912527116,-0.0066836214251344,0.00654715914592857,0.983871685703015
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,28320,3.56118786753736e-05,0.00184731434461334,-0.00358512423676678,0.00365634799411753,0.984619749507887
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,27562,-6.35317532628456e-05,0.00331612040174652,-0.00656312774068603,0.00643606423416034,0.984714836019297
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,23188,-6.75665410227049e-05,0.00373231816557609,-0.00738291014555184,0.00724777706350643,0.985556758189781
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,28142,7.62713314185815e-05,0.00454639191109027,-0.00883465681431834,0.0089871994771555,0.98661524928638
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,28307,6.05566782239325e-05,0.00494372849251027,-0.0096291511670962,0.00975026452354406,0.990226889792291
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,28496,2.43299117450191e-05,0.00260565728984198,-0.00508275837634526,0.00513141819983529,0.992550053092139
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,22936,-2.26412963247762e-05,0.00243674830155814,-0.00479866796737872,0.00475338537472917,0.992586561447014
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",22978,-3.1794990787267e-05,0.00350923230449027,-0.00690989030758819,0.00684630032601366,0.992771037427823
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,22978,3.02097007472982e-05,0.0036517205971451,-0.0071271626696571,0.0071875820711517,0.993399463124084
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,23543,-1.29902252580944e-05,0.0021297454872101,-0.00418729138018988,0.0041613109296737,0.995133443952465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",23725,-1.17330361296282e-05,0.00253417075681195,-0.00497870771948106,0.0049552416472218,0.996305901564868
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,23775,-1.35807244800913e-05,0.00364744187899455,-0.00716256680730941,0.00713540535834923,0.997029229881976
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,22978,-1.27647414731599e-05,0.00642282171003138,-0.0126014952931347,0.0125759658101883,0.998414299349745
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,23188,1.17307327551805e-05,0.00597190715889772,-0.0116932072986844,0.0117166687641947,0.998432717838434
